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Abstract 
In this thesis are reported the main research activities done during the period of my PhD 
studies, working under the supervision of Prof. Marco Lombardo and Prof. Claudio Trombini. 
My research has been focused in particular on the study of organocatalysis, and its possible 
application in different fields. 
After a brief introduction on organocatalysis, and in particular enamine and iminium ion 
activation modes, in Chapter two is reported the study of a new efficient protocol for Proline-
catalysed aldol reaction, involving the use of simple Methanol and Water as additives, that 
can be interesting as a scalable process in industrial applications. The protocol has been 
optimized for the reaction of several aromatic aldehydes and some ketones, giving good to 
excellent results if compared to the ones reported for other protocols involving simple 
proline. Moreover, the reaction has been successfully scaled up to medium scale, showing 
the possibility in future to produce aldol products in large quantities in a green,sustainable 
way. 
In Chapter three, the study of the α-Fluorination of Chiral γ-Nitroaldehydes is reported, with 
the construction of fluorinated fully substituted stereocenters. Selective incorporation of 
fluorine atoms inside biologically active molecules is a trend topic in medicinal organic 
chemistry, and not many protocols for the fluorination of α,α-dialkyl aldehydes are reported. 
This study showed how, with commercially available Jorgensen-Hayashi organocatalyst, and 
the use of trifluoroacetic acid as additive, is possible to obtain fluorinated products with good 
yields and selectivity, and the scope has been successfully expanded to several differently 
substituted aldehydes. At the same time, the mechanism of the reaction has been studied, 
together with the determination of the absolute configuration of products, all done by NMR 
spectroscopy.  
Lastly, in Chapter four, the study of Fullerene and Carbon Nanotube as solid support for 
orgacatalysis is reported. This work has been conducted together with Prof. Maurizio Prato 
and co-workers, from the university of Trieste. After many preliminary studies, we 
synthesized a derived of Maruoka trityl pyrrolidine and covalently supported it on fullerene. 
Then, we used this new organocatalyst in the classic Michael addition reaction of Malonate 
to aldehydes, with results comparable to literature. Moreover, this is the first application of 
trityl pyrrolidine in iminium ion activation. Finally, we tried to recover and reuse the catalyst, 
recycling it for 3 cycles. 
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Chapter 1. Introduction to Organocatalysis 
 
Catalysis plays a key-role for the well-being of humanity and is very important enabling 
technology that supports the global economy. Many industrial fields, including chemical, 
petroleum, agriculture, polymer, electronics and pharmaceuticals, rely heavily on catalysis. 
Over 90% of chemicals are produced with catalytic processes. The products generated 
through catalysis have reached a market value of about 900 billion dollars per annum. The 
use of catalysis provides an incredible number of benefits for businesses, the principal being 
cost reduction, time savings and less waste generation. The increasing focus on the 
development of environmentally sustainable manufacturing processes places catalysis as 
the principal technology for the green chemistry movement. Catalysis is one of the twelve 
principles of green chemistry. Compared to stoichiometric, non-selective reactions, catalytic 
transformations prevent waste from the source and increase the yield of the useful product 
in less time using less energy. Catalysis also enables smart synthetic design, allowing shorter 
routes to high-value products. The importance of catalysis in science can be readily 
appreciated by a survey of Nobel Prizes for Chemistry in the past 40 years. Many of these 
are about catalysis, the most important being the pioneering work of Ziegler and the Italian 
Natta on catalysis in polymer synthesis (1963), the fundamental work of Wilkinson and 
Fischer on organometallic compounds (1973), the asymmetric hydrogenation and oxidation 
methodologies of Knowles, Noyori and Sharpless (2001), the award for metathesis given to 
Chauvin, Grubbs, Schrock (2005), and the recent recognition of Heck, Negishi and Suzuki for 
cross-coupling reactions (2010). This is just the simpler outcome of how the scientific 
advances in catalysis have proved to be incredibly efficient in solving problems of 
considerable importance.1 The catalyst should also be able in most case to transfer also 
stereochemical information to the products, opening the route for stereoseletive synthetic 
way, obtaining products with high level of stereochemical purity. In fact, the development 
of efficient methods to provide enantiomerically enriched products is of great current 
interest to both academia and industry. The occurrence of only one enantiomer of a 
molecule in nature is connected to the evidence that enantiomers have different biological 
activity and, in general, they have a different behaviour in a chiral environment.2 Over the 
past few decades, intense research in this field has greatly expanded the scope of catalytic 
reactions that can be performed with high enantioselectivity and efficiency. Consequently, 
thousands of chiral ligands and their transition metal complexes have been developed for 
the homogeneous asymmetric catalysis of various organic transformations. 
                                                          
1 C. A. Busacca, D. R. Fandrick, J. J. Song, C. H. Senanayake, Advanced Synthesis and Catalysis, 2011, 353, 1825–1864. 
2 C. Palumbo, M. Guidotti, ScienceOpen Research, 2015. 
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In particular, in the last twenty years a new area of research was born, different from the 
classic metallocatalysis, based on the use of small organic molecules as catalyst for 
transformations, and the field was named organocatalysis.3 Even if sporadical studies on the 
use of small organic molecules as asymmetric catalyst were reported between 1968 and 
1997, is now widely accepted that the field of organocatalysis started to grow up from the 
late 1990s. Probably the first and most important example of this first unaware use of 
organocatalytic application was the work published by two different research group, guided 
by Hajos and Wiechert, on 1971 , about the use of natural (S)-Proline for promoting an 
intramolecular enantioselective aldol reaction giving as a product a bicyclic precursor in 
steroid synthesis4: 
 
Scheme 1: Hajos‐Parrish Eder‐Sauer‐Wiechert’s reaction 
This and other previous studies were viewed more as unique chemical reactions than as 
small part of a greater research field. Furthermore, there was no emphasis on the potential 
benefit of using organocatalysts, but these works were focused only about the single 
transformation accomplished. The situation changed radically with the publication of two 
works that are now widely accepted as two cornerstones in organocatalysis. The first one is 
from Barbas, Lerner and List, who performed the first Proline catalysed aldol reaction 
between acetone and aromatic aldehydes5: 
 
Scheme 2: Proline-catalysed direct asymmetric aldol reaction 
                                                          
3 Reviews on organocatalysis: a) MacMillan D. W. C., Nature 2008, 455, 304-308; b) M. J. Gaunt, C. C. C. Johansson, A. 
McNally, N. T. Vo, Drug Discovery Today 2007, 12, 8-27; c) J. Seayad, B. List, Org. Biomol. Chem. 2005, 3, 719-724; d) P. 
I. Dalko, L. Moisan, Angew. Chem. Int. Ed. 2004, 43, 5138-5175, e) P. Melchiorre, M. Marigo, A. Carlone, G. Bartoli, 
Angew. Chem. Int. Ed., 2008, 47, 6138. 
4 a) Z. G. Hajos, D. R. Parrish, J. Org. Chem. 1974, 39, 1615; b) U. Eder, G. Sauer, R. Wiechert, Angew. Chem. 1971, 83, 
492; Angew. Chem. Int. Ed. Engl. 1971, 10, 496. 
5 B. List, R. a Lerner, C. F. Barbas III, J. Am. Chem. Soc. 2000, 122, 2395–2396. 
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The impact of this paper has been unquestionably relevant: It showed that the mechanism 
of the Hajos-Parrish reaction could be extended and applied for different transformations 
with a broader applicability; moreover, it was clear that some small organic molecules (such 
as Proline) are able to catalyse transformations of enzymes using the same mechanism. 
The second paper from Macmillan and co-workers was about the use of imidazolidinone as 
organocatalyst for asymmetric Diels-Alder reactions6: 
 
Scheme 3: Asymmetric Diels-Alder cycloaddition reaction 
In this case Macmillan conceptualized Organocatalys, underlining how this activation modes 
can give impressive economic, environmental and scientific benefits, also introducing for the 
first time the term “Organocatalysis” in the literature. But both this paper were the bases 
for the generalization of their activation modes, the enamine catalysis and the iminium 
catalysis, that will be applied to a broad range of reaction classes. Going on, the field of 
organocatalysis became soon an important area of research, and the growing interest is 
explained in Table 1, which shows the exponential growth of publications in organocatalysis. 
 
Table 1: The number of publications on organocatalysis, obtained by searching ‘organocatalysis’ in Scifinder. For the 
year 2014, the number has been calculated until December 15th (see reference 2) 
                                                          
6 K. A. Ahrendt, C. J. Borths, D. W. C. MacMillan, J. Am. Chem. Soc. 2000, 122, 4243-4244 
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This because of the real advantages offered by this new branch, first of all the development 
of easy and cheap methods in carrying out such reactions. Compared to organometallic 
catalyst, that in most cases can be expensive, toxic and very sensible to air and moisture, 
organic molecules are most of the time cheap, easy-available in a single enantiomer from 
nature, nontoxic, stable and environmentally friendly. Because of the absence of transition 
metals, organocatalytic methods seem to be especially attractive for the preparation of 
compounds that do not tolerate metal contamination, e.g. pharmaceutical products. On the 
other side, common limitation of organocatalysis are the need for high catalyst loading, 
usually between 5 and 30 mol%, long reaction times, often more than 24 hours, caused by 
the poor reactivity of substrates and activated intermediate, and the low tolerance on 
different substrates. Despite of this, organocatalysis has become a trend topic in research in 
the last 17 years. 
One of the key point for the success of organocatalysis has been the invention or 
identification of generic modes of catalyst activation, induction and reactivity. A generic 
activation mode describes a reactive species, whose formation allow the reaction to 
proceed. This reactive species can participate in many reaction types providing, in many 
instances, high enantioselectivity. Such reactive species arise from the interaction of the 
substrate with a single chiral catalyst, owning a determined functional group, in a highly 
organized and predictable manner. The value of generic activation modes is that, after they 
have been established, it is relatively straightforward to use them as a platform for designing 
new enantioselective reactions.  
Among the various organocatalytic methodologies, there are different types of activation 
and two main areas can be identified on the mechanistic basis: covalent organocatalysis and 
non-covalent organocatalysis. In the former case, within the catalytic cycle, the catalyst 
covalently binds the substrate, in the latter case only non-covalent interactions, such as 
hydrogen bonding or the formation of ion pairs, activate the molecule towards the 
asymmetric transformation. Between the various types of organocatalysis belonging to this 
category, the most widespread and best known is without any doubt the aminocatalysis, so 
the use of primary and in particular secondary amine as catalyst. The two most important 
types of covalent activation with secondary amine and aldehyde is the enamine and iminium 
ion, depending on the presence or not of alpha protons. Recently aminocatalysis evolved to 
the use of primary amines as catalysts too. 
Enamine catalysis is based on the HOMO (Highest Occupied Molecular Orbital) activation of 
carbonyl compounds with the corresponding increase of electron density at the reaction 
centre allowing their α-functionalization. The reaction can take place with a diverse array of 
13 
 
electrophiles making possible reactions like aldol, Mannich and conjugate additions, α-
oxygenation, amination, chlorination, fluorination, etc.  
 
Scheme 4: α-functionalization of aldehyde via enamine catalysis 
Meanwhile MacMillan’s group presented the concept of asymmetric iminium catalysis. It is 
based on the capacity of chiral amines to work as enantioselective catalysts for several 
transformations that traditionally use Lewis acid catalysts. The reversible formation of 
iminium ions from α,β-unsaturated aldehydes or ketones and chiral amines might emulate 
the equilibrium dynamics and π-orbital electronics involved in Lewis acid catalysis. This 
LUMO (Lowest Unoccupied Molecular Orbital) lowering activates the intermediate toward 
the attack from a wide variety of nucleophiles to afford β-substituted carbonyl compounds 
or toward pericyclic reactions. 
 
Scheme 5: β-functionalization of aldehyde via iminium ion activation 
During my PhD research work I have focused the attention on these two activation modes, 
but other are present, like Hydrogen-bond activation or more recently SOMO catalysis, and 
are not going to be discussed in this work.  
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Chapter 2: New Sustainable Protocol for the direct asymmetric Proline-
catalised aldol reaction 
This chapter is based on the work done principally during my first year of PhD, and treats 
about the development of a new protocol for the asymmetric Proline-catalysed aldol 
reaction. These results will be soon submitted for publication.  
2.1 Organocatalysis in industrial application 
As reported in the introduction, organocatalysis has attracted the interest of a great part of 
academia in the last two decades, studying new activation modes and developing new 
straightforward protocols for organic synthesis. In the last years, there has been a consistent 
increase in the number of chiral, non-racemic pharmaceuticals available in the market. To 
overcome the issue, the use of new enantioselective technologies to minimize the losses 
provoked from making racemic mixtures is becoming more and more important. Due to the 
operational and economic advantages of asymmetric organocatalysis, this methodology 
represents one of the possible proposal. Moreover, several groups have made a remarkable 
effort to show the great applicability of organocatalysis to the total synthesis of drugs 
currently available in the market such as oseltamivir, warfarin, paroxetine, baclofen and 
maraviroc. (Figure 1).  
 
Figure 1: Drugs synthesized using organocatalysis 
These efforts have captured the attention of the companies, that have begun to incorporate 
organocatalysis as a synthetic tool in some industrial scale processes, and in this paragraph 
some important examples will be reported.7  
                                                          
7 J. Aleman S. Cabrera, Chem. Soc. Rev., 2013, 42, 774--793 
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One of the first example was developed by Merck in 1984 for the synthesis of a uricosuric 
drug ((+)-indacrinone)).8 This development represents the first truly catalytic asymmetric 
alkylation using phase-transfer catalysts during the 80’s. In this work, the alkylation of the 
starting compound 1 was achieved using cinchona alkaloid derivatives 3 (by N-alkylation of 
the quinuclidine core), NaOH as base, and CH3Cl as the alkylating reagent (Scheme 24). This 
process allowed the access to both enantiomers of intermediate 2, used for the synthesis of 
the indacrinone, in high yield and enantiomeric purity on a pilot plant scale (B75 kg).  
 
Scheme 6: Synthesis of the enantioenriched intermediate for the synthesis of indacrinone developed by Merck. 
its first industrial scale application for a medicinal compound did not appear until 2010. 
Therefore, Xu and co-workers reported the synthesis of a drug for the treatment of migraine 
(Scheme 7).9 Starting from 1,2-difluorobenzene (4.80 kg, 42.1 mol), with a 3 steps 
procedure, they synthesized aldehyde 4 in 82% yield. The known Hayashi catalyst was 
chosen as catalyst and was prepared in situ from the alcohol in classic conditions (1.3 equiv. 
of TMSCl and 1.7 equiv. of imidazole in THF at 50°C) and used after aqueous workup for an 
organocatalysed addition of Nitromethane to give product 5. This compound was converted 
into compound 6 with a formal Doebner–Knoevenagel reaction, using pyrrolidine as catalyst 
and acylated amino-malonic acid as the reagent. Afterwards, several transformations, 
including a reduction and cyclization, allowed the preparation of the final product. This 
synthesis is environmentally friendly, with only three isolated intermediates and a brilliant 
overall yield of 27%. 
                                                          
8 U. H. Dolling, P. Davis and E. J. J. Grabowski, J. Am. Chem. Soc., 1984, 106, 446–447. 
9 F. Xu, M. Zacuto, N. Yoshikawa, R. Desmond, S. Hoerrner, T. Itoh, M. Journet, G. R. Humphrey, C. Cowden, N. 
Strotman, P. Devine, J. Org. Chem., 2010, 75, 7829–7841 
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Scheme 7: Asymmetric synthesis of telcagepant by Merck. 
Amine catalysis was used also for the asymmetric synthesis of warfarin, an anti-coagulant 
frequently prescribed in the United States of America.10 Racemic warfarin was synthesized 
in 48% yield via a conjugate addition reaction between 4-hydroxycoumarin and 
benzalacetone11, but it was known that the (S)-warfarin is five times more active than the 
(R)- isomer, and a chemical resolution of the racemic mixture using quinine afforded the (S)-
warfarin in only 19% yield. To improve the synthetic efficiency, chiral organocatalysts were 
exploited to perform an enantioselective conjugate addition reaction between 
hydroxycoumarin and benzalacetone, described by Chin group using primary amine 
catalysts. Warfarin was formed in 99% yield and 92% ee through the catalysis of 10 mol% of 
di- amine 7.12 In another report, Chen and co-workers developed another asymmetric 
synthesis of (S)-warfarin using a Cinchona alkaloid-derived catalyst 8 (Scheme 8).13 
 
                                                          
10 E. Bush, W. F. Trager, J. Pharm. Sci., 1983, 72, 830. 
11 M. Ikawa, M. A. Stahmann, K. Paul, J. Am. Chem. Soc. 1944, 66, 902. 
12 H. Kim, C. Yen, P. Preston, J. Chin, Org. Lett. 2006, 8, 5239. 
13 J.-W. Xie, L. Yue, W. Chen, W. Du, J. Zhu, J.-G. Deng, Y.-C. Chen, Org. Lett., 2007, 9, 413. 
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Scheme 8: Organocatalysed synthesis of (S)-warfarin 
Talking about chiral amine catalysis, the most important industrial example was 
implemented even more than 40 years ago, and has been already reported in the 
introduction. Two industrial groups at Schering and Hoffmann-La Roche discovered in 1971 
that L-Proline was able to catalyse the asymmetric intramolecular aldol reactions of 
triketone 9 to afford compound 10 with up to 93% ee which was used to manufacture 
steroids on multi-kilogram scales14 (Scheme 9). This intramolecular transformation is now 
famously known as the Hajos–Eder–Sauer–Wiechert reaction. 
 
 
Scheme 9: The Hajos, Parrish, Eder, Sauer and Wiechert reaction 
This transformation also showed how simple naturally available amino acids like Proline, 
thanks to the easy availability, the low supply costs, the mostly absent toxicity and the poor 
waste production, can be seen as ideal catalyst for industrial application in the synthesis of 
enantiomerically enriched drugs and fine chemicals. Furthermore, the use of Proline as 
catalyst has been extensively studied along the golden age of organocatalysis, principally 
concerning aldol reaction.  
 
                                                          
14 C. Agami, N. Platzer, H. Sevestre, Bull. Soc. Chim. Fr. 1987, 2, 358 
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2.2 Asymmetric aldol reaction catalysed by L-Proline 
The aldol reaction, first discovered by Wurtz in 1872,15 is one of the most powerful 
transformations in organic chemistry. This process consists in the reaction of two carbonyl 
partners to give b-hydroxyketones, forming up to two new stereocenters.16 This 
transformation presents numerous challenges, including issues of chemo-, regio-, diastereo-
, and enantioselectivity to the synthetic chemist, and many powerful stoichiometric 
processes have been proposed to address these issues. Development of catalytic methods 
that avoid the production of stoichiometric by-products while maintaining the high levels of 
control available from stoichiometric processes provides an atom economical alternative. 
Indeed, numerous catalysts for the aldol reaction have been reported in recent years, 
including enzymes, catalytic antibodies and small molecules. The focus of this part of the 
work will be on the use of organocatalysts, in particular simple Proline as catalyst. 
As seen previously, the first works that demonstrates the possibility to use L-Proline as 
catalyst in the asymmetric aldol reaction, were two independent works published in 1971 
by Hajos, Parrish, Eder, Sauer and Wiechert, but the first example of an organocatalysed 
intermolecular direct asymmetric aldol reaction was described only in 2000 by List, Lerner 
and Barbas, and is reproposed in Scheme 10. This work clearly showed how simple could 
have been the use of chiral secondary amine to catalyse the functionalization of carbonyl 
compounds. They reported the use of a catalytic amount of proline to promote the direct 
enantioselective aldol reaction between a ketone, like acetone, and a series of aldehydes. 
 
 
Scheme 10: The List’s approach to aldol reaction 
Of course, the aldehydes which gives the best yields resulted to be the non enolizable ones, 
which can avoid the formation of by-products due to autocondensation. The reaction 
conditions are quite severe with the use of 30% catalyst and DMSO as solvent.  The catalytic 
cycle is reported in Figure 2 and follows the mechanism of type I aldolase:  
 
                                                          
15 A. Wurtz, Bull. Soc. Chim. Fr., 1872, 17, 436. 
16 For reviews on asymmetric aldol addition, see: a) B. List, Tetrahedron, 2002, 58, 5573; b) C. F. Barbas III, Angew. Chem. 
Int. Ed., 2008, 47, 42; c) C. Palomo, M. Oiarbide, J. M. García, Chem. Soc. Rev., 2004, 33, 65; d) H. Wennemers, Chimia, 
2007, 61, 276; e) W. Notz, F. Tanaka, C. F. Barbas III, Acc. Chem. Res., 2004, 37, 580; f) S. Mukherjee, J. W. Yang, S. 
Hoffmann, B. List, Chem. Rev., 2007, 107, 5471; g) B. Alcaide, P. Almendros, Angew. Chem. Int. Ed., 2003, 42, 858; h) B. 
Alcaide, P. Almendros, Eur. J. Org. Chem., 2002, 1595; i) G. Guillena, C. Nájera, D. J. Ramón, Tetrahedron: Asymm., 2007, 
18, 2249; j) L. M. Geary, P. G. Hultin, Tetrahedron: Asymm., 2009, 20, 131; k) B. Schetter, R. Mahrwald, Angew. Chem. 
Int. Ed., 2006, 45, 7506; l) R. Mestres, Green Chem., 2004, 6, 583. 
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Figure 2: Mechanism of the direct Proline catalysed aldol reaction 
The cycle starts with the enamine formation, generally the rate determining step, followed 
by the nucleophilic attach to the aldehyde, activated by proline’s acid group. The hydrolysis 
of the iminium thus formed gives the product. By the energetic point of view, the enamine 
formation and the following addition have similar barrier. This means that, in some cases or 
changing the substrates, the rate determining step changes, like demonstrated in studies by 
Armstrong and Blackmond.17 
 Interesting is also the role of water in the reaction. It has been determined that a little 
amount of additional water, despite a decrease in reaction rate, can limit the formation of 
off-cycle by-product, leading to better yields. After 2001 other works on proline-catalysed 
aldol reaction appeared, introducing the use of different ketones.18 Since the ketone is, in 
most protocols, also the reaction solvent, and is also used in great molar excess, is not 
possible for practical reasons to use solid ketones, or very precious substrates like steroids. 
On the other hand, many examples have been showed with cyclohexanone and 
cyclopentanone. The anti-aldol is the favourite one in both cases: the enantioselectivity of 
the reaction is granted by the geometry of the transition state, where the nucleophilic attack 
of the enamine is governed from the carboxylic acid of the proline, that binds the aldehyde 
via hydrogen bond. In this way the only possible approach is through the Si face of enamine 
(Figure 3). 
 
                                                          
17 N. Zotova, A. Franzke, A. Armstrong and D. G. Blackmond, J. Am. Chem. Soc., 2007, 129, 15100.   
18 B. List, Tetrahedron, 2002, 58, 5573; B. List, P. Pojarliev and C. Castello, Org. Lett., 2001, 3, 573.   
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Figure 3: Transition state in the aldol reaction with cyclohexanone 
It has been demonstrated that cyclohexanone gives the best diastereoselectivity, compared 
to cyclopentanone, probably thanks to the rigid chair conformation, that leads to more 
selectivity. On the other hand, cyclopentanone result to be a more reactive donor, because 
the enamine has a 120°C hybridation sp2 angle, and a stronger reactivity lead to a minor 
control in selectivity. These transformations are usually carried with 10-30 molar percent of 
catalyst and with very long reaction times (also days). 
Without any doubt, Proline represent the most important catalyst for the asymmetric aldol 
reaction. Since is a natural aminoacid, is easily available in an enantiomerically pure form at 
a cheap price. Furthermore, like many organocatalysts, is stable to moisture and oxygen, 
reactions can be carried out at open air, is not toxic and easy to dispose. But despite of this, 
the catalyst shows also great limitations, the most important of those being the low 
solubility in the commonly used organic solvents, together with a poor reactivity, that 
requires high catalyst loadings, and ofter unsatisfactory stereochemical results.19 To 
overcome solubility problems and concomitantly to raise the catalytic system reactivity, a 
huge number of proline derivatives have been designed and employed. Modification of the 
carboxylic acid with different groups able to donate hydrogen-bonding or the introduction 
of bulky substituents on the pyrrolidine ring scaffold were two of the most used strategies 
employed, as recently exhaustively reviewed by Trost20. Moreover, the insertion of strongly 
hydrophobic groups can increase also the solubility in the organic phase. Some of this 
modified catalyst are showed in figure 4: 
                                                          
19 a) W. Notz, B. List, J. Am. Chem. Soc., 2000, 122, 7386; b) B. List, P. Pojarliev, C. Castello, Org. Lett., 2001, 3, 573; 
c) K. S. Sakthivel, W. Notz, T. Bui, C. F. Barbas III, J. Am. Chem. Soc., 2001, 123, 5260; d) A. Córdova, W. Notz, C. F. 
Barbas III, Chem. Commun., 2002, 3024; e) A. I. Nyberg, A. Usano, P. M. Pihko, Synlett, 2004, 1891; f) Y.-Y. Peng, 
Q.-P. Ding, Z. Li, P. G. Wang, J.-P. Cheng, Tetrahedron Lett., 2003, 44, 3871; g) T. Darbre, M. Machuqueiro, Chem. 
Commun., 2003, 1090; h) Y. Hayashi, W. Tsuboi, M. Shoji, N. Suzuki, Tetrahedron Lett., 2004, 45, 4353; i) Y.-S. Wu, 
W.-Y. Shao, C.-Q. Zheng, Z.-L. Huang, J. Cai, Q.-Y. Deng, Helv. Chim. Acta, 2004, 87, 1377. 
 
20 B. M. Trost, C. S. Brindle, Chem. Soc. Rev., 2010, 39, 1600-1632.   
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Figure 4: several examples of organocatalyst for the aldol reaction of aromatic aldehydes and ketones 
Despite the outstanding levels of reactivity and selectivity achieved with these modified 
organocatalysts, it should be pointed out that according to the principle of green chemistry 
a catalyst should be a molecule possessing a low molecular weight, in order not to have a 
too strong impact on the reaction mass efficiency. Moreover, all proline derivatives are 
prepared using multi-step syntheses, increasing exponentially the mass intensity related to 
their preparation. From this point of view unmodified proline is the ideal candidate as a 
22 
 
catalyst, and in this perspective efforts should be directed in optimizing the reaction 
conditions to increment its activity and selectivity, rather to find different and more complex 
catalysts.  
 
An interesting alternative strategy involved the use of unmodified proline together with 
additives, usually water, acids, diols, amines, or thioureas.21 In the reported examples, the 
co-catalyst was able to tune the solubility, the reactivity and/or the stereoselectivity of 
native proline, making the asymmetric aldol process more efficient and, therefore, more 
environmentally sustainable. Nevertheless, the achieved performances were not optimal 
yet (long reaction times, stereocontrol strongly depending on the substrate) and some 
drawbacks were still present, such as high proline loadings (10-30 mol%) and the cost of the 
not recovered chiral additive. Significant advances were accomplished employing metal salts 
as additives. In particular, Reiser and co-workers developed a strategy based on cobalt(II)-
proline system22, which ensured excellent results in direct aldol reactions between aromatic 
aldehydes and both cyclic and acyclic ketones (Scheme 11).  
 
 
Scheme 11: Reiser’s aldol reaction with Proline and CoCl2 
In previous works was demonstrated23 that a metal salt in (II) oxydation state is able to 
chelate an aminoacid, allowing an amino-metallic catalysis. Reiser observed that the 
mechanism of the process could be a transition state in which two molecules of proline are 
involved, bounded trough the carboxylic moiety at the Cobalt(II), while the role of methanol 
is the coordination of the metal to stabilise a C2 symmetry complex (Scheme 12) 
 
                                                          
21  a) P. M. Pihko, K. M. Laurikainen, A. Usano, A. I. Nyberg, J. A. Kaavi, Tetrahedron, 2006, 62, 317; b) R. L. Sutar, 
N. N. Joshi, Synth. Commun., 2014, 44, 352. c) D. E. Ward, V. Jheengut, Tetrahedron Lett., 2004, 45, 8347. d) Y. S. 
Wu, Y. Chen, D.-S. Deng, J. Cai, Synlett, 2005, 1627.  e) Y. Zhou, Z. Shan, Tetrahedron: Asymm., 2006, 17, 1671; f) 
Y. Zhou, Z. Shan, J. Org. Chem., 2006, 71, 9510. g) O. Reis, S. Eymur, B. Reis, A. S. Demir, Chem. Commun., 2009, 
1088; h) N. El-Hamdouni, R. Rios, A. Moyano, Chem. Eur. J., 2010, 16, 1142; i) A. Sıtkı Demir, S. Basceken, 
Tetrahedron: Asymm., 2013, 24, 515 
22 A. Karmakar, T. Maji, S. Wittmann, O. Reiser, Chem. Eur. J. 2011, 17, 11024 – 11029.   
23 a) Z. Damaj, A. Naveau, L. Dupont, E. H_non, G. Rogez, E. Guillon, Inorg. Chem. Commun. 2009, 12, 17; b) M. L. 
Caroline, A. Kandasamy, R. Mohan, S. Vasudevan, J. Cryst. Growth 2009, 311, 1161; c) H. J. Hsu (J. H. Biotech Inc., 
Ventura), US-A 005504055A, 1996; d) M. Kunimura, S. Sakamoto, K. Yamaguchi, Org. Lett. 2002, 4, 347.   
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Scheme 12: Hypothesis for the Cobalt-Proline Interaction 
This hypothesis has been subsequently confirmed by computational investigation of Guillon 
et co-workers. Is interesting to see the compared results in presence of cobalt and without 
it. In detail, without metal the reaction with 10% Proline in methanol gives worst yields and 
also poor selectivity (only 4:1 diastereomeric ratio and 67% enantiomeric excess). By the 
way, this work by Reiser demonstrate the interest in coming back to proline as catalyst for 
the direct aldol reaction. 
 
The role of the solvent in determining the aldol reaction efficiency was also addressed by 
several authors. Invariably, the use of unmodified proline (without additives) forced to 
choose polar aprotic solvents (DMSO or DMF) to obtain acceptable yields and selectivities. 
A peculiar case was represented by ionic liquids (ILs)24, which allowed in some instances to 
decrease the catalyst loading (up to 1 mol%) and to confine proline in a separate phase, 
enabling a simple product isolation and the reuse of the catalytic system.  
A number of research groups noticed that protic media were not suitable for aldol 
condensations promoted exclusively by native proline. However, although a plethora of 
studies focused on the use and the role of water (as solvent, co-solvent or additive), very 
few authors extended their investigations to alcohols. Alcoholic media were long-neglected 
because of the much worse recorded outcomes, in terms of reaction yield and/or 
stereoselectivity. Only when proline was used in combination with metal salts as additives, 
the use of methanol as solvent or co-solvent afforded acceptable results.  
 
 
 
                                                          
24 a) T. P. Loh, L. C. Feng, H. Y. Yang, J. Y. Yang, Tetrahedron Lett., 2002, 43, 8741; b) P. Kotrusz, I. Kmentová, B. Gotov, S. 
Toma, E. Solčániová, Chem. Commun., 2002, 8, 2510; c) M. Gruttadauria, S. Riela, A. Aprile, P. L. Meo, F. D’Anna, R. Noto, 
Adv. Synth. Catal., 2006, 348, 82; d) T. Kitazume, Z. Jiang, K. Kasai, Y. Mihara, M. Suzuki, J. Fluorine Chem., 2003, 121, 
205; e) A. Córdova, Tetrahedron Lett., 2004, 45, 3949; f) W. Miao, T.-H. Chan, Adv. Synth. Catal., 2006, 348, 1711. 
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2.3 Aim of the work 
 
This project started with the aim to develop a really sustainable and scalable protocol for 
the proline catalysed direct asymmetric aldol reaction. An efficient protocol involving simple 
proline as catalyst would be an excellent tool for subsequent applications, due to the 
incredible advantages of the simple amino acid, that would allow to avoid the time- and 
cost-consuming catalyst preparation, and the waste of additives. On the other side, we had 
to face off the problem related to the low reactivity and poor solubility. 
We were intrigued by the depth exploration of the methanol impact on the asymmetric 
intermolecular aldol condensation promoted by unmodified proline. Indeed, the 
development of an aldol approach based on the combination of simple unmodified proline 
with methanol would be highly desirable as a sustainable process. Moreover, methanol 
could be advantageous from an operational point of view compared with DMSO, usually 
required for aldol reactions catalysed by native proline. In this way, the reaction work-up 
and the products isolation would become easier. 
All these factors could give the possibility of further exploitation of the direct asymmetric 
aldol reaction at production levels. Parameters taken in consideration has been the 
reproducibility, selectivity ad reactivity, and has been compared with data reported in 
literature, to investigate the effective benefits of the new approach.  
 
 
2.4 Results and discussion 
 
Reiser’s work has been choosed as the starting point for the development of the new 
protocol for Proline catalysed aldol reaction. As fully demonstrated by literature, the 
employement of a minimal amount of water in the reaction mixture, despite a decrease in 
reactivity, plays a key role in improving the stereoselectivity of the reaction. Then we 
decided to use a mixture of methanol and water as co-solvent of the reaction. As model 
reaction we chose non enolizable aldehydes as acceptors, like differently substituted 
benzaldehydes, to limit the autocondensation, and cyclic ketones as cyclohexanone. The 
objective is to have a direct correlation between the literature results and the obtained data. 
We considered as model reaction the addition of cyclohexanone (11a, 5 equivalents) to 
some differently substituted aromatic aldehydes (12a-d, 0.3 mmol) mediated by (S)-proline 
(10 mol%) at room temperature and in the presence of a mixture MeOH/H2O (20 πL/10 µL) 
(Table 2).  
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R 
(12) 
Reaction conditions Time (h) 
Conv. 
(%)a 
ee 13 
(%)b 
dr 13 
(syn:anti)a 
4-NO2Ph 
12a 
MeOH/H2O 
(20μL/10μL) 
19 100 98 1:13 
no MeOH 19 25 99 1:19 
no H2O 19 100 76 1:1.4 
4-CNPh 
12b 
MeOH/H2O 
(20μL/10μL) 
20 81 98 1:24 
no MeOH 20 30 77 1:2.6 
no H2O 20 100 98 1:1.5 
4-ClPh 
12c 
MeOH/H2O 
(20μL/10μL) 
19 43 99 1:32 
no MeOH 19 5 100 nd 
no H2O 19 64 98 1:5.6 
Ph 
12dc 
MeOH/H2O 
(20μL/10μL) 
30 55 97 1:7 
no MeOH 30 37 >99 >1:99 
no H2O 30 55 83 1:3.7 
Table 2:  a Determined by 1H NMR on the crude mixture. b Determined by chiral stationary phase (CSP)-HPLC on the 
crude mixture. c 20 mol% of (S)-proline were used. eq. = equivalents, rt = room temperature, h = hours, Conv. = 
conversion, nd = not determined.  
 
The MeOH/H2O ratio and the mixture amount were optimized to the minimum necessary to 
make proline soluble. To have a clear understanding about the role of each additive on the 
process performance, the corresponding transformations were also carried out in the 
absence of MeOH or H2O (Table 2). For all the tested aldehydes, the best balance between 
conversion and stereoselectivity was achieved employing the mixture MeOH/H2O as 
additive. Without MeOH the conversions dropped down. On the other hand, in the absence 
of H2O a significant loss of the stereocontrol occurred. These preliminary findings confirmed 
the “stereoselectivity enhancer” role played by water, and, interestingly, they suggested 
that methanol considerably increased the reaction rate. The two protic additives seemed to 
act on the aldol reaction behavior in two distinct and independent ways, and, appearing 
these effects as additive, the use of MeOH/H2O mixture allowed to considerably improve 
the process performance. 
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In detail in figure 5 are showed the chiral HPLC chromatogram for the reaction of 4-NO2-
benzaldehyde 12a with cyclohexanone 11a, both with and without water: 
 
Figure 5: Chiral HPLC chromatogram for reaction between pNO2-benzaldehyde and Cyclohexanone with and without 
water. 
 
As is clearly visible, the reaction without water is extremely less selective, both in diastereo 
and enantioselectivity. It is noteworthy that both the accelerating effect exerted by 
methanol and the selectivity gave by water were observed (with slight difference) for 
differently substituted aldehydes, therefore it appeared as generalizable. Thus, we extended 
the developed protocol to a larger number of aldehydes (Table 3).  
 
 
 
 
 
 
 
 
 
 
 
(S,R) 
(R,S) 
(R,R
) 
(S,S) 
(S,S) 
(R,R
) (R,S) 
(S,R) 
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R 
(12) 
Time (h) 
Conv. 
(%)b 
ee 13 
(%)c 
dr 13 (syn:anti)b 
C6F5 
12e 
19 100 >99 >1:99 
2-NO2Ph 
12f 
19 93 95 1:5 
4-BrPh 
12g 
19 40 99 1:49 
2-naphthyl 
12h 
24 37 95 1:10 
4-MeOPh 
12id 
70 18 90 1:6 
i-Pr 
12j 
48 30 >99 >1:99 
Table 3: MeOH/H2O-based protocol applied to different aldehydes (12).a Reaction conditions: 11a (5 equiv.), 
12 (0.3 mmol), (S)-proline (10 mol%), MeOH/H2O (20 µL/10 µL), rt. b Determined by 1H NMR on the crude 
mixture. c Determined by CSP-HPLC on the crude mixture. d 20 mol% of (S)-proline were used. 
 
For the most reactive electron-poor aldehydes (12e and 12f) we achieved high 
conversion and stereocontrol in only 19 hours. These results were excellent if 
compared with those reported in the literature for analogous transformations 
promoted by unmodified (S)-proline and exploiting more complex protocols.25 For the 
less reactive substrates 12g and 12h the conversions reached after 19 and 24 hours, 
respectively, were modest, but the enantio- and the diastereoselectivities were both 
higher than what described so far for proline-based protocols.26The electron-rich 
para-metoxy substituted aldehyde 12i is usually not considered in the scope 
screening of aldol reactions mediated by proline, because of the incredibly poor 
reactivity. The only example we found reported low conversion (15%) and absence of 
diastereoselection employing (S)-proline (20 mol%) in DMSO.27 By adding a Lewis acid 
and water the conversion even decreased. Exploiting our MeOH/H2O-based protocol 
the product conversion remained poor (18%), but we obtained good enantio- and 
diastereoselectivities. Lastly, we tested the aliphatic iso-butyl aldehyde 12j. Also in 
                                                          
25  For aldehyde 12e, see: a) W. Clegg, R. W. Harrington, M. North, F. Pizzato, P. Villuendas, Tetrahedron: 
Asymm., 2010, 21, 1262. See also ref. 15l. For aldehyde 12f, see: b) R. Tan, C. Li, J. Luo, Y. Kong, W. Zheng, D. 
Yin, Journal of Catalysis, 2013, 298, 138; c) A. Martínez-Castañeda, H. Rodríguez-Solla, C. Concellón, V. del Amo, 
J. Org. Chem., 2012, 77, 10375; d) Y. Qian, X. Zheng, X. Wang, S. Xiao, Y. Wang, Chemistry Letters, 2009, 38, 
576; e) B. Rodríguez, A. Bruckmann, C. Bolm, Chem. Eur. J., 2007, 13, 4710; f) B. Rodríguez, T. Rantanen, C. 
Bolm, Angew. Chem. Int. Ed., 2006, 45, 6924.  
26 For aldehyde 12g, see: a) A. Obregón-Zúñiga, M. Milán, E. Juaristi, Org. Lett., 2017, 19, 1108; b) Á. Martínez-
Castañeda, B. Poladura, H. Rodríguez-Solla, C. Concellón, V. del Amo, Org. Lett., 2011, 13, 3032. See also ref.s 
12, 15l and 18a,d. For aldehyde 12h, see ref. 6d.  
       27 R. Fernandez-Lopez, J. Kofoed, M. Machuqueiro, T. Darbre, Eur. J. Org. Chem., 2005, 5268 
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this case, the recorded stereoselection data were superior than those reported in the 
literature for unmodified proline.28 
The results provided by the MeOH/H2O-based protocol were very promising in terms 
of both reaction rate and stereocontrol for a variety of aldehydes (Tables 2-3). These 
findings demonstrated the potential of the MeOH/H2O mixture as additive in the 
asymmetric direct aldol condensation catalysed by native (S)-proline. Therefore, we 
focused our attention on the further improvement of the reaction performance. As 
observed during the preliminary studies (Table 2), the presence of a small amount of 
methanol in the reaction mixture exerted the main effect of increasing the reaction 
rate. Thus, we doubled the methanol volume (40 µL) and the product conversions 
resulted significantly improved for all the tested aldehydes maintaining an excellent 
level of enantiocontrol (Table 4).  
 
R 
(12) 
MeOH/H2O  
(μL/μL) 
Time (h) 13, Conv. 
(%)b 
ee 13 
(%)c 
dr 13 
(syn:anti)b 
4-NO2Ph 
12a 
20/10 
40/10 
20+20d/10 
4 
4 
4 
13aa,47 
13aa,82 
13aa,84 
97 
98 
97 
1:16 
1:11.6 
1:16 
4-CNPh 
12b 
20/10 
40/10 
4 
4 
13ab,65 
13ab,77 
97 
95 
1:19 
1:16 
4-ClPh 
12c 
20/10 
40/10 
19 
19 
13ac,43 
13ac,64 
99 
98 
1:32 
1:19 
Ph 
12d 
20/10e 
40/10 
30 
30 
13ad,55 
13ad,75 
97 
98 
1:7 
1:9 
C6F5 
12e 
20/10 
40/10 
4 
4 
13ae,63 
13ae,67 
>99 
>99 
>1:99 
>1:99 
2-NO2Ph 
12f 
20/10 
40/10 
4 
4 
13af,34 
13af,59 
>99 
>99 
1:49 
1:32.3 
4-BrPh 
12g 
20/10 
40/10 
19 
19 
13ag,41 
13ag,88 
99 
96 
>1:99 
1:16 
2-naphthyl 
12h 
20/10 
40/10 
24 
24 
13ah,37 
13ah,72 
95 
93 
1:10 
1:12 
4-MeOPh 
12ie 
20/10 
40/10 
70 
70 
13ai,18 
13ai,30 
90 
90 
1:6 
1:4 
i-Pr 
12je 
20/10 
40/10 
72 
72 
13aj,51 
13aj,63 
>99 
99 
>1:99 
>1:99 
4-CF3Ph 
12k 
40/10 4 13ak,78 96 1:31 
                                                          
28 G. Szőllősi, M. Fekete, A. A. Gurka, M. Bartók, Catal. Lett., 2014, 144, 478.  
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2-thiophen 
12le 
40/10 48 13al,65 86 1:5 
4-MePh 
12m 
40/10 40 13am,64 94 1:6.6 
Table 4: Optimization of the MeOH/H2O-based protocol. a Reaction conditions: 11a (5 equiv.), 12 (0.3 mmol), 
(S)-proline (10 mol%), rt. b Determined by 1H NMR on the crude mixture. c Determined by CSP-HPLC on the 
crude mixture. d 20 µL of MeOH added after 2 h. e 20 mol% of (S)-proline were used.  
 
For the most reactive substrates (12a, 12b, 12e and 12f) good conversions were 
achieved in only 4 hours, demonstrating for the MeOH/H2O/(S)-proline catalytic 
system an unprecedented reactivity. Moreover, interesting amounts of product were 
obtained exploiting these reaction conditions also for less electrophilic aldehydes 
(12c-d, 12g-i; Table 4). Concerning the diastereocontrol, the increased methanol 
volume produced a drop in the aldol syn:anti ratio, which however in most cases was 
slight. For benzaldehyde 12d and 2-naphthyl aldehyde 12h the diastereoselection 
resulted even improved. The most relevant diastereoselectivity deterioration was 
observed for the extremely reactive para-nitro benzaldehyde 12a. We overwhelmed 
this problem by adding the methanol in two separated portions and obtaining a 
complete restore of the diastereocontrol while maintaining a high reaction rate. In 
conclusion, the diastereoselectivity level reached with this protocol (40 μL MeOH/10 
μL H2O) remained excellent if compared with the published data obtained employing 
the simple proline as organocatalyst. At the same time, the reaction rates resulted 
significantly enhanced. Therefore, these reaction conditions demonstrated to 
represent the best balance between reactivity and stereoselectivity, and they were 
applied to some other aldehydes (12j-m, Table 4) with good results. 
The next step of our investigation concerned the ketone partner (11) of the 
asymmetric aldol condensation.  
First of all, we aimed to increase the sustainability of the process and, therefore, we 
planned to use unmodified proline in the presence of a lower excess of ketone, 
exploiting the accelerating effect of methanol additive (Table 5). Some aldehydes 
showing high or medium reactivity were selected for this study in which the ketone 
amount was decreased up to 2 equivalents. With almost all the tested substrates, 
high conversions and excellent ee values were obtained, although longer reaction 
times were required. However, the most considerable impact of the ketone 
decrement was observed on the diastereocontrol, which significantly decreased. One 
speculation could be that dilution helps to have isolated micellar-type transition 
states, while increased concentration disfavours it. Therefore, considering the 
excellent performance achieved employing the MeOH/H2O/(S)-proline protocol in 
the presence of 5 equivalents of 1a, we decided to maintain these as optimal reaction 
conditions.  
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R 
(2) 
1a 
(eq.) 
Time (h) 
Conv. 
(%)b 
ee 3 
(%)c 
dr 3 (syn:anti)b 
4-NO2Ph 
2a 
5 
5 
2 
1.05 
4 
19 
19 
19 
82 
>99 
99 
92 
98 
98 
95 
97 
1:11.6 
1:11.6 
1:11.3 
1:9.4 
4-CNPh 
2b 
5 
2 
4 
24 
77 
98 
95 
87 
1:16 
1:9 
C6F5 
2e 
5 
2 
4 
24 
67 
>99 
>99 
92 
>1:99 
>1:99 
2-NO2Ph 
2f 
5 
2 
4 
24 
59 
92 
>99 
93 
1:32.3 
1:15.7 
4-BrPh 
2g 
5 
2 
19 
24 
88 
97 
96 
91 
1:16 
1:9 
4-CF3Ph 
2k 
5 
3 
2 
4 
20 
24 
78 
96 
93 
96 
96 
94 
1:31 
1:19 
1:13.3 
Table 5: Effects of the cyclohexanone (11a) amount in the MeOH/H2O/(S)-proline-based protocol. a Reaction 
conditions: 12 (0.3 mmol), (S)-proline (10 mol%), MeOH/H2O (40 L/10 L), rt. b Determined by 1H NMR on the 
crude mixture. c Determined by CSP-HPLC on the crude mixture. 
  
Afterwards, we focused on the application of the developed catalytic system to 
different donor ketones (Table 6). For each ketone we tested three differently 
reactive aldehydes (12a, 12g and 12d).  
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R1/R2 
(11) 
R 
(12) 
Time (h) 
Prod. 
(13) 
Conv. 
(%)b 
ee 13 
(%)c 
dr 13 
(syn:anti)b 
-(CH2)2- 
11b 
4-NO2Ph 
12a 
4 13ba >95 94 1:1.6 
-(CH2)2- 
1b 
4-BrPh 
12g 
19 13bg 64 93 1:3 
-(CH2)2- 
11b 
Ph 
12d 
30 13bd 70 93 1:2.7 
H/H 
11c 
4-NO2Ph 
12a 
4 13ca >99 11 / 
H/H 
11cd 
4-NO2Ph 
12a 
4 13ca >99 11 / 
H/H 
11ce 
4-NO2Ph 
12a 
3 13ca 5 96 / 
H/H 
11cf 
4-NO2Ph 
12a 
4 13ca >99 23 / 
H/H 
11cd,f 
4-NO2Ph 
12a 
4 13ca >99 53 / 
H/H 
11c 
4-BrPh 
12g 
19 13cg 43 60 / 
H/H 
11c 
Ph 
12d 
30 13cd 58 51 / 
-CH2OCH2- 
11d 
4-NO2Ph 
12a 
24 13da >99 69 1:3.8 
-CH2OCH2- 
11d 
4-BrPh 
12g 
24 13dg 90 83 1:4 
-CH2OCH2- 
11d 
Ph 
12d 
48 13dd 82 84 
1:3.35 
 
Table 6: Ketones (11) scope of the MeOH/H2O/(S)-proline-based protocol. a Reaction conditions: 12 (0.3 mmol), 
11 (5 eq.), (S)-proline (10 mol%), MeOH/H2O (40 µL/10 µL), rt. b Determined by 1H NMR on the crude mixture. 
c Determined by CSP-HPLC on the crude mixture. d %), MeOH/H2O (20 µL/10 µL. e reaction at 0°C. f 11 eq. of 11. 
 
Under our conditions, cyclopentanone 11b showed high reaction rates, similar to 
those observed for cyclohexanone 11a in the presence of the same acceptors. The 
corresponding products 13ba, 13bg and 13bd (Table 6) were obtained with excellent 
ees, whereas the diastereoselectivities were significantly lower than those recorded 
employing cyclohexanone 11a. This behaviour might be due to the greater tendency 
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of cyclopentanone 11b, compared to cyclohexanone 11a, to assume a sp2 
hybridization and a 120° angle in the formation of intermediate enamine. This 
hypothesis is supported also by the literature data concerning the use of 
cyclopentanone 11b in the presence of unmodified proline as organocatalyst coupled 
with an additive.29 In fact, the aldol adduct 13ba was usually isolated with low or 
moderate diastereomeric ratio and, in many cases, the favourite isomer was the syn 
one. In summary, the most remarkable benefits of our protocol applied to 
cyclopentanone 11b were the high reaction rates and the excellent ees of the major 
anti isomer. These results were not trivial because obtained by using the simple 
unmodified proline. Switching from cyclopentanone to simpler acetone the reaction 
shows incredible reactivity, especially with the reactive aldehyde 12a, with full 
conversion after 4 hours, but resulted in an extremely poor enantioselectivity, with 
only 11% ee. This could possibly be due to an excess of reactivity in the MeOH/H2O 
system. Several conditions have been experimented in order to reduce the reactivity, 
in particular the reaction at 0°C resulted in a significant drop in reactivity with only 
5% of 13ca observed after3 hours, but with 96% excess.  
Then we diluted the reaction mixture using 11 equivalents of acetone, slightly 
improving the selectivity, but the maximum was reached using MeOH/H2O in 2:1 ratio 
with 11 eq. of ketone, but consisted in only 53% ee. Furthermore, the use of less 
reactive aldehydes 12g-12d results were not excellent with a maximum 60% ee. 
Considering these results, we observed that acetone is not the ideal partner for this 
aldol reaction protocol. Finally, to expand the scope of the ketones used, we switched 
to protected dihydroxyacetone 11d, that gave good results both with reactive 
aldehyde 12a, with quantitative conversion, but only 69% ee after 24 hours, while 
with less reactive aldehydes 12g-12d, with a decrease in conversion, the ee was 
improved up to 84%. Ketone 11d is interesting because is a useful building block for 
the synthesis of modified carbohydrates.30 One possible explanation in this difference 
in enantiomeric excess can be due to the presence of supplementary oxygen atoms, 
that can in some way interfere in the transition state. 
Finally, since this newly developed protocol is thought for possible industrial 
applications, we decided to perform one of the studied reactions on a medium scale, 
working on 10 millimol of limitating reagent, to check if any variations are visible 
changing the amount of material used. We decided to use as a model the reaction 
between cyclohexanone 11a and simple benzaldehyde 12d, not one of the most 
reactive ones.  
                                                          
29 Z. Wang, J. Yan, X. Zhang, L. Wang, Synthesis, 2009, 22, 3744 
30 D. Enders, C. Grondal, Angew. Chem . Int. Ed. 2005, 44, 1210 –1212 
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Scheme 13: application of the Proline/MeOH/H2O protocol on medium scale 
The results are very good and comparable to the trials performed on 0,3 mmol scale, 
and in this case the product has been purified via flash chromatography leading to 
the aldol 13ad in a good 78% yield.  
 
Peak RetTime(min) Width(min) Area(mAU*s) Area(%) 
1 6.274 0.1298 1897.90527 17.6824 
2 6.758 0.1338 339.73563 3.1652 
3 7.430 0.1622 8266.51172 77.0173 
4 9.263 0.1900 229.16388 2.1351 
Figure 6: Chiral HPLC chromatograph and area(%) of the adduct 3ad produced on 10 mmol scale 
 
This trial is a starting point that gives us promising signal for the use of this reaction 
protocol on a medium large scale or even at production levels.  
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2.5 Conclusion 
 
In this chapter a new efficient protocol for Proline catalysed aldol reaction has been 
studied and developed. The procedure involves the use of MeOH and water as 
stochiometric additives that increase the solubility of the catalyst and the reactivity 
of the reaction, allowing to shorten the reaction time without losing selectivity. The 
implemented additives are absolutely advantageous for the use of the reaction ad a 
production level, and are perfectly accepted as green reagents. The scope of the 
reaction has been expanded successfully on aromatic aldehyde and some aliphatic, 
and on a moderate number of ketones, with results comparable and in many case 
superiors to other reported protocols that involves simple proline. The reaction has 
been finally scaled up to 0.3 mmol to 10 mmol scale with absolutely comparable 
results. 
 
2.6 General Procedures and Products Characterization  
General Information. 1H and 13C NMR spectra were recorded on Varian Gemini 200 or Inova 
400 NMR instruments with a 5 mm probe. Chemical shifts (δ) are reported in ppm, relative 
to the residual peaks of deuterated solvent signals. HPLC-MS analyses were performed on 
an Agilent Technologies HP1100 instrument coupled with an Agilent Technologies MSD1100 
single-quadrupole mass spectrometer. A Phenomenex Gemini C18, 3 μm (100 x 3mm) 
column was employed for the chromatographic separation: mobile phase H2O/CH3CN, 
gradient from 30% to 80% of CH3CN in 8 min, 80% of CH3CN until 22 min, then up to 90% of 
CH3CN in 2 min, flow rate 0.4 mL min−1. CSP-HPLC analyses were performed on an Agilent 
Technologies Series 1200 instrument using Daicel® chiral columns and n-hexane/2-propanol 
(n-Hex/IPA) mixtures. Flash chromatography purifications were carried out using Merck 
silica gel 60 (230-400 mesh particle size). Thin layer chromatography was performed on 
Merck 60 F254 plates. Commercial reagents were used as received without additional 
purification. Ketone 2d was prepared according to literature.31 All synthesized compounds 
were already known in literature and were not characterized.  
General Procedure for the aldol condensation between aromatic aldehydes and Ketones. 
The aldol reaction was conducted in a 2 mL vial. In a typical reaction, the vial was charged 
with of S-Proline (0.03 mmol), methanol (40µL), water(10µL), the corresponding aldehyde 
(0.3 mmol) and the Ketone (1,5 mmol) successively at room temperature. The flask was 
capped with a stopper and sealed. Then, the reaction mixture was stirred at room 
temperature for the desired time. After the reaction was completed, the mixture was 
filtered on a pad of silica with EtOAc and concentrated under vacuum. The conversion the 
                                                          
31 M. Majewski, D. M. Gleave, P. Nowak, Canadian Journal of Chemistry, 1995, 73, 1616-1626, 
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aldehyde and the diasteroisomeric ratio were determined by 1H-NMR in CDCl3. The 
enantiomeric excess was determined by chiral HPLC of the crude product.  
 
Chiral-HPLC Condition: All separation conditions were optimized performing the reaction 
catalysed by (RS)-Proline, to ensure the best separation of the enantiomers. 
  
13ab: CSP-HPLC: AD 90/10 n-Hex/IPA, flow rate 1 mL/min at 40 °C; λ 220 nm; tR = 13.9 min 
(syn minor), 16.9 min (syn major), 19.4 min (anti minor), 24.6 min (anti major). 
13ac: CSP-HPLC: AD 90/10 n-Hex/IPA, flow rate 1 mL/min at 40 °C; λ 220 nm; tR = 7.6 min 
(syn minor), 8.9 min (syn major), 11.1 min (anti minor), 13.1 min (anti major). 
13ad: CSP-HPLC: OD-H 90/10 n-Hex/IPA, flow rate 1 mL/min at 40 °C; λ 220 nm; tR = 6.3 min 
(syn major), 6.8 min (syn minor), 7.5 min (anti major), 9.5 min (anti minor). 
13ae: CSP-HPLC: OJ 99/01 n-Hex/IPA, flow rate 1 mL/min at 40 °C; λ 254 nm; tR = 8.0 min 
(anti major).  
13af: CSP-HPLC: OJ 95/05 n-Hex/IPA, flow rate 1 mL/min at 40 °C; λ 230 nm; tR = 12.4 (syn 
minor), 14.3 min (syn major), 17.5 min (anti minor), 21.0 min (anti major). 
13ag: CSP-HPLC: AD 90/10 n-Hex/IPA, flow rate 1 mL/min at 40 °C; λ 220 nm; tR = 8.0 min 
(syn minor), 9.6 min (syn major), 12.2 min (anti minor), 14.7 min (anti major). 
13ah: CSP-HPLC: OD 90/10 n-Hex/IPA, flow rate 0.7 mL/min at 40 °C; λ 220 nm; tR = 11.6 
min (syn major), 12.5 min (syn minor), 13.8 min (anti major), 16.3 min (anti minor). 
13ai: CSP-HPLC: OD-H 95/05 n-Hex/IPA, flow rate 0.8 mL/min at 40 °C; λ 230 nm; tR = 14.1 
min (syn minor), 14.7 min (syn major), 17.8 min (anti minor), 22.8 min (anti major). 
13aj: CSP-HPLC: OJ 99/01 n-Hex/IPA, flow rate 0.2 mL/min at 40 °C; λ 280 nm; tR = 25.3 min 
(anti major), 27.6 min (anti minor). 
13ak: CSP-HPLC: AD 95/05 n-Hex/IPA, flow rate 1 mL/min at 40 °C; λ 230 nm; tR = 9.1 min 
(syn minor), 11.3 min (syn major), 14.6 min (anti minor), 20.5 min (anti major). 
13al: CSP-HPLC: AD 85/15 n-Hex/IPA, flow rate 0.5 mL/min at 40 °C; λ 210 nm; tR = 15.4 min 
(syn minor), 16.9 min (syn major), 19.2 min (anti minor), 20.6 min (anti major). 
13am: CSP-HPLC: OD-H 95/05 n-Hex/IPA, flow rate 0.7 mL/min at 40 °C; λ 210 nm; tR = 10.6 
min (syn major), 11.1 min (syn minor), 13.3 min (anti major), 16.1 min (anti minor). 
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13ba: CSP-HPLC: AD 90/10 n-Hex/IPA, flow rate 1 mL/min at 40 °C until 17 minutes, after 0.3 
mL/min; λ 254 nm; tR = 12.0 min (syn major), 15.3 min (syn minor), 20.8 min (anti minor), 
23.6 min (anti major). 
13bg: CSP-HPLC: AD 90/10 n-Hex/IPA, flow rate 0.4 mL/min at 40 °C; λ 230 nm; tR = 18.9 min 
(syn minor), 22.3 min (syn major), 27.4 min (anti major), 28.8 min (anti minor). 
13bd: CSP-HPLC: OD-H 90/10 n-Hex/IPA, flow rate 1 mL/min at 40 °C; λ 220 nm; tR = 6.8 min 
(syn major), 8.1 min (syn minor), 8.9 min (anti major), 10.0 min (anti minor). 
13ca: CSP-HPLC: OJ 90/10 n-Hex/IPA, flow rate 1 mL/min at 40 °C for 20 min, after 0.7 
mL/min; λ 254 nm; tR = 27.2 min (minor), 31.3 min (major). 
13cg: CSP-HPLC: AD 95/05 n-Hex/IPA, flow rate 0.4 mL/min at 40 °C; λ 220 nm; tR = 35.2 min 
(major), 37.7 min (minor). 
13cd: CSP-HPLC: OD-H 90/10 n-Hex/IPA, flow rate 1 mL/min at 40 °C; λ 220 nm; tR = 8.5 min 
(minor), 8.8 min (major). 
14da: CSP-HPLC: OD-H 85/15 n-Hex/IPA, flow rate 0.5 mL/min at 40 °C; λ 254 nm; tR = 14.3 
min (anti major), 15.5 min (anti minor), 19.3 min (syn minor), 19.7 min (syn major). 
14dg: CSP-HPLC: OD-H 85/15 n-Hex/IPA, flow rate 0.5 mL/min at 40 °C; λ 210 nm; tR = 10.6 
min (anti major), 11.2 min (anti minor), 12.7 min (syn minor), 13.1 min (syn major). 
14dd: CSP-HPLC: OD-H 85/15 n-Hex/IPA, flow rate 0.4 mL/min at 40 °C; λ 210 nm; tR = 12.5 
min (anti major), 13.4 min (anti minor), 14.6 min (syn), 15.8 min (syn). 
General Procedure for the aldol condensation between Benzaldehyde and Cyclohexanone 
on 10mmol scale. The aldol reaction was conducted in a 25 mL flask. In a typical reaction, 
the flask was charged with of S-proline (115 mg, 1 mmol), methanol (1,33 mL), water (330 
µL), the corresponding aldehyde (0.3 mmol) and cyclohexanone (5,18 mL, 50 mmol) and the 
mixture was stirred for 10 min at room temperature. After the mixture was cooled at 0°C 
and benzaldehyde (1,06 mL, 10 mmol) was slowly added. The flask was capped with a 
stopper and sealed. Then, the reaction mixture was stirred at room temperature for 30 h. 
After the reaction was completed, the mixture was filtered on a pad of silica with ethyl 
acetate and concentrated under vacuum. The conversion of the aldehyde and the 
diasteroisomeric ratio were determined by 1H-NMR in CDCl3. Then, the residue was obtained 
by purification by column chromatography (ethyl acetate–cyclohexane 2-8 as the eluent) to 
aﬀord the product with 78% yield. The product was further characterized by 1H-NMR, 13C-
NMR and HPLC-MS analysis. The enantiomeric excess was determined by chiral HPLC of the 
purified product. Compound already known in literature.  
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Chapter 3: Study of the α-Fluorination of Chiral γ-Nitroaldehydes 
 
This chapter of the thesis is strongly based on a paper published by my research group in 
2016, and treats about the study of an organocatalysed methodology for the α-fluorination 
of α-disubstituted chiral γ-Nitroaldehydes for the construction of fully substituted fluorinated 
stereocenters, a serious challenge in the field of α-functionalization of aldehyde, that can 
possibly open up interesting ways for the synthesis of biologically active compounds. 
 
3.1 Organocatalysis in the synthesis of biologically active compounds 
 
Despite their great development, the application of organocatalytic methodologies to the 
synthesis of active compounds in medicinal chemistry in the past years has rarely been 
reported. However, in most recent years organocatalytic methodologies for the synthesis of 
enantioenriched molecules for medicinal chemistry purposes have been gaining momentum 
being particularly attractive for the preparation of compounds that do not tolerate metal 
contamination. In academia, several groups have made a remarkable effort to show the 
great applicability of organocatalysts to the total synthesis of bioactive natural products32 
and of drugs33 most of them currently available in the market. These efforts mainly focused 
on the removal of barriers for scale-up by addressing issues such as catalyst loading, product 
inhibition, substrate scope, and bulk availability of designer catalysts which have drawn the 
attention of the companies34 that have begun to incorporate organocatalysis as a synthetic 
tool in some industrial scale processes.1 
In the past 10 years, the number of chiral, non-racemic pharmaceuticals available in the 
market has consistently increased. It is becoming more and more important to prepare these 
compounds using new enantioselective technologies to minimize the losses provoked from 
making racemic mixtures. Due to the operational and economic advantages of asymmetric 
organocatalysis, this methodology has a significant impact on chemical synthesis. I will 
report a couple of well-known examples of organocatalysis at the service of drug synthesis. 
The first is the synthesis of the alkaloid (−)-epibatidine, an analgesic studied as a morphine 
replacer, developed by the Takemoto’s group, and based on an enantioselective double 
Michael addition with hydrogen bond-based organocatalysis35 The bifunctional thiourea-
based organocatalyst 14 catalysed the first Michael addition of the 𝛾,𝛿-unsaturated 𝛽-
ketoester 16 to the nitroalkene 15, and after there is a base-promoted cyclization of the 
intermediate to form the polysubstituted cyclohexene 17 with good yield and 
enantioselectivity (Scheme 14). The total synthesis of (−)-epibatidine was achieved in further 
seven steps.  
                                                          
32 R. M. de Figueiredo, M. Christman, European Journal of Organic Chemistry, 2007, 16, 2575–2600. 
33 J. Alem´an, S. Cabrera, Chemical Society Reviews, 2013, 42, 2, 774–793. 
34 a) H. U. Blaser, E. Schmidt, Wiley-VCH,Weinheim, Germany, 2004. b) H. Groger, Organocatalysis, 2008, 227–258.  
35 Y. Hoashi, T. Yabuta, Y. Takemoto, Tetrahedron Letters, 2004, 45, 50, 9185–9188.  
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Scheme 14: Organocatalyzed cascade synthesis of (−)-epibatidine 
Epibatidine is not a usually prescribed therapeutic because of its toxicity, but is an example 
of complex natural alkaloid that can be synthesized in an elegant and straightforward way 
using organocatalysis. As another example, Hayashi and co-workers successfully reported an 
efficient, enantioselective total synthesis of (-)-oseltamivir36, in which the key step is a Nitro-
Michael addition catalysed by the diarylprolinol VII, demonstrating the power of asymmetric 
reactions catalysed by organocatalysts. 
 
Scheme 15: Key-step for the organocatalysed synthesis of (-)-oseltamivir 
This organocatalytic step is the core of a straightforward synthesis of composed by three 
one-pot procedures that leads to the final compound with 57% overall yield, and is a 
representative example of organocatalysis at the service of drug synthesis. 
However, like exposed previously, the application of organocatalysis to the synthesis of 
molecules of interest in various fields, including medicinal chemistry, is still facing problems 
such as high catalyst loading, long reaction time, difficulties in recyclability etc. 
 
 
 
 
 
                                                          
36 H. Ishikawa, T. Suzuki, Y. Hayashi, Angew. Chem. Int. Ed. 2009, 48, 1304 –1307 
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3.2 Fluorine in medicinal chemistry 
 
The use of fluorine-containing compounds in last 30 years has grown in many different fields, 
from pharmaceutical to material science, as well as the study of their peculiar property.37 In 
particular, it is well known that the introduction of one or more fluorine atoms into a 
biologically active molecule often incredibly enhances its activity.  
 
Figure 7: Examples of fluorinated drugs, characterized by very diverse structures and bioactivities. 
 
                                                          
37 For reviews on various applications of fluorinated compounds, see: a) N. V. S. D. K. Bhupathiraju, W. Rizvi, J. D. Batteas, 
C. M. Drain, Org. Biomol. Chem. 2016, 14, 389–408; b) C. D. Murphy, Appl. Microbiol. Biotechnol. 2016, 100, 2617–2627; 
c) A. R. Jennings, S. T. Iacono, Polym. Int. 2016, 65, 6–10; d) T. Okazoe, J. Fluorine Chem. 2015, 174, 120–131; e) T. 
Sugiishi, M. Matsugi, H. Hamamoto, H. Amii, RSC Adv. 2015, 5, 17269–17282; f) P. Pengo, L. Pasquato, J. Fluorine Chem. 
2015, 177, 2–10; g) C. Ni, M. Hu, J. Hu, Chem. Rev. 2015, 115, 765–825; h) D. Cosco, E. Fattal, M. Fresta, N. Tsapis, J. 
Fluorine Chem. 2015, 171, 18–26; i) M. Kiel, K.-H. Engesser, Appl. Microbiol. Biotechnol. 2015, 99, 7433–7464; j) M. 
Reindl, A. Hoffmann- Roder, Curr. Top. Med. Chem. 2014, 14, 840–854; k) C. Samojłowicz, A. Kajetanowicz, K. Grela, 
Olefin Metathesis in Fluorous Phases and in Fluorinated Aromatic Solvents, in: Olefin Metathesis: Theory and Practice 
(Ed.: K. Grela), Wiley-VCH, Weinheim, Germany, 2014, chapter 23, p. 537–545; l) W.-B. Yi, J.-J. Ma, L.-Q. Jiang, C. Cai, W. 
Zhang, J. Fluorine Chem. 2014, 157, 84–105; m) D. Cahard, V. Bizet, Chem. Soc. Rev. 2014, 43, 135–147; n) F. Menaa, B. 
Menaa, O. N. Sharts, J. Mol. Pharm. Org. Process Res. 2013, 1, 104, DOI: 10.4172/2329-9029.1000104; o) T. Stahl, H. F. 
T. Klare, M. Oestreich, ACS Catal. 2013, 3, 1578–1587; p) X.-G. Hu, L. Hunter, Beilstein J. Org. Chem. 2013, 9, 2696–2708; 
q) F. Giornal, S. Pazenok, L. Rodefeld, N. Lui, J.-P. Vors, F. R. Leroux, J. Fluorine Chem. 2013, 152, 2–11; r) X.-J. Zhang, T.-
B. Lai, R. Y.-C. Kong, Top. Curr. Chem. 2012, 308, 365–404; s) A. Belardini, Appl. Sci. 2012, 2, 682–708; t) M. Crespo, 
Organometallics 2012, 31, 1216–1234; u) V. Curtui, G. Brambilla, A. di Domenico, S. van Leeuwen, EFSA J. 2012, 10, 
2743, p. 55; v) J. Ruiz-Cabello, B. P. Barnett, P. A. Bottomley, J. W. M. Bulte, NMR Igaku 2011, 24, 114–129; w) R. Berger, 
G. Resnati, P. Metrangolo, E. Weber, J. Hulliger, Chem. Soc. Rev. 2011, 40, 3496–3508; x) D. Zhi, S. Zhang, B. Wang, Y. 
Zhao, B. Yang, S. Yu, Bioconjugate Chem. 2010, 21, 563–577. 
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This is basically due to the fact that the presence of fluorine can confer several desirable 
characteristics to an active compound.38 First of all, it can increase lipophilicity, allowing a 
better absorption into and across biological membranes; the electronegativity of fluorine 
and its low polarizability can radically change the electronic features of a biologically active 
molecule, changing its conformation, the pKa of neighbouring functional groups, and the 
hydrogen-bond network; moreover, fluorine's van der Waals radius (1.4 A) makes it an 
isostere of hydrogen (van der Waals radius 1.1 A), giving the fluorine-hydrogen substituted 
compound several changes in the electronical property but, at the same time, only minimal 
structural changes relative to a carbon–hydrogen bond. Therefore, the incorporation of 
fluorine atoms is used to modulate both the pharmacokinetic and pharmacodynamic 
properties of a drug. It has been estimated that 30 % of the leading 30 blockbuster drugs by 
sales contain at least one fluorine atom. In this context, fluorinated pharmaceuticals show 
notable and very diverse biological activities.39 They include HIV-protease inhibitors40, 
                                                          
38 For reviews on fluorine-containing biologically active compounds, see: a) Y. Zhou, J. Wang, Z. Gu, S. Wang, W. Zhu, J. 
L. Acena, V. A. Soloshonok, K. Izawa, H. Liu, Chem. Rev. 2016, 116, 422–518; b) E. P. Gillis, K. J. Eastman, M. D. Hill, D. J. 
Donnelly, N. A. Meanwell, J. Med. Chem. 2015, 58, 8315–8359; c) B. Gomes, J. A. Loureiro, M. A. N. Coelho, M. d. Carmo 
Pereira, Curr. Pharm. Des. 2015, 21, 5725–5735; d) K. Kaur, V. Kumar, G. Kumar Gupta, J. Fluorine Chem. 2015, 178, 306–
326; e) D. Barnes-Seeman, J. Beck, C. Springer, Curr. Top. Med. Chem. 2014, 14, 855–864; f) P. A. Gale, R. Perez-Tomas, 
R. Quesada, Acc. Chem. Res. 2013, 46, 2801–2813; g) M. Tredwell, V. Gouverneur, Fluorine in Medicinal Chemistry: 
Importance of Chirality in Comprehensive Chirality (Eds.: E. M. Carreira, H. Yamamoto), Elsevier, 2012, vol. 1, chapter 5, 
p. 70–85; h) D. O'Hagan, J. Fluorine Chem. 2010, 131, 1071–1081; i) S. Purser, P. R. Moore, S. Swallow, V. Gouverneur, 
Chem. Soc. Rev. 2008, 37, 320–330; j) K. L. Kirk, Curr. Top. Med. Chem. 2006, 6, 1447–1456; k) F. M. D. Ismail, J. Fluorine 
Chem. 2002, 118, 27–33; l) B. E. Smart, J. Fluorine Chem. 2001, 109, 3–11. 
39 a) E. A. Hallinan, S. W. Kramer, S. C. Houdek, W. M. Moore, G. M. Jerome, D. P. Spangler, A. M. Stevens, H. S. Shieh, 
P. T. Manning, B. S. Pitzele, Org. Biomol. Chem. 2003, 1, 3527–3534; b) A. A. Sauve, Y. Cen, WO2011003018, 2011; c) P. 
Wai Chia, S. C. Brennan, A. M. Z. Slawin, D. Riccardi, D. O'Hagan, Org. Biomol. Chem. 2012, 10, 7922–7927; d) U. Bothe, 
B. Menzenbach, P. Droescher, H.-U. Schweikert, W. Elger, A. Hillisch, G. Reddersen, B. Schneider, WO2005100376, 2005; 
e) W. R. Antonios-Mccrea, P. A. Barsanti, C. Hu, X. Jin, E. J. Martin, Y. Pan, K. B. Pfister, M. Sendzik, J. Sutton, L. Wan, 
WO2012066065, 2012. 
40 a) A. Abouabdellah, L. Boros, F. Gyenes, J. T. Welch, J. Fluorine Chem. 1995, 72, 255–259; b) E. Kim, G. Huan Shen, J. 
Hee Hong, Nucleosides Nucleotides Nucleic Acids 2011, 30, 798–813; c) M. J. Boyd, C. Molinaro, A. Roy, V. L. Truong, 
WO2012055031, 2012; d) R. D. Tung, F. G. Salituro, D. D. Deininger, M. A. Murcko, P. M. Novak, G. R. Bhisetti, 
WO95/24385, 1995. 
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anticancer41 and antiviral42 drugs (B), antibacterials43 (C), and drugs for the treatment of 
neurodegenerative disorders (D).44  
 
3.3 The Organocatalytic α-fluorination of aldehydes 
 
In last years the scientific community started to develop new efficient fluorination protocols, 
using both nucleophilic and electrophilic fluorine donors, pushed by the beneficial effects 
related to the presence of fluorine atoms into drugs and materials. Several different 
synthetic approaches45 to fluorinated products have been proposed, including, more 
recently, organocatalytic processes.46  
 
                                                          
41 For reviews on fluorinated anticancer drugs, see: a) W. Tongkao-on, C. Gordon-Thomson, K. M. Dixon, E. J. Song, T. 
Luu, S. E. Carter, V. B. Sequeira, V. E. Reeve, R. S. Mason, Dermato-Endocrinology 2013, 5, 20–33; b) T. Goslinski, J. 
Piskorz, J. Photochem. Photobiol. C 2011, 12, 304–321; c) T. Fujishima, S. Fujii, T. Harayama, Curr. Org. Chem. 2010, 14, 
962–976; d) C. Isanbor, D. O'Hagan, J. Fluorine Chem. 2006, 127, 303–319; e) G. Giannini, Med. Chem. Rev. -Online 2004, 
1, 47–71; f) I. Ojima, ChemBioChem 2004, 5, 628–635. For selected patents on fluorinated anticancer drugs, see: g) T. J. 
Guzi, D. A. Parry, M. A. Labroli, M. P. Dwyer, K. Paruch, K. E. Rosner, R. Shen, J. Popovici-Muller, WO2009061781, 2009; 
h) D. D. Wirth, US5559222, 1996; i) X. Han, Y. Lou, C. Michoud, S. G. Mischke, S. Remiszewski, K. C. Rupert, 
WO2014009495, 2014. 
42 a) Q. Huang, S. Zhou, WO2013013009, 2013; b) M. Sznaidman, US7291726B2, 2007. 
43 a) N. Boechat, M. M. Bastos, Curr. Top. Med. Chem. 2013, 13, 2885–2904; b) P. Ball, J. Antimicrob. Chemother. 2003, 
51, 21–27, Supplement S1. 
44 a) A. Nakazato, in: Fluorine in Medicinal Chemistry and Chemical Biology (Ed.: I. Ojima), Blackwell Publishing, 2009, 
chapter 3, p. 67–97; b) M. S. Malamas, J. J. Erdei, W. F. Fobare, D. A. Quagliato, S. A. Antane, A. J. Robichaud, 
US2007/0072925A1, 2007; c) S. J. Green, E. J. Hembre, D. J. Mergott, Y. Shi, B. M. Watson, L. L. Winneroski, Jr., 
US2014371212, 2014. 
45 For different synthetic approaches to fluorinated compounds, see: a) M. Inoue, M. Shiosaki, Curr. Org. Chem. 2015, 
19, 1579–1591; b) Z. U. H. Khan, D. Kong, Y. Chen, N. Muhammad, A. U. Khan, F. U. Khan, K. Tahir, A. Ahmad, L. Wang, 
P. Wan, J. Ind. Eng. Chem. 2015, 31, 26–38; c) C. Chatalova-Sazepina, R. Hemelaere, J.-F. Paquin, G. M. Sammis, Synthesis 
2015, 47, 2554–2569; d) A. D. Dilman, V. V. Levin, Mendeleev Commun. 2015, 25, 239–244; e) B. W. Thuronyi, M. C. Y. 
Chang, Acc. Chem. Res. 2015, 48, 584–592; f) J.-A. Ma, S. Li, Org. Chem. Front. 2014, 1, 712–715; g) X. Mu, G. Liu, Org. 
Chem. Front. 2014, 1, 430–433; h) Y. Qiao, L. Zhu, B. R. Ambler, R. A. Altman, Curr. Top. Med. Chem. 2014, 14, 966–978; 
i) W. Kong, E. Merino, C. Nevado, Chimia 2014, 68, 430–435; j) M. C. Walker, M. C. Y. Chang, Chem. Soc. Rev. 2014, 43, 
6527–6536; k) V. Gouverneur, Nat. Chem. 2012, 4, 152–154; l) V. Hugenberg, G. Haufe, J. Fluorine Chem. 2012, 143, 
238–262; m) C. B. McPake, G. Sandford, Org. Process Res. Dev. 2012, 16, 844–851; n) G. Liu, Org. Biomol. Chem. 2012, 
10, 6243–6248; o) X.-L. Qiu, F.-L. Qing, Eur. J. Org. Chem. 2011, 3261–3278; p) Y. Zeng, C. Ni, J. Hu, Chem. Eur. J. 2016, 
22, 3210–3223; q) P. A. Champagne, J. Desroches, J.-D. Hamel, M. Vandamme, J.-F. Paquin, Chem. Rev. 2015, 115, 9073–
9174; r) T. A. Unzner, T. Magauer, Tetrahedron Lett. 2015, 56, 877–883; s) T. Borg, J. Danielsson, M. Mohiti, P. Restorp, 
P. Somfai, Adv. Synth. Catal. 2011, 353, 2022–2036; t) R. Clarkson, Z. Komsta, B. A. Mayes, A. Moussa, M. Shelbourne, 
A. Stewart, A. J. Tyrrell, L. L. Wallis, A. C. Weymouth- Wilson, J. Org. Chem. 2015, 80, 2198–2215; u) T. Konno, A. Ikemoto, 
T. Ishihara, Org. Biomol. Chem. 2012, 10, 8154-8163. 
46 For reviews on organocatalytic fluorination reactions, see: a) Y. Zhao, Y. Pan, S.-B. Derek Sim, C.-H. Tan, Org. Biomol. 
Chem. 2012, 10, 479–485; b) Z. Ye, G. Zhao, Chimia 2011, 65, 902–908; c) V. Guillem, X. Companyo, R. Rios, Chem. Eur. 
J. 2011, 17, 2018–2037; d) M. Ueda, T. Kano, K. Maruoka, Org. Biomol. Chem. 2009, 7, 2005–2012. 
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One of the principal fluorination organocatalytic protocol is the stereoselective α-
fluorination47 of aldehydes via enamine formation, that can open up the route to useful 
intermediates for the synthesis of pharmaceuticals. The fluorine is introduced using a source 
of electrophilic fluorine, the most common of those being molecules bearing N-F bond such 
as Selectfluor, N-fluorobenzene sulfonimide (NFSI), or various fluoropyridinium salts (figure 
8). 
 
Figure 8: A selection of commonly used electrophilic fluorinating reagents. 
 
In 2005, many enantioselective fluorination of aldehydes catalyzed by chiral secondary 
amines were reported. Enders and Huttl reported the organocatalytic direct α-fluorination 
of aldehydes and ketones employing Selectfluor and proline-related secondary amine 98 as 
catalyst (Scheme 16).48 
 
Scheme 16: enantioselective fluorination of ketones catalzsed by 98 
But results were still poor with only low enantioselectivity (36% ee) observed with 
cyclohexanone (96), and no selectivity for the aldehydes.  
An enantioselective α-fluorination of aldehydes was proposed by Jørgensen and co-workers, 
catalysed by the silylated prolinol derivative VIII, using NFSI as fluorine source in MTBE, and 
reducing the α-fluorinated aldehydes to the corresponding alcohol (for stability reasons) 
with high enantioselectivities (up to 97%).49 
 
 
                                                          
47 X. Yang, T. Wu, R. J. Phipps, F. D. Toste, Chem. Rev. 2015, 115, 826−870 
48D. Enders, M. R. M.  Huttl, Synlett 2005, 6, 991. 
49 M. Marigo,D. Fielenbach, A. Braunton,A. Kjærsgaard, K.A. Jørgensen, Angew. Chem., Int. Ed. 2005, 44, 3703. 
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Scheme 17: Jorgensen Fluorination of aldehydes 
They also tried to expand the scope on the formation of quaternary stereocenters (Scheme 
18), using a less bulky catalyst V and a higher temperature, but they observed the product 
formation with a poor 48% ee. 
 
Scheme 18: Jorgensen approach for the formation of fluorinated quaternary stereocenters 
In a similar way, Barbas and co-workers focused on the enantioselective fluorination of α-
branched aldehydes using other  chiral secondary amine catalysts (Scheme 19).50 The best 
results were obtained  using catalysts VI and 19, but the enantiomeric excess is only slightly 
improved (45% ee for VI; 66% ee for 19).  
 
 
Scheme 19: Barbas fluorination of branched aldehydes 
Also MacMillan and co-workers were interested in fluorination, and they reported the use 
of imidazolidinone dichloroacetate XXI for the fluorination of linear aldehydes, using NFSI in 
THF.51 (Scheme 20) In this case excellent enantioselectivity was observed (up to 99% ee), 
expecially when isopropanol is added to the reaction mixture as a co-solvent. The reaction 
                                                          
50 D. D. Steiner, N. Mase, C. F. Barbas III. Angew. Chem, Int. Ed. 2005, 44, 3706 
51 T. D. Beeson, D. W. C. MacMillan, J. Am. Chem. Soc. 2005, 127, 8826. 
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is tolerant to a wide range of functional groups and is possible to apply this protocol to 
several aldehydes, except for α-branched ones.  
 
Scheme 20:Macmillan fluorination of linear aldehydes 
In 2006, Jørgensen and co-workers reported the asymmetric α-fluorination of α-branched 
aldehydes with the use of derivative 20, synthesized through an asymmetric Friedel−Craft 
amination.52 The results were satisfying with ee up to 90% (Scheme 21). In general, good 
enantioselectivities were achieved in presence of one aromatic group in the α position, while 
poorer ee were observed with alkyl groups. 
 
Scheme 21: fluorination of α-branched aldehydes proposed by Jorgensen 
Together with simple protocols, many one-pot reactions that incorporates α-fluorination of 
aldehydes has been reported in literature53. These procedures open new routes in the 
design of synthetic strategies, and allows to strongly reduce the number of steps during the 
synthesis, to avoid also further purifications, to save time and cut costs, thus reducing the 
sustainability of the process.  
 
 
 
 
 
 
 
 
 
 
                                                          
52 S. Brandes, B. Niess, M. Bella, A. Prieto, J. Overgaard, K. A. Jørgensen, Chem. Eur. J. 2006, 12, 6039. 
53 For some examples of one-pot fluorination reactions: a) Y. Huang, A. M. Walji, C. H. Larsen, D. W. C. MacMillan, J. 
Am. Chem. Soc. 2005, 127, 15051. b) C. Appayee, S. E. Brenner-Moyer, Org. Lett. 2010, 12, 3356. c) H. Jiang, A. 
Falcicchio, K. L. Jensen, M. W. Paixao, S. Bertelsen,K. A. Jørgensen, J. Am. Chem. Soc. 2009, 131, 7153. d) O. O. Fadeyi, 
C. W. Lindsley, Org. Lett. 2009, 11, 943. 
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3.4 Aim of the work 
 
 Despite the recent advantages in the organocatalytic synthesis of α-fluoro aldehydes, as 
exposed before, the scope of the reaction is still limited to simple achiral aldehydes, and in 
many cases is focused to the construction of tertiary fluorinated stereogenic centres 
[Scheme 22, Equation (1)]. In contrast, the stereoselective organocatalytic α-fluorination of 
α,α-dialkyl aldehydes appears to be way more difficult, and only a few paper have reported 
it, achieving only moderate levels of stereoselectivity [eemax = 69 %, Equation (2)].54 
Additionally, there are only few reports55 documenting the stereoselective construction of 
quaternary stereocenters at the Cα position, and the best are obtained only with α-chloro- 
and α-aryl-substituted aldehydes, able to stabilize the enamine formation. 
 
Scheme 22: Previous works  
 
With this in mind, we wondered the study of the organocatalytic α-fluorination of chiral 
aldehydes containing two contiguous α and β stereocenters (Scheme 23), thus creating a 
quaternary stereogenic center. To the best of our knowledge, this is the first study 
committed to the stereoselective organocatalytic fluorination of enantioenriched α,α-dialkyl 
aldehydes containing two stereogenic centers. 
 
Scheme 23: aim of the work 
 
 
 
 
 
 
                                                          
54 M. R. Witten, E. N. Jacobsen, Org. Lett. 2015, 17, 2772–2775, see reference 52. 
55 M. D. Hayes, M. Rodriguez-Alvarado, S. E. Brenner-Moyer, Tetrahedron Lett. 2015, 56, 4718–4720, see reference 52. 
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3.5 Result and discussion 
 
We began our investigation by studying the fluorination of a mixture of (2R,3S)- and (2S,3S)-
2-methyl-4-nitro-3-phenylbutanal (21a; syn/anti = 68:32). This kind of Chiral γ-
nitroaldehydes are easy accessible by conjugate addition of an aldehyde to a nitroalkene 
catalysed by commercially available Jorgensen–Hayashi catalysts, giving products with a 
high stereocontrol at the β stereocenter, while lower control at the α stereocenter is present 
(Scheme 24).56  
 
Scheme 24: Synthesis of the starting material 
This represent an ideal substrate for an ulterior α-functionalization like fluorination. Then, 
we started our investigation with a deepened screening of catalysts and additive the, 
reported in Table 7: 
 
 
                                                          
56 a) K. Patora-Komisarska, M. Benohoud, H. Ishikawa, D. Seebach, Y. Hayashi, Helv. Chim. Acta 2011, 94, 719–745; b) 
X. Hu, Y.-F. Wei, N. Wu, Z. Jiang, C. Liu, R.-S. Luo, Tetrahedron: Asymmetry 2016, 27, 420–427. 
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Entry Catalyst Additive Time Conversion (%)b dr 23ab 
dr 21ab 
(syn/anti) 
1 I - 
26h 
5d 
77 
100 
65:35 
64:36 
66:34 
- 
2 ent-I - 
26h 
5d 
65 
100 
33:67 
32:68 
87:13 
- 
3 II - 
24h 
6d 
15 
34 
55:45 
54:46 
68:32 
65:35 
4 III - 
24h 
6d 
36 
69 
56:44 
48:52 
63:37 
67:33 
5 IV - 
24h 
6d 
32 
51 
53:47 
53:47 
71:29 
63:37 
6 V - 
24h 
6d 
24 
57 
22:78 
28:72 
80:20 
80:20 
7 VI - 
24h 
3d 
77 
90 
72:28 
71:29 
52:48 
- 
8 VII - 
24h 
6d 
9 
41 
- 
90:10 
66:34 
66:34 
9 ent-VII - 
24h 
6d 
5 
48 
- 
50:50 
68:32 
70:30 
10 VIII - 
24h 
5d 
16 
47 
- 
91:9 
57:43 
48:52 
11 ent-VIII - 
24h 
5d 
15 
38 
- 
20:80 
72:28 
77:23 
12 I TFA 23h 86 71:29 - 
13 VI TFA 23h 100 77:23 - 
14 VII TFA 
19h 
3d 
75 
94 
92:8 
92:8 
56:44 
- 
15 ent-VII TFA 23h 76 20:80 72:28 
16 VIII TFA 
5h 
23h 
46h 
53 
73 
76 
92:8 
90:10 
93:7 
62:38 
55:45 
46:54 
17 ent-VIII TFA 
5h 
23h 
46h 
37 
56 
69 
7:93 
8:92 
7:93 
81:19 
78:22 
72:28 
18 IX - 
24h 
6d 
9 
43 
- 
52:48 
67:33 
64:36 
19 IX TFA 
24h 
7d 
42 
95 
69:31 
71:29 
64:36 
- 
20 X TFA 24h 100 63:37 - 
21 ent-X TFA 24h 100 15:85 - 
22 XI DCA 
24h 
3d 
6d 
42 
77 
91 
91:9 
87:13 
88:12 
69:31 
60:40 
- 
23 ent-XI DCA 
24h 
4d 
8d 
39 
80 
94 
24:76 
20:80 
20:80 
74:26 
83:17 
- 
24 XII - 
24h 
6d 
38 
61 
51:49 
51:49 
69:31 
66:34 
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25 XII TFA 
19h 
7d 
56 
82 
50:50 
52:48 
61:39 
61:39 
26 VII XIII 
24h 
3d 
7d 
42 
52 
67 
84:16 
83:17 
89:11 
57:43 
55:45 
51:49 
 
27 
VII XIV 
24h 
7d 
18 
50 
77:23 
74:26 
64:36 
59:41 
28 ent-VII XIV 
24h 
5d 
7d 
10 
22 
33 
- 
27:73 
28:72 
68:32 
69:31 
67:33 
29 XI HCl 
24h 
3d 
6d 
12 
35 
54 
83:17 
82:18 
81:19 
69:31 
69:31 
68:32 
30 XV - 
24h 
3d 
7d 
31 
51 
56 
43:57 
48:52 
50:50 
63:37 
60:40 
61:39 
31 ent-XV - 
24h 
3d 
7d 
25 
46 
50 
37:63 
29:71 
31:69 
66:34 
61:39 
61:39 
32 ent-XV HCl(3 eq.) 
24h 
3d 
9 
21 
- 
53:47 
66:34 
66:34 
33 XV - 
24h 
3d 
7d 
38 
53 
56 
45:55 
49:51 
51:49 
61:39 
60:40 
58:42 
34 XVI - 
24h 
3d 
7d 
14 
32 
41 
45:55 
49:51 
51:49 
61:39 
60:40 
58:42 
35 ent-XVI - 
24h 
3d 
7d 
14 
27 
52 
69:31 
58:42 
53:47 
70:30 
69:31 
72:28 
36 XVI TFA 
24h 
3d 
7d 
19 
31 
38 
55:45 
64:36 
62:38 
67:33 
66:34 
70:30 
37 XVII - 
24h 
5d 
7d 
29 
33 
43 
43:57 
42:58 
44:56 
69:31 
71:29 
69:31 
38 XIV - 24h - - 65:35 
 
Table 7: a Reaction conditions: 21a (10 mg, 0.0483 mmol), 22 (1.2 equiv), catalyst (30 mol%), tetrahydrofuran (THF, 0.4 
mL), room temperature (rt). b Determined by 1H NMR of the crude mixture. h = hours, d = days, TFA = trifluoroacetic 
acid, DCA = dichloroacetic acid.  
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We started testing several enantiopure secondary amines as catalysts (I–XI), running the 
reactions in THF at room temperature, and choosing N-fluorobenzenesulfonimide (NFSI; 22) 
as the electrophilic fluorine source. First catalysts tested were the two enantiomers of 
proline (I and ent-I), and gave good conversions after 26 h (entries 1 and 2). The (S) 
enantiomer was slightly more efficient, and interestingly, the two enantiomers provided the 
fluorinated product (i.e., 23a) with analogous but opposite diastereomeric ratios. (S)-
Prolinol (II) and two different (S)-prolinamides (III and IV) gave slower reactions (entries 3–
5) and poor stereoselectivity. (R)-2-Benzhydrylpyrrolidine (V) showed a similar poor 
reactivity (entry 6), but it gave a significant diastereoselectivity (dr = 28:72), for the same 
isomer favoured by (R)-proline (ent-I). (S)-tetrazole derivative VI also gave interesting 
outcomes (entry 7). After, we screened four silylated diarylprolinols as organocatalysts 
(entries 8–11), observing slow reactions, but also the best diastereoselectivity of this series 
(dr = 90:10), that was achieved with (S)-configured catalysts VII and VIII (entries 8 and 10, 
respectively). This first part of the screening led us to infer that enantiomeric catalysts (I and 
ent-I, VII and ent-VII, VIII and ent-VIII) could establish matched (S-configured) and 
mismatched (R-configured) pairs with the chiral substrate (i.e., 21a), favoring opposite Cα 
absolute configurations of the fluorinated product (i.e., 23a) with different efficiencies. The 
preferential reaction of each enantiomer of the catalyst with a particular diastereoisomer of 
aldehyde 21a was also suggested by the variation of the diastereomeric ratio of 21a during 
the reaction (Table 7). 
Since the fastest fluorinations took place in the presence of organocatalysts bearing 
significantly acidic protons (I and VI), we decided to add an external acid to check if a possible 
enhancement in reactivity is observed. The addition of trifluoroacetic acid (TFA) increased 
the reaction rate for all the organocatalysts tested (entries 12–17), especially when 
combined with silylated diarylprolinols VII and VIII. Good conversions (73–75 %) were 
achieved in less than one day, together with a slightly better diastereoselectivity, in 
particular in the mismatched-pair using (R)-configured diarylprolinols (ent-VII and ent-VIII). 
The results with imidazolidinones IX–XI, which are commonly used in the presence of protic 
acids, confirmed the enhancement of rate and diastereoselectivity in the presence of TFA 
(entries 18 and 19), and also the different abilities of enantiomeric catalysts to favour 
opposite Cα-configurations. 
Some acids have been tested in the presence of the already studied catalysts VII, ent-VII and 
XI, only with moderate results. The primary bifunctional amines XV, ent-XV, XVI, ent-XVI, 
and the squaramide derivative XVII were screened with and without acid, but poorer results 
were invariably observed, confirming the secondary amines as the best catalysts in this 
fluorination reaction. Lastly, we performed the fluorination reaction using simple achiral 
pyrrolidine XII with and without acid (entries 25 and 24, respectively). No diastereoselection 
was observed, supporting the idea of catalyst-controlled stereodifferentiation as seen in the 
results of previous experiments, without notable influence of the Cβ-stereocenter. 
 
Jorgensen's diarylprolinols VIII and ent-VIII emerged as the best organocatalyst for the α-
fluorination of α,α-dialkyl aldehyde 21a, allowing to obtain both stereoisomers with the two 
opposite absolute configurations of the Cα quaternary stereocenter (entries 16 and 17) with 
high levels of diastereocontrol. Furthermore, we demonstrated that the presence of TFA 
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improves both the rate and the stereocontrol. Using these findings as a starting point, we 
further examined the role of solvent and catalyst loading on the reactivity and selectivity of 
the fluorination reaction (Table 8). 
 
Entry 
Catalyst 
(mol%) 
Solvent Time Conversion (%)b dr 23ab 
dr 21ab 
(syn/anti) 
1c VIII (30) THF 
19h 
40h 
72 
85 
94:6 
93:7 
58:42 
58:42 
2c VIII (30) CH3CN 
19h 
40h 
34 
41 
94:6 
96:4 
68:32 
66:34 
3c VIII (30) DCM 
19h 
40h 
12 
16 
85:15 
85:15 
65:35 
63:37 
4c VIII (30) Hexane 54h 50 90:10 55:45 
5c VIII (30) TBME 19h 95 94:6 51:49 
6d ent-VIII (30) TBME 
19h 
24h 
44h 
74 
80 
92 
12:88 
11:89 
10:90 
84:16 
82:18 
69:31 
7d VIII (15) TBME 
19h 
44h 
81 
91 
96:4 
96:4 
37:63 
51:49 
8d VIII (10) TBME 
24h 
4d 
73 
88 
97:3 
95:5 
31:69 
43:57 
9d VIII (5) TBME 4d 66 95:5 42:58 
10d ent-VIII (20) TBME 22h 65 12:88 90:10 
11d ent-VIII (15) TBME 
24h 
4d 
58 
90 
11:89 
10:90 
86:14 
72:28 
12c,e VIII (5) TBME 
23h 
2d 
34 
44 
76:24 
74:26 
71:29 
61:39 
13f VIII (15) TBME 
18h 
2d 
80 
87 
98:2 
98:2 
53:47 
55:45 
14f ent-VIII (15) TBME 
18h 
2d 
35 
42 
12:88 
14:86 
86:14 
73:27 
Table 8: Reaction conditions optimization.a Reaction conditions: 21a (10 mg, 0.0483 mmol), 22 (1.2 equiv), 
trifluoroacetic acid (TFA, equimolar amount with the catalyst), solvent (0.2 mL), room temperature (rt). b Determined 
by 1H NMR of the crude mixture. c Initial dr (21a): syn/anti = 72/28. d Initial dr (21a): syn/anti = 67/33. e Reaction set at 
50 °C. f Initial dr (21a): syn/anti = 99/1. h = hours, d = days, THF = tetrahydrofuran, DCM = dichloromethane, TBME = 
tert-butylmethylether.  
 
The solvent screening (entries 1–5) confirmed ethers as the best solvents in terms of both 
reactivity and stereoselectivity, with tert-butyl methyl ether (TBME; entry 5) resulting as the 
best. Acetonitrile slowed down the transformation (entry 2), while nonpolar or slightly polar 
solvents, such as dichloromethane or hexane (entries 3 and 4, respectively) gave worse 
diastereomeric ratios. The better performance of TBME was further confirmed by the good 
results obtained with enantiomeric catalyst ent-VIII (entry 6). Finally, the catalyst loading 
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was studied (entries 7–11), and high conversions were obtained in reasonable times using 
15 mol-% of VIII and 20 mol-% of ent-VIII (entries 7 and 10, respectively). 
However, the fluorination proceeded also using lower catalyst loadings (entries 8 and 11). 
With the lowest amount of catalyst (5 mol-%), we tried to speed up the reaction by 
increasing the temperature (50 °C), but a significant decrease in diastereomeric ratio was 
observed (entry 12). We carried out also trials on a syn enriched sample of 21a (entries 13 
and 14) to check the role of the α stereocenter in the overall catalytic cycle. A slightly 
improved stereocontrol was recorded for VIII [dr = 98:2 (entry 13) vs. 96:4 (entry 7)], while 
with ent-VIII was less selective and slower (entry 14 with entry 11). These findings further 
confirmed syn-1a/VIII as the matched pair, and that, even with acid additive, the syn-21a 
and anti-21a equilibration is a slow process. Indeed, if the syn/anti equilibration was fast, 
we should not observe a difference in terms of reaction rate between entries 11 and 14 of 
Table 2. 
Concluding, we identified the best reaction conditions for the α-fluorination of model 
substrate 21a,: catalyst VIII (15 mol-%) or catalyst ent-VIII (20 mol-%) to obtain the two Cα-
epimers of fluorinated product 23a; TFA as an acid additive in an equimolar amount with 
the organocatalyst; TBME as the reaction solvent (0.24 M)and room temperature. Based on 
this protocol, we investigated the wider substrate scope of the reaction (Table 9). 
The two Cα-epimers of fluorinated product 23a, namely anti-23a (Table 3, entry 1) and syn-
23a (entry 2), were obtained in good yields and with high stereoselectivities by fluorination 
of 21a in the presence of VIII and ent-VIII, respectively. We applied the same protocol to 
(3R)-2-methyl-4-nitro-3-phenylbutanal (21b), which resulted in the stereoselective synthesis 
of the enantiomeric forms of compounds anti-23a and syn-23a: anti-23b from catalyst ent-
VIII (Table 3, entry 4), and syn-23b from catalyst VIII (entry 3), respectively. As expected, 
21b/VIII acted as the mismatched pair, and 21b/ent-VIII as the matched pair. As a result, the 
anti fluorinated products were always formed with excellent stereocontrol (dr 23a = 97:3, 
dr 23b = 96:4), while the syn analogs showed slightly worse diastereomeric ratios (dr 23a = 
89:11, dr 23b = 84:16). 
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Entry 
Substrate 21 
R1/Ar/R 
Catalyst 
(mol%) 
Time 
[h] 
Product 
Conversion 
(%)b 
(Yield %)c 
dr 23b 
(anti:syn) 
er 23d 
 
1 
21a 
Me/(S)-
Ph/CH2NO2 
VIII (15) 22 
 
anti-23a 
100 (75)e 97:3 >99:1f 
2 
21a 
Me/(S)-
Ph/CH2NO2 
ent-VIII 
(20) 
20 
 
syn-23a 
100 (85)e 11:89 >99:1f 
3 
21b 
Me/(R)-
Ph/CH2NO2 
VIII (20) 20 
 
syn-23b 
95 (86)e 16:84 >99:1f 
4 
21b 
Me/(R)-
Ph/CH2NO2 
ent-VIII 
(15) 
20 
 
anti-23b 
100 (80)e 96:4 >99:1f 
5 
21c 
Me/(S)-
pOMePh/CH2NO2 
VIII (15) 22 
 
anti-23c 
95 (79) 93:7 99:1g 
6 
21d 
Me/(S)-
pBrPh/CH2NO2 
VIII (15) 22 
 
anti-23d 
85 (53) 95:5 >99:1g 
7 
21e 
Pr/(S)-Ph/CH2NO2 
VIII (20) 72 
 
anti-23e 
32 97:3 >99:1g 
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8h 
21e 
Pr/(S)-Ph/CH2NO2 
VIII (20) 48 
 
anti-23e 
69 (35) 85:15 >99:1g 
9h 
21f 
iPr/(S)-
Ph/CH2NO2 
VIII (20) 48 
 
anti-23f 
19 80:20 >99:1g 
10 
21g 
Me/(S)-
Ph/CH(Me)NO2 
VIII (20) 72 
 
anti-23g 
74 
(35)i 
96:4 >99:1g 
11 
rac-21h 
Me/C6H3OCH2O/
H 
ent-VIII 
(20) 
48 
 
23h 
81  
(75) 
- 82:18f 
12 
21i 
Me/(S)-
Cy/CH2NO2 
VIII (15) 24 
 
anti-23i 
100 
(85) 
91:9 >99:1g 
13 
21j 
Me/(S)-
iBu/CH2NO2 
VIII (15) 17 
 
anti-23j 
100 
(81) 
90:10 nd 
14 
21k 
Me/(S)-
iPr/CH2NO2 
VIII (15) 24 
 
anti-23k 
100 
(25)1 
86:14 >99:1g 
Table 9: Substrates scope.a Reaction conditions: 1 (0.1448 mmol), 2 (NFSI, 1.2 equiv), TFA (equimolar amount with the 
catalyst), TBME (0.6 mL), rt. b Determined by 1H NMR of the crude mixture. c Determined after chromatographic 
purification. d Determined by chiral stationary phase (CSP)-HPLC on isolated product. e Reaction set at 50 °C. f 
Determined on product reduced with NaBH4. [g] Derived from ee of starting aldehyde 1.[h] Reaction carried out at 50 °C. 
[i] Data obtained from a not optimized process. nd = not determined. Cy = cyclohexyl, iBu = isobutyl, iPr = isopropyl. 
 
 
The developed asymmetric fluorination was applied to differently substituted α,α-dialkyl 
aldehydes 21c–21k (Table 3). The introduction of electron-donating (entry 5, 21c) and 
electron-withdrawing (entry 6, 21d) groups on the Cβ-aromatic ring did not interfere with 
the successful fluorination reaction. Conversely, increasing the steric hindrance at the Cα 
position significantly affected the efficiency of the construction of the quaternary carbon 
(entries 7–9). With an n-propyl substituent (21e), the conversion was low at room 
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temperature (entry 7), and it increased at 50 °C (entry 8), although the diastereomeric ratio 
decreased slightly. For the isopropyl derivative (i.e., 21f) the fluorination proceeded very 
slowly, despite a higher temperature (entry 9). Afterwards, we applied our protocol to 
(3S,4R)-2-methyl-4-nitro-3-phenylpentanal (21g), which contains three stereocenters, and 
was used as mixture of two Cα epimers (dr = 84:16). The α-fluorination took place, and 
although the process was not optimized, product 23g was obtained with excellent 
stereoselectivity (Table 3, entry 10). 
Next, racemic 2-methyl-3-(3,4-methylenedioxyphenyl) propanal (21h) was subjected to the 
organocatalytic asymmetric fluorination (entry 11). The reaction proceeded smoothly in the 
presence of catalyst ent-VIII, and the two enantiomers of product 23h were formed in a 
noteworthy 82:18 ratio.57 This result represents the second most enantioselective 
fluorination of a racemic α,α-dialkyl aldehyde, and the best ever result obtained using a 
commercially available secondary amine as an organocatalyst. The enantiocontrol recorded 
for Cβ-unsubstituted product 23h did not reflect the diastereocontrol observed for the Cβ-
substituted compounds 23a–23g. Although in many examples we obtained evidence of a 
catalyst-controlled process, in the case of 21h the steric and geometric constraints imposed 
by a longer branched chain significantly affect the distribution of the enamines and/or their 
reactivity with the fluorinating agent. 
We also successfully applied our protocol to α,α-dialkyl aldehydes derived from aliphatic 
nitroalkenes (21i–21k, entries 12–14), demonstrating the efficiency of the developed 
asymmetric fluorination process. 
 
The α-fluorination of substrates similar as aldehyde 21h has been studied also by Shibatomi 
and coworkers.58They revealed that a kinetic resolution of the starting aldehydes was 
involved. We decided to further investigate the α-fluorination of 21h under different 
reaction conditions (Table 10). 
Entrya Catalyst TFA (%) t (h) 
Conversion 
(%)b 
erc 
1 Ent-VIII 20 
20 h 
48 h 
70 
81 
- 
18:82 
2 VIII 20 3.5 h 85 73:27 
3 Ent-VIII - 
3.5 h 
24h 
31 
59 
- 
46:54 
Table 10: a Reaction conditions: 1a (30 mg, 0.048 mmol), NFSI (1.2 equiv), catalyst (20 mol%), TBME (0.6 mL), room 
temperature (rt). b Determined by 1H NMR of the crude mixture. c Determined by chiral stationary phase (CSP)-HPLC 
after reduction to the corresponding alcohol. h = hours, TFA = trifluoroacetic acid, TBME = tert-butylmethylether. 
                                                          
57 For the synthesis and stereochemical determination of substrate 1g, see: G. Sahoo, H. Rahaman, A. Madarasz, I. Papai, 
M. Melarto, A. Valkonen, P. M. Pihko, Angew. Chem. Int. Ed. 2012, 51, 13144–13148; Angew. Chem. 2012, 124, 13321–
13325. 
58 K. Shibatomi, T. Okimi, Y. Abe, A. Narayama, N. Nakamura, S. Iwasa, Beilstein J. Org. Chem. 2014, 10, 323. 
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As showed by the data summarized in Table 10, catalyst ent-VIII provided the fluorinated 
product 23h with higher stereocontrol (er = 18/82, entry 1), but catalyst VIII promoted a 
faster reaction (entry 2). Moreover, we further demonstrated that the acid additive was able 
to increase both reaction rate and stereocontrol (cf. entry 1 with entry 3).  
 
In order to determinate the absolute configuration of compounds anti-23a and syn-23a, we 
reduced and cyclized giving the corresponding cyclized substitute pyrrolidine (i.e., cis-24 and 
trans-24; Scheme 25) and recorded several nOe experiments. The stereochemistry 
determined in this way was extended to all the molecules of the series (Table 9) provided by 
the same organocatalytic protocol (see Chapter 3.8 for the spectra).  
 
 
Scheme 25: Synthesis of fluorinated pyrrolidines cis-24 and trans-24, derived from the stereochemically defined α-
fluoro-γ-nitro aldehydes anti-23a and syn-23a, respectively. 
 
In order to investigate the enamine formation in the developed fluorination reaction we 
studied the enamine formation by mixing 21a (syn/anti = 68:32) and catalyst VII or ent-VII 
(30 mol-%) in d8-THF in a standard 5 mm NMR tube at the same concentrations used for the 
synthetic experiments. 
Entrya Catalyst Time (h) Conversion (%)b 
dr enamine 
E/Zb 
dr 21ab  
(syn/anti) 
1 ent-VII (30%) 
1 
2.5 
5.5 
20 
24 
26 
92/8 
92/8 
88/12 
74/26 
76/24 
76/24 
2 VII (30%) 
1 
2.5 
5.5 
22 
23 
30 
94/6 
94/6 
94/6 
54/46 
52/48 
52/48 
Table 11: Scanning of enamine formation with catalyst VII and ent-VII. a Reaction conditions: 1a (30 mg, 0.145 mmol), 
catalyst (14 mg, 30 mol%), THF-d8 (0.6 mL), room temperature (rt), reaction carried out into NMR sample tube. b 
Determined by 1H NMR of the crude mixture. h = hours.  
 The enamine formation was almost complete after 1 h at room temperature (24 % 
conversion, with respect to 30 mol-% of catalyst present) for catalyst VII, while a slower 
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reaction was observed for ent-VII (17 % conversion). After 5.5 h, the conversion reached 30 
% for VII and 21 % for ent-VII. In both cases, only two enamine intermediates were detected, 
in ratios of 95:5 and 90:10, respectively. These observations agree with the results of the 
fluorination reported, which identify VII/1a and ent-VII/1a as the matched and the 
mismatched pair, respectively. nOe experiments showed how the major enamine formed is 
an E-configured s-trans enamine (25a or 26a); the minor enamine was presumably the less 
stable Z-configured s-trans enamine (25c or 26c).  
  
Figure 9: 1H-NMR at 5.5 h with catalyst VII (entry 2) / 1D NOESY, irradiation at 6.1 ppm 
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Figure 10: 1H-NMR at 5.5 h with catalyst ent-VII (entry 1) / 1D NOESY, irradiation at 6.1 ppm 
The 1D NOESY spectra of enamines showed no answer for the CH3 signals for both the 
catalysts VII and ent-VII, confirming the E-configuration of the double bond. The nOe signal 
for proton H1 confirmed also the preferential s-trans conformation.  
Moreover, during the NMR experiments, we confirmed that when (S)-configured catalyst VII 
was used, the syn-21a isomer was consumed preferentially (21a syn/ anti = 52:48 after 5.5 
h). The anti-21a isomer was the favoured substrate when (R)-configured catalyst ent-VII (21a 
syn/anti = 76:24 after 5.5 h) was used. The preferential formation of E-configured s-trans 
enamines was not unexpected, since according to the most credited reaction mechanism for 
the formation of enamines from the corresponding iminium intermediates, deprotonation 
must occur opposite to the side of the bulky substituent of the pyrrolidine ring, arranging 
the hydrogen parallel to the iminium π-orbital system. Based on this result, we propose a 
mechanism for the formation of the enamines as reported in Scheme 26.  
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Scheme 26: Proposed reaction mechanism for the formation of enamine intermediates 25a, 25c and 26a, 26c using 
catalysts VII and ent-VII, respectively. 
Finally, we integrated into a one-pot process the synthesis of anti-23a starting from propanal 
and trans-nitro-styrene, thus carrying out the Michael–fluorination sequence with the same 
organocatalyst, and avoiding the intermediate purification step (Scheme 27). The good 
results obtained reflects the performances of the separate synthetic steps, and allow us to 
save catalyst, solvent, and time. 
 
Scheme 27: One-pot Michael/fluorination sequence, stereoselectively giving compound anti-23a starting from 
propanal and trans-β-nitrostyrene. 
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3.6 Conclusion 
 
In conclusion a new organocatalysed protocol for the α-fluorination of α,α-dialkyl aldehydes 
has been accomplished. The results are comparable and superior to the one reported in 
literature. The presence of β stereocenters does not interferes with the the 
diastereoselection of the reaction, that appears to be catalyst-governed. The transformation 
allows easily to build fully substituted quaternary stereocenters, often presents in 
pharmaceuticals and drugs. The one-pot nitromichael-fluorination reaction gives results 
similar to the single steps. The absolute configuration of the intermediates has been 
determined and the mechanism of the reaction has been clearified. 
 
3.7 General Procedures and Products Characterization 
 
General Information. 1H and 13C NMR spectra were recorded on Varian Gemini 200 or 
Inova 400 NMR instruments with a 5 mm probe. Chemical shifts (δ) are reported in ppm, 
relative to the residual peaks of deuterated solvent signals.  
HPLC-MS analyses were performed on an Agilent Technologies HP1100 instrument coupled 
with an Agilent Technologies MSD1100 single-quadrupole mass spectrometer. A 
Phenomenex Gemini C18, 3 μm (100 x 3mm) column was employed for the chromatographic 
separation: mobile phase H2O/CH3CN, gradient from 30% to 80% of CH3CN in 8 min, 80% of 
CH3CN until 22 min, then up to 90% of CH3CN in 2 min, flow rate 0.4 mL min−1. Mass 
spectrometric detection was performed in full-scan mode from m/z 50 to 2500, scan time 
0.1 s in positive ion mode, ESI spray voltage 4500 V, nitrogen gas 35 psi, drying gas flow rate 
11.5 mL min-1, fragmentor voltage 30 V.  
GC-MS spectra were taken by EI ionization at 70 eV on a Hewlett-Packard 5971. They are 
reported as: m/z (rel. intense).  
CSP-HPLC analyses were performed on an Agilent Technologies Series 1200 instrument using 
Daicel® chiral columns and n-hexane/2-propanol (n-Hex/IPA) mixtures.  
Optical rotation measurements were performed on a polarimeter Schmidt+Haensch UniPol 
L1000.  
Flash chromatography purifications were carried out using Merck silica gel 60 (230-400 mesh 
particle size). Thin layer chromatography was performed on Merck 60 F254 plates.  
Commercial reagents were used as received without additional purification.  
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Synthesis of aldehydes 1a-g.  
Compounds 21a-g are known and were prepared according to the literature procedures.59 
Aliphatic nitroalkenes are also known and were prepared according to the literature 
procedures.60 Compound 21h is commercially available and was used without further 
purification. 
 
 
Scheme 28: synthesis of the starting materials 
 
                                                          
59 a) K. Patora-Komisarskaa, M. Benohouda, H. Ishikawaa, D. Seebach, Y. Hayashi, Helvetica Chimica Acta, 2011, 94, 719. 
b) S. Zhu, S. Yu, D. Ma, Angew. Chem. Int. Ed. 2008, 47, 545 c) G. Sahoo, H. Rahaman, A. Madaràsz, I.Pàpai, M. Melarto, 
A. Valkonen, P. M. Pihko, Angew. Chem., 2012, 124, 13321.  
60 a) Q. Yan, M. Liu, D. Kong, G. Zi, G. Hou, Chem. Commun. 2014, 50, 12870. b) Sivakumar, B. Venkata et al, PCT Appl, 
2008117305, 02 oct 2008. 
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General Procedure for the Organocatalyzed Fluorination of aldehydes 21.  
NFSI (0.058 mmol, 1.2 equiv) was added to a solution of aldehyde 21 (0.048 mmol, 1 equiv), 
VIII (20 mol%) and TFA (20% mol) in MTBE (0.2 mL). The mixture was stirred at room 
temperature and the conversion was monitored by TLC and 1H NMR. The crude mixture was 
quenched with 0.1 mL of NH4Cl (saturated solution) and extracted with AcOEt (3 × 2 mL). 
The organic phases were collected and dried over Na2SO4, the solvent was evaporated under 
reduced pressure without heating, and the product was purified by flash chromatography 
on silica gel (cyclohexane/ethyl acetate = 90/10). 
 
  
anti-23a (anti/syn = 97:3): 75% yield, brown oil. 1H NMR (400 MHz, CDCl3) δ = 9.8 (d, J = 5 
Hz, 1H, maj), 9.40(d, J = 5.3 Hz, 1H, min), 7.32(m, 5H,) 4,83 (dd, J = 10.3, 13.2 Hz, 1H, maj), 
4.67(dd, J = 4.7, 13.2 Hz, 1H, maj), 3.98(ddd, J = 4.7, 10.2, 28.5 Hz, 1H, maj), 1.20(d, J = 22.3 
Hz, 3H, maj). 13C NMR (100 MHz, CDCl3) δ = 199.9 (d, J = 39.2 Hz, 1C), 133.7, 129.33, 129.31, 
129.3 (2C), 128.9, 99.6 (d, J = 185 Hz, 1C), 75.7 (d, J = 6.3 Hz, 1C), 48.6 (d, J = 19.2 Hz, 1C), 
20.0 (d, J = 23.6 Hz, 1C). 19F NMR (400 MHz, CDCl3) δ = −169.7 (m, 1F). GC-MS: tR = 13.58 min, 
m/z = 225 (2.8, M), 178 (18.5, M − HNO2), 104 (100, PhCH2CH2). [α]D25 = 38 (c = 0.50, CH2Cl2). 
[α]D25 = -16 (c = 0.84, CH2Cl2). The enantiomeric excess was determined after reduction to 
the corresponding alcohol. 
 
syn-23a (anti/syn = 11:89): 85% yield, brown oil. 1H NMR (400 MHz, CDCl3) δ = 9.8 (d, J = 5 
Hz, 1H, min), 9.40 (d, J = 5.3 Hz, 1H, maj), 7.30 (m, 5H), 4.97 (dd, J = 5, 13.3 Hz, 1H, maj), 4.84 
(dd, J = 9.8, 13.4 Hz, 1H, maj), 4.67 (dd, J = 4.7, 13.2 Hz, 1H, min), 3.95 (ddd, J = 5.1, 9.7, 26.9 
Hz, 1H, maj), 1.54 (d, J = 21.7 Hz, 3H, maj). 13C NMR (100 MHz, CDCl3) δ = 199.7 (d, J = 39.2 
Hz, 1C), 133.5, 129.14, 129.12, 129.07 (2C), 128.8, 99.4 (d, J = 185 Hz, 1C), 75.5 (d, J = 6.3 Hz, 
1C), 48.4 (d, J = 19.2 Hz, 1C), 19.8 (d, J = 23.6 Hz, 1C). 19F NMR (400 MHz, CDCl3) δ = −168.3 
(m, 1F, maj), -170.5 (m, 1F, min). GC-MS: tR = 13.65 min, m/z= 225 (1, M), 178 (17.6, M − 
HNO2), 104 (100, PhCH2CH2). The enantiomeric excess was determined after reduction to 
the corresponding alcohol. 
 
syn-23b (anti/syn = 16:84): 86% yield, brown oil. 1H NMR (400 MHz, CDCl3) δ = 9.8 (d, J = 5 
Hz, 1H, min), 9.40 (d, J = 5.3 Hz, 1H, maj), 7.30 (m, 5H), 4.95 (dd, J = 5.0, 13.4 Hz, 1H, maj), 
4.83 (dd, J = 9.7, 13.4 Hz, 1H, maj), 4.67(dd, J = 4.7, 13.2 Hz, 1H, min), 3.94 (ddd, J = 5.1, 9.7, 
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26.8 Hz, 1H, maj), 1.53 (d, J = 21.8 Hz, 3H, maj), 1.20(d, J = 22.3 Hz, 3H, min). 13C-NMR (100 
MHz, CDCl3) δ = 199.7 (d, J = 39.2 Hz, 1C), 133.5, 129.14, 129.12, 129.07(2C), 128.8, 99.4 (d, 
J = 185 Hz, 1C), 75.5 (d, J = 6.3 Hz, 1C), 48.4 (d, J = 19.2 Hz, 1C), 19.8 (d, J = 23.6 Hz, 1C). 19F 
NMR (400 MHz, CDCl3) δ = −168.3 (m, 1F, maj), −170.5 (m, 1F, min). GC-MS: tR = 13.65 min, 
m/z = 225 (1, M), 178 (17.6, M − HNO2), 104 (100, PhCH2CH2). The enantiomeric excess was 
determined after reduction to the corresponding alcohol. 
 
anti-23b (anti/syn = 96:4): 80% yield, brown oil. 1H NMR (400 MHz, CDCl3) δ = 9.8 (d, J = 5 
Hz, 1H, min), 9.40 (d, J = 5.3 Hz, 1H, maj), 7.30 (m, 5H), 4.97 (dd, J = 5, 13.3 Hz, 1H, maj), 4.84 
(dd, J = 9.8, 13.4 Hz, 1H, maj), 4.67 (dd, J = 4.7, 13.2 Hz, 1H, min), 3.95 (ddd, J = 5.1, 9.7, 26.9 
Hz, 1H, maj), 1.54 (d, J = 21.7 Hz, 3H, maj). 13C NMR (100 MHz, CDCl3) δ = 199.9 (d, J = 39.2 
Hz, 1C), 133.7, 129.33, 129.31, 129.3 (2C), 128.9, 99.6 (d, J = 185 Hz, 1C), 75.7 (d, J = 6.3 Hz, 
1C), 48.6 (d, J = 19.2 Hz, 1C), 20.0 (d, J = 23.6 Hz, 1C). 19F NMR (400 MHz, CDCl3) δ = −169.7 
(m, 1F). GC-MS: tR = 13.58 min, m/z= 225 (2.8, M), 178 (18.5, M − HNO2), 104 (100, 
PhCH2CH2). The enantiomeric excess was determined after reduction to the corresponding 
alcohol. 
 
anti-23c (anti/syn = 93:7): 79% yield, brown oil. 1H NMR (400 MHz, CDCl3) δ = 9.77 (d, J = 5.1 
Hz, 1H, maj), 9.38(d, J = 5.4 Hz, 1H, min), 7.18(d, J = 8.6 Hz, 2H, maj), 6.87 (m, 2H, maj), 
6.83(m, 2H, min), 4.91(dd, J = 5, 13.1 Hz, 1H, min), 4.76 (dd, J = 10.4, 13 Hz, 1H, maj), 4.61 
(dd, J = 4.7, 13 Hz, 1H, maj), 3.90 (ddd, J = 4.7, 10.4, 28.5 Hz, 1H, maj), 3.78 (s, 3H, maj), 3.76 
(s, 3H, min), 1.18 (d, J = 22.4 Hz, 3H, maj). 13C NMR (100 MHz, CDCl3) δ = 199.9 (d, J = 5, 39 
Hz, 1C), 159.8, 130.2 (2C), 125.3, 114.4 (2C), 99.6 (d, J = 184.4 Hz, 1C), 75.7 (d, J = 6.2 Hz, 1C), 
55.2, 47.8 (d, J = 19.3 Hz, 1C), 19.8 (d, J = 23.4 Hz, 1C). 19F NMR (400 MHz, CDCl3) δ = −167.8 
(m, 1F, min), −169.8 (dqd, J = 27.3, 22.4, 5.3 Hz 1F, maj). GC-MS: tR = 16.49 min, m/z= 255 
(9.2, M), 208 (8.6, M − HNO2), 134 (100, CH3OPhCH2CH2). [α]D25 = -26.4 (c = 1.2, CH2Cl2). The 
enantiomeric excess was not determined. 
64 
 
 
anti-23d (anti/syn = 95:5): 53% yield, brown oil. 1H NMR (400 MHz, CDCl3) δ = 9.79 (d, J = 4.8 
Hz, 1H, maj), 9.41 (d, J = 5.1 Hz, 1H, min), 7.52 (d, J = 8.5 Hz, 2H, maj), 7.18 (d, J = 8.5, 2H, 
maj), 4,78 (dd, J = 10.6, 13.1 Hz, 1H, maj), 4.63 (dd, J = 4.5, 13.3 Hz, 1H, maj), 3.95(ddd, J = 
4.6, 10.6, 28.8 Hz, 1H, maj), 1.20 (d, J = 22.3 Hz, 3H, maj). 13C NMR (100 MHz, CDCl3) δ = 
199.4 (d, J = 39.6 Hz, 1C), 132.6, 130.3 (2C), 130.8 (2C), 123.1, 99.1 (d, J = 185 Hz, 1C), 75.3 
(d, J = 6.1 Hz, 1C), 47.9 (d, J = 19.1 Hz, 1C), 19.9 (d, J = 23.4 Hz, 1C). 19F NMR (400 MHz, CDCl3) 
δ = −170 (m, 1F, min), −168(dqd, J = 27.4, 22.2, 8.4 Hz 1F, maj). GC-MS: tR = 16.90 min, m/z= 
305 (8.3, M), 258 (22, M − HNO2), 182 (100, BrPhCH2CH2). [α]D25 = -20 (c = 1.12, CH2Cl2). The 
enantiomeric excess was determined for the corresponding starting aldehyde 21d. 
  
anti-23e (anti/syn = 82:15): 35% yield, brown oil. 1H NMR (400 MHz, CDCl3) δ = 9.81 (d, J = 
5.6 Hz, 1H, maj), 9.40 (d, J = 5.9 Hz, 1H, min), 7.33 (m, 5H), 4.94 (dd, J = 4.9, 13.4 Hz, 1H, 
min), 4.81 (dd, J = 10.3, 13.2 Hz, 1H, maj), 4.61 (dd, J = 4.5, 13.2 Hz, 1H, maj), 3.97 (ddd, J = 
4.4, 10.4, 28.9 Hz, 1H, maj), 1.53 (m, 2H), 1.28(m, 2H), 0.93(t, J = 7.4 Hz, 3H, min), 0.78 (t, J 
= 7.3 Hz, 3H, min). 13C NMR (100 MHz, CDCl3) δ = 199.7 (d, J = 39.2 Hz, 1C, maj), 133.5, 129.14, 
129.12, 129.07 (2C), 128.8, 99.4 (d, J = 185 Hz, 1C), 75.5 (d, J = 6.3 Hz, 1C), 48.4 (d, J = 19.2 
Hz, 1C), 19.8 (d, J = 23.6 Hz, 1C). 19F NMR (400 MHz, CDCl3) δ = −176.5 (m, 1F, min), −177 
(ddt, J = 5.6, 10.4, 29.7 Hz, 1F, maj). GC-MS: tR = 15.56 min(maj), m/z= 206 (8.3, M-HNO2),150 
(22, M – PHC2H3NO2), 104 (100, PhC2H2NO2), tR = 15.66 min(min), m/z= 206 (8.3, M-HNO2), 
104 (100, PhC2H2NO2). The enantiomeric excess was determined for the corresponding 
starting aldehyde 21e. 
 
anti-23g (anti/syn = 96:4): 35% yield, brown oil. 1H NMR (400 MHz, CDCl3) δ = 9.91 (d, J = 5.1 
Hz, 1H), 7.34 (m, 5H), 5.11 (dq, J = 10.3, 6.8 Hz, 1H), 3.78(dd, J = 30.4, 10.2 Hz, 1H), 1.54 (d, 
J = 6.7Hz, 3H), 1.97 (d, J = 22.5 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 200.5 (d, J = 40.1 Hz, 
1C), 134.7, 129.5 (2C), 129.1 (2C), 128.8, 100.2 (d, J = 186.5 Hz, 1C), 85.7 (d, J = 6.0 Hz, 1C), 
54.2 (d, J = 18.8 Hz, 1C), 21.5 (d, J = 23.6 Hz, 1C), 20.5. 19F NMR (400 MHz, CDCl3) δ = −172.4 
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(m, 1F). GC-MS: tR = 14.11 min, m/z= 221 (8, M-F), 118 (100, PhCHCHCH3), 91 (60, PhCH2) 
[α]D25 = 5 (c = 0.11, CH2Cl2). The enantiomeric excess was not determined. 
  
23h: 75% yield, brown oil. 1H NMR (400 MHz, CDCl3) δ = 9.7 (d, J = 5 Hz, 1H), 6.70 (m, 4H), 
5.95 (s, 2H), 3.05 (dd, J = 14.6, 24.6 Hz, 1H), 2.89 (dd, J = 14.6, 23.3 Hz, 1H), 1.38 (d, J = 21.5 
Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 202 (d, J = 40.6 Hz, 1C), 147.1 (d, J = 84.1, 1C), 127.3, 
123.6, 110.7, 108.1, 101.0, 98.7 (d, J = 179.2, 1C), 41.6 (d, J = 21.5 Hz, 1C), 20.3 (d, J = 23.6 
Hz, 1C). 19F NMR (400 MHz, CDCl3) δ = −155.4 (m, 1F). GC-MS: tR = 12.88 min, m/z= 218 (20, 
M), 135 (100, PhC2H4O2). The enantiomeric excess was determined after reduction to the 
corresponding alcohol. 
 
23i: (anti/syn = 91:9): 85% yield, yellow oil. 1H NMR (400 MHz, CDCl3) δ = 1H NMR (400 MHz, 
CDCl3) δ = 9.79 (d, J = 5.9 Hz, 1H, maj), 9.74(d, J = 5.4 Hz, 1H, min), 4.60(dd, J = 14.6, 6.5 Hz, 
1H, min), 4.51(dd, J = 14.1, 5.9 Hz, 1H, maj), 4.44 (dd, J = 14.5, 5.1 Hz, 1H, maj), 2.84 (dtd, J 
= 20.0, 5.8, 2.9 Hz, 1H, maj), 1.72 (m, 4H, maj), 1.47 (d, J = 22.4 Hz, 3H, maj), 1.16(s, 7H, maj). 
13C NMR (100 MHz, CDCl3) δ 200.1 (d, J = 39.2 Hz, 1C), 99.5 (d, J = 182.2 Hz, 1C), 72.4 (d, J = 
7.7 Hz, 1C), 47.6 (d, J = 20.5 Hz, 1C), 36.9 (d, J = 1.5 Hz, 1C), 31.8 (d, J = 1.1 Hz, 1C), 28.9 (d, J 
= 2.3 Hz, 1C), 26.7, 26.4, 26.0, 19.4 (d, J = 23.7 Hz, 1C).  19F NMR (400 MHz, CDCl3) δ = −162.3 
(dp, J = 22.1, 5.4 Hz 1F, maj), −167.6 (m, 1F, min). GC-MS: tR = 14.15 min, m/z= 202 (5, M-
CHO), 83 (60, Cycloesyl) 55 (100, CH3CHCHCH2). 
 
23j: (anti/syn = 84:16): 81% yield, yellow oil. 1H NMR (400 MHz, CDCl3) δ = = 9.73 (d, J = 5.4 
Hz, 1H, maj), 9.69 (d, J = 5.5 Hz, 1H, min), 4.55(dd, J = 13.4, 6.4 Hz, 1H, maj), 4.40(dd, J = 12.5, 
7.2 Hz, 1H, min), 4.29 (ddd, J = 13.4, 5.3, 1 Hz, 1H, maj), 2.89 (m, 1H, maj), 1.57 (m, 2H, maj), 
1.40 (d, J = 22.4 Hz, 3H, maj), 1.18 (m, 1H, maj), 0.91 (dd, J = 7.0 Hz, 3H, maj), 0.92 (d, J = 6.6 
Hz, 3H, maj), 0.90 (d, J = 6.4 Hz, 3H, maj).  13C NMR (100 MHz, CDCl3) δ = 199.9 (d, J = 39.9 
Hz, 1C), 99.9 (d, J = 179.6 Hz, 1C), 75.1 (d, J = 6.1 Hz, 1C), 40.2 (d, J = 21.4 Hz, 1C), 36.2 (d, J = 
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3.5 Hz, 1C), 25.8, 23.4, 21.4, 17.7 (d, J = 23.6 Hz, 1C). 19F NMR (400 MHz, CDCl3) δ = −161.9 
(dqd, J = 22.5, 14.1, 4.6 Hz 1F, maj), −167.6 (m, 1F, min).  GC-MS: tR = 9.97 min, m/z = 192 
(100, isobutylene).  
 
23k: (anti/syn = 83:17): 25% yield, brown oil. 1H NMR (400 MHz, CDCl3) δ = 9.78 (d, J = 6.0 
Hz, 1H, maj), 9.69(d, J = 5.5 Hz, 1H, min), 4.59(dd, J = 14.6, 6.6 Hz, 1H, min), 4.50(dd, J = 14.1, 
6.1 Hz, 1H, maj), 4.38 (ddd, J = 14.2, 5.2, 1 Hz, 1H, maj), 2.86 (dtd, J = 21.0, 5.9, 2.9 Hz, 1H, 
maj), 2.20 (pd, J = 7.0, 3.0 Hz, 4H, maj), 1.46 (d, J = 22.4 Hz, 3H, maj), 1.38 (d, J = 22.0 Hz, 3H, 
min), 1.01 (d, J = 7.0 Hz, 3H, maj), 0.9 (dd, J = 6.9, 1.3 Hz, 3H, maj). 13C NMR (100 MHz, CDCl3) 
δ = 200.2 (d, J = 39.7  Hz, 1C), 99.7 (d, J = 182.5 Hz, 1C), 71.8 (d, J = 7.1 Hz, 1C), 47.5 (d, J = 
20.3 Hz, 1C), 29.8, 21.6, 19.4 (d, J = 23.8 Hz, 1C), 18.2.  19F NMR (400 MHz, CDCl3) δ = −164.3 
(dqd, J = 22.1, 21.6, 4.6 Hz 1F, maj), −169.4 (m, 1F, min).  GC-MS: tR = 9.45 min, m/z = 115 
(50, NO2CHCHCH(CH3)2). 
 
General Procedure for the reduction of fluorinated aldehydes 23. 
NaBH4 (0.45 mmol, 3 equiv) was added to a solution of the aldehyde 23 (0.15 mmol, 1 equiv) 
in MeOH (1.5 mL) at 0 °C. The mixture was stirred at room temperature and the conversion 
was monitored by TLC. The crude mixture was quenched with 1 mL of NH4Cl (saturated 
solution) and extracted with AcOEt (3 × 3 mL). The organic phases were collected and dried 
over Na2SO4, the solvent was evaporated under reduced pressure and the product was 
purified by flash chromatography on silica gel (cyclohexane/ethyl acetate = 85/15). 
 
anti-27a (anti/syn = 97:3): 1H NMR (400 MHz, CDCl3) δ = 7.32 (m, 5H), 5.04 (m, 1H), 4.89 (dd, 
J = 10.1, 13.2 Hz, 1H), 4.21(ddd, J = 13.5, 10.1, 5.8 Hz, 1H, maj), 3.88 (ddd, J = 14.9, 8.4, 6.6 
Hz, 1H, min), 1.36 (d, J = 22.2 Hz, 3H, min), 1.23 (d, J = 22.4 Hz, 3H, maj). 13C NMR (100 MHz, 
CDCl3) δ = 135.5 (d, J =5.0 Hz, 1C, min), 135.3 (d, J =6.6 Hz, 1C, maj), 129.2, 129.0 (3C), 128.4, 
98.2 (d, J = 175.5 Hz, 1C, maj), 97.6 (d, J = 177.1 Hz, 1C, min), 76.5 (d, J = 5.7 Hz, 1C, min), 
75.7 (d, J = 5.2 Hz, 1C, maj), 66.8 (d, J = 23.5 Hz, 1C, maj), 66.2 (d, J = 24.6 Hz, 1C, min), 51.1 
(d, J = 21.0 Hz, 1C, min), 47.9 (d, J = 21.3 Hz, 1C, maj), 21.7 (d, J = 23.3 Hz, 1C, min), 18.7 (d, 
J = 23.4 Hz, 1C, maj). 19F NMR (400 MHz, CDCl3) δ = −159.1.7 (m, 1F, maj), -160.0 (m, 1F, min). 
GC-MS: tR = 15.75 min, m/z = 227 (2.4, M), 180 (10, M − HNO2), 150 (15, M − CHOH), 104 
(100, PhCH2CH2). [α]D25 = -9.6 (c = 0.16, CH2Cl2). CSP-HPLC: IC 95/5 n-Hex/IPA, flow rate 0.5 
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mL/min at 40 °C; λ 214 nm; tR = 26.3 min (syn major), 30.1 min (syn minor), 37.2 min (anti 
major), 43.1 min (anti minor). 
 
syn-27a (anti/syn = 11:89): 1H NMR (400 MHz, CDCl3) δ = 7.32 (m, 5H), 5.04 (m, 1H), 4.89 
(dd, J = 10.1, 13.2 Hz, 1H), 4.21 (ddd, J = 13.5, 10.1, 5.8 Hz, 1H, min), 3.88 (ddd, J = 14.9, 8.4, 
6.6 Hz, 1H, maj), 1.36 (d, J = 22.2 Hz, 3H, maj), 1.23 (d, J = 22.4 Hz, 3H, min). 13C NMR (100 
MHz, CDCl3) δ = 135.5 (d, J =5.0 Hz, 1C, maj), 135.3 (d, J =6.6 Hz, 1C, min), 129.2, 129.0 (3C), 
128.4, 98.2 (d, J = 175.5 Hz, 1C, min), 97.6 (d, J = 177.1 Hz, 1C, maj), 76.5 (d, J = 5.7 Hz, 1C, 
maj), 75.7 (d, J = 5.2 Hz, 1C, min), 66.8 (d, J = 23.5 Hz, 1C, min), 66.2 (d, J = 24.6 Hz, 1C, maj), 
51.1 (d, J = 21.0 Hz, 1C, maj), 47.9 (d, J = 21.3 Hz, 1C, min), 21.7 (d, J = 23.3 Hz, 1C, maj), 18.7 
(d, J = 23.4 Hz, 1C, min). 19F NMR (400 MHz, CDCl3) δ = −159.1.7 (m, 1F, min), -160.0 (m, 1F, 
maj). GC-MS: tR =15.76 min, m/z= 227 (0.5, M), 180 (17, M − HNO2) 150 (17.5, M − CHOH), 
104 (100, PhCH2CH2). CSP-HPLC: IC 95/5 n-Hex/IPA, flow rate 0.5 mL/min at 40 °C; λ 214 nm; 
tR = 26.3 min (syn major), 32.5 min (syn minor), 37.3 min (anti major), 43.1 min (anti minor). 
 
syn-27b (anti/syn = 16:84): 1H NMR (400 MHz, CDCl3) δ = 9.8 (d, J = 5 Hz, 1H, min), 9.40 (d, J 
= 5.3 Hz, 1H, maj), 7.30 (m, 5H), 4.95 (dd, J = 5.0, 13.4 Hz, 1H, maj), 4.83 (dd, J = 9.7, 13.4 Hz, 
1H, maj), 4.67 (dd, J = 4.7, 13.2 Hz, 1H, min), 3.94 (ddd, J = 5.1, 9.7, 26.8 Hz, 1H, maj), 1.53 
(d, J = 21.8 Hz, 3H, maj), 1.20 (d, J = 22.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 135.5 (d, J 
=5.0 Hz, 1C, maj), 135.3 (d, J =6.6 Hz, 1C, min), 129.2, 129.0 (3C), 128.4, 98.2 (d, J = 175.5 Hz, 
1C, min), 97.6 (d, J = 177.1 Hz, 1C, maj), 76.5 (d, J = 5.7 Hz, 1C, maj), 75.7 (d, J = 5.2 Hz, 1C, 
min), 66.8 (d, J = 23.5 Hz, 1C, min), 66.2 (d, J = 24.6 Hz, 1C, maj), 51.1 (d, J = 21.0 Hz, 1C, maj), 
47.9 (d, J = 21.3 Hz, 1C, min), 21.7 (d, J = 23.3 Hz, 1C, maj), 18.7 (d, J = 23.4 Hz, 1C, min). 19F 
NMR (400 MHz, CDCl3) δ = −159.1.7 (m, 1F, min), -160.0 (m, 1F, maj). GC-MS: tR =15.76 min, 
m/z= 227 (0.5, M), 180 (17, M − HNO2) 150 (17.5, M − CHOH), 104 (100, PhCH2CH2). CSP-
HPLC: IC 95/5 n-Hex/IPA, flow rate 0.5 mL/min at 40 °C; λ 214 nm; tR = 26.3 min (syn minor), 
30.1 min (syn major), 37.4 min (anti minor), 42.3 min (anti major). 
 
anti-27b (anti/syn = 96:4): 1H NMR (400 MHz, CDCl3) δ = 7.32 (m, 5H), 5.04 (m, 1H), 4.89 (dd, 
J = 10.1, 13.2 Hz, 1H), 4.21 (ddd, J = 13.5, 10.1, 5.8 Hz, 1H, maj), 3.88 (ddd, J = 14.9, 8.4, 6.6 
Hz, 1H, min), 1.36 (d, J = 22.2 Hz, 3H, min), 1.23 (d, J = 22.4 Hz, 3H, maj). 13C NMR (100 MHz, 
CDCl3) δ = 135.5 (d, J =5.0 Hz, 1C, min), 135.3 (d, J =6.6 Hz, 1C, maj), 129.2, 129.0 (3C), 128.4, 
98.2 (d, J = 175.5 Hz, 1C, maj), 97.6 (d, J = 177.1 Hz, 1C, min), 76.5 (d, J = 5.7 Hz, 1C, min), 
75.7 (d, J = 5.2 Hz, 1C, maj), 66.8 (d, J = 23.5 Hz, 1C, maj), 66.2(d, J = 24.6 Hz, 1C, min), 51.1 
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(d, J = 21.0 Hz, 1C, min), 47.9 (d, J = 21.3 Hz, 1C, maj), 21.7 (d, J = 23.3 Hz, 1C, min), 18.7 (d, 
J = 23.4 Hz, 1C, maj19F NMR (400 MHz, CDCl3) δ = −159.1.7 (m, 1F, maj), -160.0 (m, 1F, min). 
GC-MS: tR =15.75 min, m/z = 227 (2.4, M), 180 (10, M − HNO2), 150 (15, M − CHOH), 104 
(100, PhCH2CH2). CSP-HPLC: IC 95/5 n-Hex/IPA, flow rate 0.5 mL/min at 40 °C; λ 214 nm; tR = 
26.4 min (syn minor), 29.9 min (syn major), 37.4 min (anti minor), 43.1 min (anti major). 
 
27h: 1H NMR (400 MHz, CDCl3) δ = 6.73 (m, 2H), 6.66 (m, 1H), 5.92 (s, 2H), 3.56 (d, J = 19.4 
Hz, 2H), 2.89 (m, 2H), 1.24 (d, J = 21.9 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 146.1 (d, J = 
112.1, 1C), 129.5, 123.3, 110.7, 108.0, 100.8, 97.2 (d, J = 169.8, 1C), 67.5 (d, J = 24 Hz, 1C), 
41.9 (d, J = 23 Hz, 1C), 20.8 (d, J = 23.7 Hz, 1C). 19F NMR (400 MHz, CDCl3) δ = −155.4 (m, 1F). 
GC-MS: tR = 14.37 min, m/z = 192 (83, M − HF), 135 (100, CH3PhO2CH2). CSP-HPLC: OD-H, 
95/5 n-Hex/IPA, for 10 min, flow rate 0.5 mL/min at 40 °C; λ 214 nm; tR = 22.7 min (minor), 
23.9 min (major). 
General Procedure for the Michael/Fluorination one-pot reaction. 
Propanal (0.15 mmol, 1.5 equiv) was added dropwise to a solution of trans-β-nitrostyrene 
(0.1 mmol, 1 equiv), p-nitrophenol (20 mol%) and catalyst VIII (20 mol%) in toluene (600 L). 
The reaction was stirred at room temperature for 1 h. Then the solvent was evaporated 
under reduced pressure and the crude mixture was dissolved in MTBE (600 L). TFA (20 
mol%) and NFSI (0.12 mmol, 1.2 equiv) were added and the mixture was stirred at room 
temperature for 16 h. The crude mixture was quenched with 1 mL of NH4Cl (saturated 
solution) and extracted with AcOEt (3 × 2 mL). The organic phases were collected and dried 
over Na2SO4, the solvent was evaporated under reduced pressure without heating, and the 
product was purified by flash chromatography on silica gel (cyclohexane/ethyl acetate = 
90/10). 
 
General Procedure for the synthesis of pyrrolidines 4.61 
Ni-Raney (2.1 mmol, 5 equiv) was added at room temperature to the fluorinated aldehyde 
anti-23a or syn-23a (0.42 mmol, 1 equiv) dissolved in MeOH (3.5 mL). After stirring the 
reaction mixture for 24 h under hydrogen atmosphere (balloon, 1 bar), the reaction was 
filtered through a pad of celite and the solvent was evaporated under reduced pressure. The 
crude product was purified by flash chromatography (DCM/MeOH/NH4OH = 80:19:1) to 
provide the pure product 24. 
                                                          
61 D. Petruzziello, A. Gualandi, S. Grilli, P. G. Cozzi, Eur. J. Org. Chem. 2012, 6697. 
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cis-24: 13% yield, yellow oil. 1H NMR (400 MHz, CDCl3) δ = 7.34 (m, 2H), 7.25 (m, 3H), 3.74 
(dd, J = 11.8, 8.1, 1H), 3.43 (dt, J = 26.1, 7.1, 3H), 3.35 (dd, J = 17.3, 13.1, 1H), 3.25 (dd, J = 
11.8, 5.7 Hz, 1H), 2.96 (dd, J = 34.3, 13.2 Hz, 1H), 1.11 (d, J = 22.1 Hz, 3H). 13C NMR (100 MHz, 
CDCl3) δ = 135.2, 129.6, 129.5, 128.5 (2C), 127.6, 101.6 (d, J = 179.8 Hz, 1C), 58.0 (d, J = 24.4 
Hz, 1C), 54.8 (d, J = 19.2 Hz, 1C), 51.3, 20.1 (d, J = 27.1 Hz, 1C). 19F NMR (400 MHz, CDCl3) δ 
= −155.5(m, 1F). HPLC-MS (ESI) tr = 2.43 min; [M+H]+ 180.0 m/z. [α]D25 = -55 (c = 0.31, CH2Cl2). 
 
  
trans-24: 33% yield, yellow oil. 1H NMR (400 MHz, CDCl3) δ = 7.30 (m, 5H), 3.56 (m, 3H), 3.34 
(dd, J = 34.8, 13.1, 1H), 3.19 (dt, J = 30.5, 9.8 Hz, 1H), 1.37 (d, J = 20.8 Hz, 3H). 13C NMR (100 
MHz, CDCl3) δ = 139.9 (d, J = 8.7 Hz, 1C), 128.8 (1C),128.4 (1C), 127.3, 105.7 (d, J = 175.2 Hz, 
1C), 57.8 (d, J = 25.1 Hz, 1C), 55.7 (d, J = 24.3 Hz, 1C), 53.1, 19.9 (d, J = 26.0 Hz, 1C). 19F NMR 
(400 MHz, CDCl3) δ = −130.9(m, 1F). HPLC-MS (ESI) tr = 2.48 min; [M+H]+ 180.0 m/z. [α]D25 = 
21 (c = 1.13, CH2Cl2). 
Determination of Stereochemistry of Pyrrolidines cis-24 and trans-24 
 
1D NOESY experiments on both the stereoisomers of compound 24 allowed us to establish 
the relative configuration of the two stereocenters present in the molecules.  
Based on the known absolute stereochemistry of the Cβ stereocenter of starting aldehyde 
21a, we were able to establish also the absolute stereochemistry of products 24. 
The stereochemistry established for the two isomers of pyrrolidine 24 was extended to all 
the products of this series, obtained with the same catalytic system.  
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1H NMR spectrum of isomer trans-24. 
 
13C-NMR spectrum of trans-24. 
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1D NOESY spectrum of isomer trans-24, irradiation at 7.3 ppm 
 
 
1D NOESY spectrum of isomer trans-24, irradiation at 3.75 ppm 
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1D NOESY spectrum of isomer trans-24, irradiation at 3.5 ppm 
1D 
NOESY spectrum of isomer trans-24, irradiation at 3.4 ppm 
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1D NOESY spectrum of isomer trans-24, irradiation at 3.25 ppm 
1D 
NOESY spectrum of isomer trans-24, irradiation at 3.0 ppm 
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1D NOESY spectrum of isomer trans-24, irradiation at 1.1 ppm 
 
1H-NMR spectrum of isomer cis-24 
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1 
3C-NMR spectrum of isomer cis-24 
 
1D NOESY spectrum of isomer cis-24, irradiation at 7.4 ppm 
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1D NOESY spectrum of isomer cis-24, irradiation at 3.2 ppm 
 
1D NOESY spectrum of isomer cis-24, irradiation at 1.4 ppm 
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Chapter 4: Organocatalysis with carbon-based nanomaterials 
 
This part of the thesis focuses on a work done in collaboration with Prof. Maurizio Prato and 
co-workers from the University of Trieste,and treats the functionalization of Carbon 
Nanotubes and Fullerene with stable organocatalysts synthesized during my PhD, with the 
aim to study the use of these nanomaterials in organocatalytic transformations with the 
possibility to recycle the catalyst. These results will be soon submitted for publication. 
 
4.1 Organocatalysis on different supported materials 
 
Although organocatalyzed transformations can be considered as a green process, one of the 
principal drawback is the need for high catalyst loading. Usually a quantity between 5 and 
20 percent of catalyst is used in principal organocatalyzed reactions, while organometallic 
catalyst are often used less than 1 molar percent. Apart from economic advantages it is also 
very essential to elude the accumulation of unwanted waste products to make the processes 
environmentally benign. One way to overcome this lack is to make the organocatalyst highly 
recoverable. It is therefore of interest to develop efficient approaches for the recovery and 
reuse of asymmetric organocatalysts, which will make the reactions economical and 
environmentally friendly. Undoubtedly, the immobilization of catalysts onto different 
platforms is one of the promising processes and displays some advantage since it can allow 
simple product separation while offering the possibility of catalyst recycling as an additional 
bonus. Up to now, several papers have been reported describing how to immobilize the 
asymmetric organocatalysts on different supports.  
There are different example and approaches. One could be the immobilization of an 
organocatalyst on a silica support62, like the one reported by Fernandez-Mayoralas63 in 
Scheme 29, where the link is between the catalyst functionalized with a sylil group and 
MCM-41 (a mesophorous silica). 
 
                                                          
62 S. Rostamnia, E. Doustkhah; RSC Adv., 2014, 4, 28238–28248 
63 E. G. Doyaguez, F. Calderon, F. Sanchez, and A. Fernandez-Mayoralas; J. Org. Chem. 2007, 72, 9353-9356 
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Scheme 29:  Functionalization of MCM41 and aldol reaction catalysed by MCM41-Pro 
The supported catalyst is used for the reaction of aldehyde with a derivative of 
dihydroxyacetone and the paper investigates the role of different solvents in the reaction 
system.  
Another approach could be the use of a polimer, such as PEG or polystyrene, as a solid 
support for an organocatalyst. This support can also be used for flow processes. In this case, 
a great work has been done by Prof. Pericas and co-workers, who successfully investigated 
the immobilization of catalyst and the improvement of organocatalyzed reactions using a 
flow process. In the example reported in Scheme 3064, an analog of Hayashi catalyst is 
covalently binded via click reaction to a functionalized polystyrene polimer. The catalyst is 
used, both in batch and flow processes, in nitro michael reaction with very good results. 
 
 
Scheme 30: Immobilization of catalyst on Polystirene bound and application in nitro Michael reaction 
                                                          
64 E. Alza, S. Sayalero, P. Kasaplar, D. Almas¸ M. A. Pericas; Chem. Eur. J. ,2011, 17, 11585 – 11595 
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Another strategy could be the immobilization of catalyst on magnetic materials, to use the 
magnetic property of it for recycle, like magnetic nanoparticles65. In this case, an example 
always by Prof. Pericas is the immobilization of the Hayashi catalyst on Ferromagnetic 
nanoparticles and their use in nitro Michael reaction,66 showed in Scheme 31. 
 
Scheme 31: Immobilization of catalyst on ferromagnetic nanoparticles and application in nitro Michael reaction 
And another way can be the functionalization of catalyst in order to modify its property, in 
particular the solubility in organic solvent, and use it for recycling. An example is the use of 
ionic liquids, which solubility can be very different. In particular, an example reported by my 
research group in 200967 and showed in Scheme 32, is the development of an ion-tagged 
proline, and its application in aldol reaction of cyclohexanone with different aldehydes, that 
showed an incredible reactivity and a very good recyclability.  
 
Scheme 32: Application of ion-tagged Proline in the enantioselective aldol reaction. 
 In this last years a new trend in material chemistry is the use of carbon-based nanomalerials. 
One of carbon atom’s most important feature is the possibility to form compound built only 
                                                          
65 Y. Huang, W. Zhang; Green Process Synth, 2013; 2, 603–609 
66 Riente P, Mendoza C, Pericas MA. J. Mater. Chem. 2011, 21, 7350–7355. 
67 M. Lombardo, S. Easwar, F. Pasi, C. Trombini; Adv. Synth. Catal., 2009, 351, 276 – 282 
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by his atoms, named usually allotropes. The first known are carbon, diamonds or graphite, 
but several other have been discovered among the years, starting from fullerenes in 198568, 
and after carbon nanotubes, endohedrical fullerenes, nanohorns, nano-onions, nanodots 
and graphenes. Every allotrope has particular chemical and physical properties, that allows 
particular functionalization for different applications. During my thesis work I have focused 
my attention on fullerenes and nanotubes, so I will elucidate the main features of this 
nanomaterials. 
4.2 Fullerene 
Fullerenes are a family of compounds in which the most studied and most interesting is C60, 
also called “buckminsterfullerene”, which is made of 20 hexagons and 12 pentagons fused 
together giving his classical hollow spherical shape. From the chemical point of view is a 
polyenic structure69, with two different types of covalente bond: the one that binds two 
hexagons is 1,38 Å long, while the other that binds a pentagon to an hexagon is 1,45 Å long. 
 
Figure 11: Fullerene C60 
Although Fullerene is a stable molecule, it is not totally unreactive. Fullerenes reactivity is 
based on the deviation of planarity of double bonds, with the angle strain that is significantly 
released during a reaction that leads to a change in the ibridation of carbon to sp2 to sp3.70 
Professor Wuld was the first to study C60 reactivity, and its electrophilic nature.71 Fullerene 
functionalization is interesting because it allows to increase solubility in common organic 
solvents, or to modify their property, and usually the site involved in functionalization is the 
junction between two six-membered rings. The typical functionalization reactions are 
cicloaddizione [1+2], [2+2], [3+2], [4+2] cycloaddition reaction, Bingel-Hirsch nucleofilic 
addition with bromomalonates, organometallic addition, radicalic reaction etc. 
                                                          
68 H. W. Kroto, J. R. Heath, S. C. O’Brien, R. F. Curl, R. E. Smalley, Nature 1985, 318, 162. 
69 J. M. Hawkins, A. Meyer, T. A. Lewis, S. Loren, F. J. Hollander, Science 1991, 252, 312–313. 
70 R. C. Haddon, Science 1993, 261, 1545–1550., R. C. Haddon, Acc. Chem. Res. 1992, 25, 127–133. 
71 F. Wudl, A. Hirsch, K. C. Khemani, T. Suzuki, P. M. Allemand, A. Kosh, H. Eckert, G. Srdanov, H. M. Webb, ACS Symp. 
Ser. 481, ACS Washingt. DC 1992, 161. 
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Figure 12: Some commonly known C60 functionalization 72 
Since has been used in this work, in this thesis the attention will be focused in particular only 
in one particular functionalization, the [3+2] 1,3-dipolar cycloaddition usually named “Prato 
reaction”. In this reaction the dipolar compound is an azomethyne ylide, formed in situ from 
an aminoacid and formaldehyde, while the dipolarophile compound is fullerene. The 
product of this reaction is a substituted pyrrolidine located on a 6,6-fullerene junction: 
 
Scheme 33: generic “Prato Reaction” 
In this case azomethine ylide generation is based on a decarboxilation and a dehydration 
step, which is the common way, but there are also other tipe like termic degradation of 
aziridine or desilylation of silyl-derivatives, but are usually less common. 
These products are usually characterized by 1H e 13C-NMR. In particular, in the proton 
spectra are very well visible the pyrrolidinic ring CH2 signals, more or less around 4 ppm 
                                                          
72 A. M. López, A. Mateo-Alonso, M. Prato, J. Mater. Chem. 2011, 21, 1305–1318. 
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depending on substitution, while in carbon spectra 16 signals are usually observed between 
136 and 155 ppm, related to fullerene’s sp2 atoms, 2 signals around 70 ppm related to 
fullerene’s sp3 atoms and other 2 signals around 70 ppm, related to pyrrolidine’s CH2 groups. 
Another important tool for characterization is HRMS, in particular MALDI-TOF analysis. 
The first Prato reaction involves the N-methyl glicine, also known as sarcosine, and 
paraformaldehyde, a stable polymer of formaldehyde, to form an N-methyl pyrrolidine on a 
6,6-fullerene junction. This compound as a C2v symmetry.73 
By variation of sostituent of the N atom of the aminoacid is possible to obtain several N-
substituted pyrrolidines, while using different aldehydes leads to the synthesis of pyrrolidine 
with a substituent in 2-position: 
 
Figure 13: Formation of substituted fullerene-pyrrolidine 
In this way is possible to obtain several libraries of compounds for many application, both 
chemical and related to material science. Other important advantages of the “Prato 
Reaction” are the use of simple and cheap reagents, the possibility to obtain both 
monoadducts and multiadducts depending on reaction conditions, and finally the possibility 
to insert two different substituenton the pyrrolidinic ring, in order to modulate solubility 
and chemical property of the desired product. A disadvantage is that the substituent in 2 
position gives racemic products, and if other stereocenters are present this leads to a 
complex mixture of diastereoisomers74. Pristine Fullerene is soluble in Toluene forming a 
deeply purple solution. They are slightly soluble in Chloroform and very soluble in 1,2-
dichlorobenzene. Functionalized fullerenes are soluble in several solvents depending on the 
nature of the substituents. 
This is a simplified mechanism for a common “Prato Reaction”: 
                                                          
73 M. Maggini, G. Scorrano, M. Prato, J. Am. Chem. Soc. 1993, 115, 9798–9799. 
74 M. Prato, M. Maggini, Acc. Chem. Res. 1998, 31, 519–526. 
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Figure 14: simplified mechanism for a common “Prato Reaction” 
 
The amino acid reacts with the aldehyde forming an immonium ion, after there is the 
decarboxilation that gives the corresponding azomethine ylide, that reacts with fullerene’s 
6,6 double bond in a 1,3-dipolar cycloaddition. Theoretical studies have demonstrated that 
the yield of the reaction depends directly the HOMO – LUMO difference between the two 
partners and also from the substituent of the aldehyde.75 
These functionalized fullerenes are comparable to mostly apolar organic molecules, and 
they can be derivatized giving other interesting compounds with classic organic chemistry. 
All this important property allowed to their discoverer Prof. Kroto76 to win the Noble Prize 
for Chemistry in 1996, and fullerene is still used in many fields of scientific research. 
4.3 Carbon Nanotubes 
 
Carbon nanotubes (CNTs) are allotropes of carbon with a cylindrical nanostructure. They can 
be considered like graphene sheets, with hexagon made up only of sp2 carbon atoms, rolled 
together to form a cylindrical structure, closed on both edges by half fullerenic structures. 
These objects have incredible electronic and mechanic property and are broadly studied in 
many scientific areas. The exact structure of CNTs is dependent from their rolling angle, and 
different nanotubes has different electronic property. Usually CNTs are 1 μm long and their 
diameter is variable from 0,5 to more than 100 nm. They often tend to form aggregate, and 
                                                          
75 P. Piotrowski, J. Pawłowska, J. Pawłowski, A. Więckowska, R. Bilewicz, A. Kaim, J. Mater. Chem. A 2014, 2, 2353–
2362. 
76 H. W. Kroto, J. R. Heath, S. C. O’Brien, R. F. Curl, R. E. Smalley, Nature 1985, 318, 162. 
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usually are divided in Single Walled Carbon Nanotubes “SWCNTs” and Multi Walled Carbon 
Nanotubes “MWCNTs”, with different dimension and property.  
 
Figure 15:  SWCNT e MWCNT[55] 
In fact, SWCNT are really tiny with a diameter of only 0,8-1,5 nm, while MWCNT usually 20-
30 nm, depending on the production method. SWCNT then have a bigger superficial area, 
that leads to a different reactivity. First MWCNT were discovered by Iijima group in 1991 
during arch discharge evaporation of fullerene. He discovered tube of carbon atom with 2 
to 50 layers.77 After two years also SWCNT were discovered by Iijima, Ichihaschi e Bethune78. 
Actually, carbon nanotubes are produced using the “chemical vapour deposition” method 
(CVD), that allows to have a better control on length, orientation, diameter, purity and 
density of the CNTs synthesized. Other methods, like pyrolysis or “bottom-up” syntheses are 
less common. Different synthesis leads to different kind of impurities.  Usually the principal 
impurities are traces of other carbon-based materials, such as graphite, amorphous carbon, 
IPA, fullerenes or, when are used for synthesis, transition metals. Usually, CNT undergoes to 
acid treatment in order to eliminate some impurities.79 
Moreover, in the regular structure often some defects are present. Most of the times are 
dislocations, holes or other topological variation, like the presence of pentagons and 
heptagons next to each other, named “Stone-Wales defects”. This are the most common 
and leads to a distortion in the graphitic nanotube’s structure. They usually start to a local 
rotation of 90° of a C-C bond of a hexagon that form two pentagons and two heptagons.80 
                                                          
77 S. Iijima, Nature 1991, 354, 56–58. 
 
78 N. Karousis, N. Tagmatarchis, D. Tasis, Chem. Rev. 2010, 110, 5366–5397.  
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Figure 16: Stone-Wales defect formation 
The propagation of these defect along the structure of nanotubes can represent a problem 
in CNTs growth during their synthesis. Despite of this, defects are also the most reactive sites 
in all their structure, and they can be exploited to carry out functionalization reactions.  
in order to use CNTs for organic synthesis chemists have to face off a big problem in 
solubility. Nanotubes are almost insoluble in both common organic and inorganic solvents, 
due to the strong Van der Waals interactions occurring, and they tend to form complex 
aggregates. To face off this problem and expand the reactivity of nanotubes is possible to 
functionalize them, in a covalent or non covalent way, or to use endohedral inclusion inside 
their cavity. The first is the most used one, while the second exploits the possibility to use 
π-π stacking on NTs structure. In this way is possible to obtain modified CNTs that can be 
partially dispersed in organic solvents, and after they can be used for other functionalization 
reactions. In possible in fact to bind also complex organic molecules and even biological ones 
to give very interesting nanomaterials.  
 
Now we will focus our attention on covalent functionalization of carbon nanotubes. The 
most common way is oxidation. With oxidative treatment is possible to introduce, in 
particular on the lateral wall were defects are present, oxygen-containing functional groups, 
carboxylic acids in most of the cases. In this process the nanotubes are broken, 
consequentially a significant shortening of the material is observed. 
 
Figure 17: Cabon nanotube functionalized on their edges using oxidation (simplified representation) 
Also in this case, the change in ibridation of functionalized carbon from sp2 to sp3 leads to a 
deplanarization of the local structure, that is the proper “driving force” for functionalization 
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reaction. Moreover, they are more reactive respect to graphene because of the curvature 
of CNTs scheleton, that helps the carbon pyramidalization.81 Moreover, is demonstrated by 
theoretical studies82 that another functionalization site is in presence of Stone-Wales 
defects. The percentage of functionalization reported in literature, referred to COOH groups, 
is almost 1,7 μmol/mg (2% molar) for MWCNT83,  and 3,5-7 μmol/mg (5-10% molar) for 
SWCNT84, depending on reaction conditions. The oxidation reaction is carried with aqueous 
nitric acid, sometimes mixed with sulphuric acid at 100°C. 85 Other oxidant can be used to 
modify the oxidation grade and the length of the resulting material. 
Introduction of carboxylic groups on nanotube surface open the way for many other re-
functionalization process, first of all the formation of an amidic bond with an amine, that 
will be treated more deeply in this chapter. 
Another important methodology for CNT functionalization is arylation. First proposed by 
Tour, involves the addition of diazonium salt, both in situ or ex situ, to the lateral wall of 
nanotube to give aryl-derivatives more soluble and easy to functionalize.86  
 
 
Scheme 34: Generic arylation reaction of nanotube, with in situ and ex situ formation of diazonium salt. 
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The functionalization percentage for arylation is almost 2 μmol/mg (3% molar) for SWCNT87 and 0,8 
μmol/mg (1% molar) for MWCNT88. The presence of substituent on the aromatic ring can affect 
these results. 
The functionalization of CNT with carboxylic moiety is very important because it allows a rapid re-
functionalization of the material, in particular through amide-formation using amide coupling 
reactions. 
 
Scheme 35: Generic Amide coupling on CNT 
In literature are present many publications about amide coupling reactions, often using 
classic coupling reactives as EDC/HOBt89, EDC/NHS90, or SOCl2/pyridine91. Other common 
coupling reagents are TBTU or HATU. 
 
Figure 18: Common coupling reagents (EDC, HOBt, NHS, TBTU, HATU) 
These reactants are able to activate the carboxylic moiety present on CNTs surface, allowing 
the nucleophilic substitution with an amine, allowin the formation of the amide bond. This 
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connection is usually very stable, and usually only strong acidic conditions are able to cleave 
it, and this is ideal for application of this nanomaterial in organic synthesis.  
These reations on CNT needs very diluted condition because of the low dispersion in 
common solvent for coupling reaction. Usually concentration is around 1 mL of solvent for 
mg of material for MWCNT, while for SWCNT sometimes also 10 mL for 1 mg of SWCNT. The 
solvent used are DMF, CH3CN, DCM etc. In some case is also possible to form and ester using 
an alcohol instead of an amine, always using coupling reagents with catalytic DMAP (N,N-
dimethyl-4-amminopyridine), but they are usually less common because alcohol are less 
reactive. 
A critical point in carbon nanomaterials and in particular in nanotube is the qualitative and 
quantitative characterization of the functionalized products. Infact, differently from 
common organic molecules, nanomaterials need a totally different analytical approach for 
the determination of their structure, and that cannot lead to the complete elucidation of it. 
In fact, these materials are not made up of precise single entity such as organic molecules, 
but aggregates of nanometric structures insoluble in organic solvents, that is not enhanced 
with functionalization. It is easy to understand that, differently from fullerene-derivatives, 
nuclear magnetic resonance spectroscopy and chromatographic techniques are not useful 
for the characterization of CNT, but other methodologies are needed. In particular, are used 
measurement of other property that doesn’t need to solubilize the adduct. The most 
important are analytical thermogravimetry (TGA), UV-VIS spectroscopy, IR and Raman 
analysis, elemental analysis, Electronic microscopy (SEM, TEM, AFM, STM) X-ray diffraction 
(XRD), etc. Thanks to these analysis is possible to measure in a general way the dimension, 
the chemical composition, the electronical and optical property, and the percentage of 
functionalization of examined nanomaterials. In particular, TGA and Raman analysis have 
been used in this thesis work.  
Analytical thermogravimetry (TGA) is the most common characterization of carbon-based 
nanomaterials and in particular of nanotubes. It measures the loss of mass on a sample 
exposed to heating under inert and oxidant conditions. In this thesis work it has been applied 
for measuring the percentage of functionalizations of the synthesized materials, because the 
loss of mass is attributed to the molecules covalently bind to the nanotube’s surface. With 
this is possible to calculate the number of moles of molecules on the material and the 
functionalization percentage. Of course, the data should be corrected with the loss of mass 
of pristine CNT. It’s appropriate to remember that these data are not precise due to 
approximations, but TGA can give a useful indication on functionalization, and the quality of 
data is enhanced if compared with other analysis like Raman spectroscopy. 
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Raman spectroscopy is broadly used for qualitative and semi-quantitative analysis, in 
particular with SWCNT. Is based on anelastic scattering of incident light on a sample. During 
this, an electron is excited from the valency band to the conduction band of the 
nanomaterial by photon absorption. After there is relaxation to the ground state with 
emission of a photon with less energy that the incidental photon. Then, the Raman spectra 
is made on this difference in the wavenumber of emitted radiation, called Raman shift. In 
these spectra are always present characteristic band of CNT and of CNT’s defects, and from 
them is possible to take information on their functionalization. Also in this case, the bands 
are normalized on pristine CNTs. As said before, the results of TGA analysis can be 
implemented by Raman analysis, and an high level of functionalization in TGA has to be 
confirmed by high presence of defects-band. If this is not, the data can’t be associated to 
CNT functionalization but to other impurities or byproducts not directly binded to CNT. 
4.4 Fullerene and Carbon Nanotubes in catalysis 
If on one side the poor solubility in organic solvents of functionalized CNT and in some cases 
of fullerene can be seen as a limitation, on the other side the use of non-solvent during the 
work up procedures can allow an easily recycle of this material, if used as catalyst. For these 
characteristics these materials are now used as solid support for the synthesis of catalytic 
systems. Since the field is quite new, there are not a lot of examples of application in 
catalysis. For example, Prof. Gruttadauria and co-workers reported the synthesis of many 
supported systems for oxidation, both with C60 and CNTs. For example, in Scheme 36 is 
showed a multifunctionalized fullerene derivative bearing both imidazolium salts and 
TEMPO, used for catalysed oxidation of alcohols with good results. The catalyst can be fully 
recovered and also used in combination with silica gel in a “release and catch” protocol92. 
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Scheme 36: Oxidation of alcohol promoted by TEMPO-IL-functionalized fullerene 
Similar examples of these systems are reported also with CNTs. Another peculiar approach 
is the use of non-covalent functionalization of CNT. Using catalyst tagged with proper 
aromatic moieties, is possible to exploit the π-stack interactions to adsorb the molecule on 
the nanotube surface. An example is reported always from Prof. Gruttadauria93, and showed 
in Scheme 37: 
                                                          
93A. M. P. Salvo, V. La Parola, L. F. Liotta, F. Giacalone, M. Gruttadauria; ChemPlusChem, 2016, 81, 471 – 476 
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Scheme 37: Synthesis of non-covalently nanotube-supported catalyst and application to Sukuzi cross-coupling using a 
“release and catch” approach. 
 
In this case a bis imidazolium salt is adsorbed on CNTs using pyrene groups. After, the cations 
are used to bind Palladium on the surface and catalyse a classic Suzuki Cross Coupling 
reaction with good results.  
Regarding organocatalysis, there are only a few examples. The group of Prof. Kokotos and 
co-workers reported the functionalization of CNT with proline derivatives to promote the 
enantioselective aldol reaction between acetone and 4-nitrobenzaldehyde.9495 The example 
is showed in Scheme 38. 
 
 
 
 
 
                                                          
94 D. D. Chronopoulos, C. G. Kokotos, N. Karousis, G. Kokotos, N. Tagmatarchis, Nanoscale 2015, 7, 2750–7.  
 
95 D. D. Chronopoulos, C. G. Kokotos, M. Tsakos, N. Karousis, G. Kokotos, N. Tagmatarchis, Mater. Lett. 2015, 157, 212–
214. 
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Scheme 38: Kokotos aldol reaction catalysed by nanotube-supported proline derivatives.  
 
In this example the yield is generally good (70-99%) while the enantiomeric excess is not 
very satisfacting (up to 76%). 
Another example always by Kokotos is the functionalization of fullerene with proline, using 
the classic “Prato Reaction” and a proper spacer, and the application in aldol reaction., 
showed in Scheme 39. 
 
Scheme 39: Kokotos aldol reaction catalysed by fullerene-supported Proline 
In this case the best results in ee are with the longer spacer, due to the fact that there is 
less hindrance during the formation of the active conformations.  
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4.5 Aim of the work 
The aim of this work is the use of Carbon-based Nanomaterials as solid support for 
organocatalyst.  
The first part of the work is really innovative, and concern the use of nanomaterials, and in 
particular carbon nanotubes, in order to hinder one of the diastereotopic face of the iminium 
ion formed by reaction of the chiral catalyst and α,β-γ,δ-saturated aldehyde, favouring the 
1,6 reaction the only possible and most of all stereocotrolled. For doing this, the secondary 
amine has to be binded covalently to the CNT and very near to the surface.   
 
Figure 19: Mechanism of asymmetric induction of CNTs 
In Figure 19: the mechanism of stereocontrolled addition is showed, and is mediated by the 
CNT. The catalyst should be a modified diarylprolinol. The key-concept is the π-π stacking 
interaction between the conjugated double bonds of the iminium and the aromatic system 
of the material, that allows to the substrate to be totally stretched on the surface on the 
CNT, by fact blocking completely one face. On the other side, the presence of a highly 
hindered group on the other face prevent the 1,4 addition, usually very favoured. In 
conclusion, theoretically the only reaction possible should be the 1,6 of the face opposite to 
the material, obtaining only one defined product. The nucleophile should be a “soft” one 
like a thiol. 
 
Scheme 40: 1,6 stereocontrolled addition to α,β-γ,δ-unsaturated aldehyde 
Moreover, the catalyst should be easily recycled via filtration or centrifugation, and 
recovered.  
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The catalytic unity, should be a very stable one, and we need to synthesize a proper catalyst. 
In fact, the classic Hayashi-Jorgensen catalyst suffer from stability problems due to the 
presence of the silylether group that is unstable in particular in acidic conditions.  Finally, 
the last part of the work is the functionalization of Fullerene with the synthesized catalysts, 
in order to promote enantioselective Michael reactions.  Also in this case is interesting to 
recover the catalyst for several reactions. 
 
 
Scheme 41: Fullerene supported Modified pyrrolidine to promote racemic of diastereoselective michael addition 
reaction.   
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4.6 DISCUSSION AND RESULTS 
Since the synthesis of very complex molecules without any information about the possible 
results can be seriously risky, in the beginning we decided to start this study with the 
synthesis of a simple pyrrolidinic catalyst 1, able to promote a simple Michael reaction, even 
if not stereoselective. This allows us not to waste time and resources. 
The catalyst 31 can be obtained in some synthetic steps starting from relatively simple L-4-
trans-hydroxyproline, as shown in Scheme 42: 
 
Scheme 42: retro-synthesis of catalyst 1 
The synthesis starts with decarboxylation of commercial hydroxyproline using 
cyclohexanone, heating at reflux and removing the water formed during the process with 
the use of a Dean-Stark apparatus. The reaction is based on the formation of the 
corresponding iminium ion that leads to the enamine via decarboxylation. After, the 
enamine is hydrolysed giving the corresponding hydroxypyrrolidine 32. 
 
Scheme 43: L-4-trans-hydroxyproline decarboxylation 
 
3-hydroxypyrrolinine 32 is then protected using Boc Anhydride and triethylamine in DCM to 
give the protected pyrrolidine 33, with 70% yield on this first two steps.      
 
Scheme 44: Boc Protection of 32 
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This protection is necessary because the free amine can interfere in the next steps. After, 
the alcohol is turned into a good leaving group through a mesylation reaction with mesyl 
chloride and triethylamine to give compound 34 in 94% yield. 
 
Scheme 45: Mesylation of 34 
Mesylated compound 7 is turned into the azide 35 via nucleophilic substitution with sodium 
azide in DMF, with 90% yield. This last two passages have been performed according to 
literature procedures.96 
 
Scheme 46: Nucleophilic substitution on mesylated 35 
Finally, the azido-derivative 8 is reduced to the corresponding amine through catalytic 
hydrogenation with Palladium/Carbon as catalyst in methanol, to give the product 1 with 
70% yield. 
 
Scheme 47: Hydrogenation of derivative 35 
The critical point in this synthetic procedure are the difficult decarboxylation reaction, with 
a difficult work up, that can be avoided using directly the commercially available 
chlorohydrate pyrrolidinol, and the final reduction, due to the poisoning of the catalyst in 
presence of the free amine, and to the difficult in column chromatography. The reaction can 
be better performed in presence of acid, or even in acid solvent instead of MeOH, and by 
using Al2O3 instead of silica for chromatography. 
                                                          
96 H. Zhang, Y. Chuan, Z. Li, Y. Peng, Adv. Synth. Catal. 2009, 351, 2288–2294. 
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From the point of view of nanomaterial, we started with the use of CNTs. The idea was to 
functionalize the nanotubes introducing carboxylic moieties, that can be coupled with the 
free anime of catalyst 1 in presence of coupling reagents to form an amide bond, as shown 
in Scheme 48. 
 
Scheme 48: functionalization of oxidized nanotube 
 
The work of functionalization of CNTs has been done collaborating with the research group 
of Prof. Maurizio Prato from the University of Trieste, for their long expertise in 
functionalization of carbon-based nanomaterials. As functionalization reaction we chosed 
the simple oxidation of CNT and the Arylation with the use of diazonium salts, and the 
functionalization was tried on both single and multiwalled carbon nanotubes, in order to 
understand which material is the best for our purposes. The two functionalizations reaction 
has been chosen because simple oxidation often gives nanotubes functionalized on the 
borders and edges, while the arylation could give product with different functionalization 
points. 
The reaction has been carried out using a great dilution, generally 1 mL for mg of material, 
in order to have a better dispersion. Moreover, sonication of the solution is very important. 
TGA is the principal technique used for the determination of the functionalization 
percentage. 
We started with the oxidation of both pSWCNT 32 and pMWCNT 33, using 4M nitric acid in 
water at reflux, obtaining the oxidized product 34 and 35. 
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Scheme 49: Oxidation of carbon nanotubes 
The results are showed in the following table. 
Entry Nanotubes Functionalization % μmol/mg 
1 SWCNT Ox 34 5,4 % 3,8 
2 MWCNT Ox 35 0,5 % 0,4 
Table 12: results ofr the oxidation of CNTs 
The value of functionalization for the SWCNT Ox is similar to other reported in literature, 
while for MWCNT OX is too low. Then, another oxidation on the same nanotubes is 
performed, using 8M nitric acid, that increase the functionalization up to 1%, almost 0,8 
μmol/mg of material.  
For the arylation reaction we decided to use 3-carboxybenzendiazonium tetrafluoroborate 
36, synthesized starting from 3-aminobenzoic acid with HBF4 and sodium nitrite with 77% 
yield, as reported in literature.97 (Scheme 50) 
 
 
Scheme 50: Synthesis of diazonium salt 
The choice of this particular diazonium salt is due to the presence of the carboxylic acid, that 
is needed for the coupling reaction with the catalyst. Moreover, the meta position gives the 
best compromise between proximity to the wall and steric hindrance.  
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Once the diazonium salt has been synthesized, we proceeded with the arylation of both 
pSWCNT and pMWCNT in orthodichlorobenzene or N-methyl-pyrrolidone as solvent at 60°C 
to obtain the arylated materials 37 and 38. 
 
Scheme 51: Arylation of CNTs 
The results are showed in the following table. 
Entry Nanotubes Solvent Functionalization % μmol/mg 
1 SWCNT Ar 37 ODCB 1,6 – 2,7 % 1,1 – 1,8 
2 SWCNT Ar 37 NMP 2,8 % 1,8 
3 MWCNT Ar 38 OCDB 0,5 % 0,4 
 
Table 13: Results for Arylation of CNTs 
As shown in the table, the reaction proceeded almost in the same way using ODCB or NMP 
as solvents, So ODCB was chosen as solvent for next arylation. Concerning the results, they 
are similar to the one reported in literature. Both arylation has been repeated on the 
arylated material but only with a slight increase in functionalization in case of SWCNT (from 
1,6 to 1,8%). 
After these functionalization of pristine CNT, we proceeded with the amide coupling with 
catalyst 31, both with oxidized SWCNT Ox 34 and with the arylated SWCNT Ar 37 and 
MWCNT Ar 38. MWCNT Ox have not been functionalized for time reason. HATU and 
EDC/NHS has been chosen as coupling reagents in DMF. The reaction time is several days, 
as usual for nanomaterials. In particular, the amine is added one day after, respect to the 
coupling reagents.  
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Scheme 52: Peptide coupling between oxidated and arylated CNTs and catalyst 31 
In this way the derivatized materials 39, 40 e 41 has been obtained. The functionalization 
has been calculated considering that the molecular weight of the residue is increased 
respect to the starting material. In Table 14 the changes in functionalization are showed. 
Entry Nanotubes 
Coupling  
reagent 
Dilution 
(mg/mL) 
% 
funz 
μmol/mg 
∆% 
funz 
∆ 
μmol/mg 
1 SW Ox – CAT 39 HATU 0,1 1,8 % 1,1 - 3,6 % - 2,7 
2 SW Ox – CAT 39 EDC/NHS 0,1 1,1 % 0,8 - 4,3 % - 3,0 
3 SW Ar – CAT 40 HATU 0,25 1,2 % 0,8 - 0,4 % - 0,3 
4 MW Ar – CAT 41 HATU 0,25 0,2 % 0,2 - 0,3 % - 0,2 
 
Table 14: results for amide coupling on functionalized CNTs 
What is soon evident is that the percentage are decreased, also dramatically in some cases. 
We can also observe that arylated nanotubes are less affected by this loss. Despite of the 
unpromising result, we proceeded with the last step, the removal of the Boc protective 
group, that release the active catalyst. The deprotection is carried out in presence of 
trifluoroacetic acid in THF. 
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Scheme 53: Deprotection of the catalysts 
The last step allowed to obtain the active materials 42, 43 and 44. Also in this case the 
variations in functionalization are showed in Table 15: 
Entry Nanotubes 
[TFA] 
(mL/mL THF) 
% 
funct 
μmol/mg 
∆% 
funz 
∆ μmol/mg 
1 SW Ox – CAT att 42 0,2 2,7 % 1,8 + 1,6 % + 1,0 
2 SW Ar – CAT att 43 0,2 1,6 % 1,1 + 0,4 % + 0,3 
3 MW Ar – CAT att 44 0,2 0,4 % 0,3 + 0,2 % + 0,1 
 
Table 15: Results for boc deprotection 
The work up of the reaction is the similar to the other, but a basic wash with saturated 
NaHCO3 is added in order to neutralize the ammonium salt formed during the reaction. We 
can observe an increase in functionalization, even if there is not a direct explanation for this. 
Entry 1 is relative to amide coupling with EDC/NHS. Once the catalytic system is ready, the 
materials were tested in the classic Michael addition reaction between cinnamaldehyde and 
dimethyl malonate in different condition. 
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Scheme 54: Organocatalyzed Michael Reaction 
 
The reactions were carried out with 7,5 mol % of active catalyst, considering the different 
load between the materials. The results were verified by 1H-NMR of the reaction mixture. 
The reaction condition and the results are reported in Table 16. 
Entry Nanotubes Solvent 
funct 
μmol/mg 
[C] 
(mg/mL) 
47a 
1× SW Ox – CAT att 42 THF 1,8 1,8 - 
2 SW Ar – CAT att 43 THF 1,1 2 - 
3 SW Ar – CAT att 43 EtOH 1,1 2 traces 
4 SW Ar – CAT att 43 DCM 1,1 2 - 
5≠ SW Ar – CAT att 43 EtOH 1,1 2 - 
6≠ SW Ar – CAT att 43 
EtOH/THF 
4:1 
1,1 2 - 
7 SW Ar – CAT att 43 EtOH 1,1 2 - 
8×≠ SW Ox – CAT att 42 EtOH 1,8 1,8 - 
9 MW Ar – CAT att 44 EtOH 0,3 4,5 traces 
 
Table 16: results for the organocatalysed Michael addition. Conversion determined by 1H-NMR of the reaction 
mixture. 
Entry signed with (×) are relative to CNT functionalized with EDC/NHS coupling, while entry 
signed with (≠) to CNTs recovered from previous catalysis. Reactions were checked until 4 
days. Entry 7 and 9, after this period, were heated at 40°C for another day without any 
difference. The important data is that none of the entries gives any Michael adduct, and only 
traces in some cases were observed without any reproducibility. The percentage of 
functionalization is only from 0,3 to 1 μmol/mg. 
Before going on some control reaction were performed, using simple pyrrolidine as a 
catalyst, and also adding pristine SWCNT, in order to verify if the simple reaction works or, 
for some reason, the presence of the nanomaterial itself disfavour the reaction. 
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Entry Nanotube Loading 47a 
1 - 7,5% mol > 50% in 2h 
2 pSWCNT 7,5% mol > 50% in 2h 
 
Table 17: results for Michael addition with pyrrolidine. Conversion determined by 1H-NMR of the reaction mixture. 
As showed in Table 17 the control reactions lead easily to the formation of product. 
Moreover, the introduction of pSWCNT does not interfere with the reaction. Then, the 
absence of product in presence of the new materials is due to other factors. 
The low percentage in functionalization of CNT is probably the most important factor: 
despite it is comparable to results reported in literature, is clearly not enough to have a good 
load of active catalyst during the reaction. Moreover, even the use of large quantities of 
nanomaterial, a great dilution is necessary for its dispersion. This limitation in 
functionalization of the CNTs convinced the research group in abandon this first part of the 
work, and also the idea to use the surface of carbon-based nanomaterials for perform 
stereoselective 1,6 addition.  
Despite of this, the work with nanotubes highlighted the right features that are essentials 
for a good supported catalyst. The need for high loading and solid analytical procedures are 
extremely important. In this sense, Fullerene is comparable to common organic molecules: 
is soluble, relatively easy to functionalize with solid protocols, can be purified via simple flash 
chromatography, and can be characterized with NMR and HRMS. Is clear that fullerenes are 
not useful for 1,6-reaction, because of their shape and dimension, but however is possible 
to carry out simple 1,4 Michael reaction, and in the end to recycle the catalyst using specific 
non-solvents. 
The first step is to bind the catalyst 31, already synthesized, to fullerene C60 and to test this 
system in the simple Michael reaction, even with racemate product. First of all, the catalyst 
has to be modified for being suitable for Michael reaction, and then the first step is the 
reaction of catalyst 1 with ethyl bromoacetate in presence of triethylamine, to give the 
amino acid 25 with 48% yield after purification.  
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Scheme 55: Alchilation of N-Boc-4-aminopyrrolidine 31 
Now with compound 48 is possible to perform a Prato reaction with paraformaldehyde and 
fullerene. The experimental conditions are toluene as solvent, 1 mL for 1 mg of fullerene, 
and heating to reflux. 
 
Scheme 56: Prato reaction between formaldehyde, fullerene and compound 48 
 The aim is to obtain only the monoadduct 49, then the reaction needs to be stopped when 
the TLC of reaction mixture shows the formation of poly adducts. At that point the 
conversion is almost 50%. Poly adducts, like for example the double adduct 50 are not 
desirable gives a mixture of diastereoisomers. Thanks to this functionalization the adduct is 
soluble in slightly polar solvents like chloroform, despite of pristine fullerene. 
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Figure 20: Mono adduct 49 and double adduct 50 
The work up of the Prato reaction is a direct flash chromatography, that is possible thanks 
to a great difference in polarity between pristine Fullerene, mono adduct 49 and double 
adduct 50. After, the product is centrifuged with chloroform /methanol to remove traces of 
reagents. After, compound 49 is treated with a mixture of trifluoroacetic acid and 
dichloromethane for the removal of boc group, leading to the active catalyst 51. The yield 
of the reaction is 74%, after a neutralization with saturated NaHCO3. 
 
Scheme 57: Deprotection of the amine of compound 49 
Once catalyst 51 has been obtained is possible to test its reactivity in the organocatalyzed 
Michael reaction between Cynnamaldehyde and dimethyl malonate. 
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Scheme 58: Michael addition catalyzed by 51 
The result is reported in Table 18: 
Entry Solvent Concentration 3 Loading 3 Additive time Conversion 
1 DCM/EtOH 1:1 20 mg/mL 30% mol PhCOOH 3 d 90 % 
 
Table 18: results for Michael addition. Conversion determined by 1H-NMR of the reaction mixture. d = days 
This time, the catalyst supported on fullerene gave the first promising results, with 90% 
conversion after 3 days determined by 1H-NMR. The mixture of solvents is necessary for the 
solubility of the material, even if not complete. It’s clear that the conversion is not due to 
background reaction, never observed in the other cases, even after several days. After, the 
supernatant, containing the reagents and the product, is removed, while the catalyst is 
washed with diethyl ether and centrifuged for recycle. For the determination of the 
enantiomeric excess the product is derivatized via wittig reaction, that gives the 
corresponding α,β-unsaturated ester. 
 
Scheme 59: Derivatization of the Michael adduct via Wittig reaction 
The Chiral HPLC analysis showed, as expected, that the product obtained with catalyst 3 is a 
racemic mixture. the two enantiomers were present at almost 50%. Since this part of the 
project gave promising results, we decided to go on with the synthesis of a new catalyst, 
able to perform enantioselective reaction, to support on Fullerene. 
Encouraged by these first promising trials, we started wondering about the synthesis of a 
secondary amine capable both to induce asymmetric Michael reactions, and at the same 
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time to be covalently supported on fullerene. A molecular linker should be incorporated in 
the catalyst, both for binding the two parts of the catalyst, and to act as a spacer between 
them. 
 
Figure 21: Project of the active catalyst 
For covalently bind the catalyst to the spacer, we decided to perform a classic Huisgen 
cycloaddition reaction, placing an azide functional group on the linker (easy obtainable via 
interconversion of the correspondin alcohol), and a triple bond on the catalytic core. On the 
other side, an amino acid is needed in order to perform the final functionalization via “Prato 
reaction”.  
Regarding the catalytic center, the idea was to develop a structure like the commercially 
available Jorgensen-Hayashi catalyst, capable to promote chirality using the extremely 
hindered group in the α-position respect to the nitrogen, a TMS-protected diarylmethanol, 
but avoiding the presence of the silyl ether, unstable under acid conditions. Furthermore, 
the catalyst should bring an alkine functional group for the click functionalization reaction. 
Our choice was to synthesize a modification of a catalyst previously studied by Maruoka and 
coworkers, bearing a very stable trytil group as chirality promoter98. The catalyst has been 
applied in α-functionalization reaction such as α-benzoxylation, and the reactivity has been 
extensively studied, revealing a high reactivity of the corresponding iminium ion respect to 
Jorgensen-Hayashi catalyst99.  
                                                          
98 T. Kano, H. Mii, K. Maruoka, J. Am. Chem. Soc., 2009, 131 , 3450–3451 
99 H. Erdmann, F. An, P. Mayer, A. R. Ofial, S. Lakhdar, H. Mayr, J. Am. Chem. Soc. 2014, 136, 14263−14269 
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Scheme 60: Design of the catalyst 
The catalyst should be synthesized converting the Pirrolydinol 32 into the corresponding 
nitrone. After, addition of Trytyllithium should provide the anti-functionalized pyrrolidine as 
major product. Additions of organometallic compounds to pyrrolidine-derived nitrones have 
been already reported in literature.100 
 
 
Scheme 61: retrosynthetic analysis for the catalyst 
The synthesis of the catalyst started with the protection of the nitrogen of the 3-pyrrolidinol. 
This time, we decided to use the commercially available chlorohydrate 53, and to use as 
protective group for the first part of the synthesis the cheaper ethyl chloroformiate. The 
reaction in presence of potassium carbonate as a base, gave the corresponding N-protected 
pyrrolidinol 54 with 78% yield. 
 
Scheme 62: Nitrogen protection of compound 53 
                                                          
100 a) P. Merino, T. Tejero, J. Revuelta, P. Romero, S. Cicchi, V. Mannucci, A. Brandi, A, Goti, Tetrahedron: Asymmetry, 
2003, 14, 367–379; b) S. Wu, Y. Ruan, X. Zheng, P. Huang, Tetrahedron, 2010, 1653-1660; c) P. Merino, I. Delso, T. Tejero, 
F. Cardona, M. Marradi, E. Faggi, C. Parmeggiani, A. Goti, Eur. J. Org. Chem. 2008, 2929–2947; d) S. Cicchi,M. Bonanni,F. 
Cardona,J. Revuelta, A. Goti, Org. Lett., 2003, 5, 1773–1776; e) S. Wu, X. Zheng, Y. Ruan, P. Huang, Org. Biomol. Chem., 
2009, 7, 2967–2975; f) R. Pulz, S. Cicchi, A. Brandi, H. Reißig, Eur.J. Org. Chem. 2003, 1153-1156 
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After, also the oxygen needs a protective group orthogonal to the first. The benzyl group 
was choosen and the benzylation reaction proceeded with benzyl bromide in THF, with a 
catalytic amount of tetrabutyl ammonium bromide. The yield of the reaction is 83%. 
 
Scheme 63: Benzylation of compound 54 
Then, the nitrogen needs to be deprotected, using Potassium hydroxide and an 
Ethanol/Water mixture at reflux. The amine 56 was obtained in quantitative yield. 
 
Scheme 64: Deprotection of compound 54 
The amine 55 is now ready for the oxidation with Oxone, EDTA and NaHCO3 in CH3CN/THF 
at 0°C, following condition reported in literature101, to give nitrone 56 in 60% yield after the 
separation of the minor regioisomer.  
 
 
Scheme 65: oxidation of 55 
Nitrone 56 is the major stereoisomer, and this is probably due to the proximity of the oxygen 
that stabilizes the double bond formation or the intermediate. It is good for our purposes, 
because the subsequent alkylation has got high chance to be totally anti-selective. The 
alkylation was carried out in THF at 0°C, and the first step is the lithiation of 
                                                          
101 R. Alibés, C. Gella, P. De March, M. Figueredo, J. Font, E. Ferrer, F. Busquè, J. Org. Chem. 2009, 74, 6365–6367. 
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triphenylmethane using butyllithium as base. Then the corresponding Nitrone 56 is added 
to the mixture, giving the corresponding hydroxylamine 57 in 74% yield. 
 
Scheme 66: alkylation of nitrone 56 
The hydroxylamine is not stable and undergoes to decomposition, then it has to be rapidly 
reduced. The reaction allows to reduce the hydroxylamine to the corresponding secondary 
amine, and in the same time to remove the benzyl group. This reaction is carried out using 
Pd/C as catalyst and atmosphere of hydrogen. The reaction in MeOH gave mixture of 
products, because the amine formation poisons the catalyst. Instead, the use of acetic acid 
as solvent for the reaction, following Maruoka’ work102, gave only the product 58 in 76% 
yield. 
 
Scheme 67: reduction of 57 
The 2-trytyl-3-hydroxypyrrolidine 58 is now again protected on the nitrogen, this time with 
Boc2O and TEA in DCM as solvent, obtaining the product 59 in 96% yield. 
 
Scheme 68: Protection of compound 58 
The protected catalyst can now be functionalized with the propargyl group for the click 
reaction with the spacer. The alcohol was subjected to metalation with sodium hydride, then 
                                                          
102 T. Kano, H. Mii, K. Maruoka, J. Am. Chem. Soc. 2009, 131, 3450–3451 
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to reaction with propargyl bromide and a catalytic amount of TBAI, in THF at 0°C. The 
reaction allowed to obtain compound 60 in 90% yield and to complete the first part of the 
synthesis. 
 
Scheme 69: Propargylation of 59 
Ad this point, we decided to test the performance of the catalytic subunit in the Michael 
reaction in homogeneous phase. We compared three different molecules, the benzylated 
adduct 61, obtained during the reduction trials, the amino alcohol 58 and the R-Hayashi 
catalyst ent-VII as a reference. The reactivity has been evaluated through the conversion, 
determined via 1H-NMR, and the selectivity via Chiral HPLC after derivatization. The results 
are showed in Table 19: 
 
 
 
 
Entry Solvent 
Concentration 
CAT 
Loading 
CAT 
Time Conversion ee 
CAT OBn DCM/EtOH 1:1 20 mg/mL 30% mol 18 h 79 % 90 % 
CAT OH DCM/EtOH 1:1 20 mg/mL 30% mol 18 h 85 % 92 % 
Hayashi DCM/EtOH 1:1 20 mg/mL 30% mol 18 h 99 % 74 % 
Table 19: results for the test of catalyst in the homogeneous phase. Conversion determined by 1H-NMR of the reaction 
mixture. d = days ee determined by CSP-HPLC of derivatized product  
The results are quite interesting. The new catalysts are characterized by a low reactivity, 
compared to Hayashi catalyst, and can be explained with the presence of two substituent 
on the pyrrolidinic ring, that decrease the nitrogen’s nucleophilicity. On the other side, these 
systems resulted to be more selective, probably due to the best stability of the trityl group 
during the reaction.  
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Now that the reactivity of the catalytic unity has been verified, the synthesis of the spacer is 
reported. The idea for the synthetic strategy is to have a quite long spacer, in order not to 
be too near to the fullerene, an amino acid on one side, that allows the fullerene 
functionalization, and an azide on the other side, to perform the click reaction with the 
propargylated catalytic unity. The amino acid needs to be protected for the cycloaddition. 
 
Figure 22: Strategy for the choice of the spacer  
The first step is a nucleophilic substitution reaction between 2-Bromobenzyl acetate and 3-
amino-1-propanol to give the amino alcohol 63. Reaction time needs to be only two hours 
to avoid the double substitution, and allowed to obtain the product with 71% yield. 
 
Scheme 70: Nucleophilic Substitution reaction to give product 9 
The second step is the protection of the amine using CbzCl and TEA in DCM. The nitrogen 
needs to be protected in a way that allows the removal of both the benzyl ester and the 
Protective group. The reaction gave product 64 in 95% yield. 
 
Scheme 71: Cbz Protection of 63 to afford compound 64 
The alcohol needs to be converted into an azide group. The first step is a mesylation reaction 
using mesyl chloride and TEA in DCM, to obtain the mesylated product 65 in quantitative 
yield. The mesyl group is a better leaving group compared to simple OH. 
 
Scheme 72: Mesylation of 64 to give compound 65 
The final step for the spacer synthesis is the nucleophilic substitution using Sodium Azide in 
DMF. Is important to do the work up extraction using EtOAc and not DCM to avoid risk due 
to the presence of NaN3. The product 62 was obtained in 71% yield. 
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Scheme 73: Nucleophilic substitution of mesylated 65 with NaN3 
Once the synthesis of the spacer has been accomplished, the final part of the synthesis 
begins. In order to do as less steps possible using fullerene, we decided first to bind the 
spacer to the catalytic unit, and only after the subsequent deprotection of the amino acidic 
portion to functionalize the fullerene. The click reaction between the azide 62 and alchine 
60 took place in classic condition with a catalytic amount of copper sulphate and sodium 
ascorbate, in a mixture of water and tert-butanol. The reaction gave the product 66 in 93% 
yield. 
 
Scheme 74: click reaction between azide 62 and alkine 60 
After, the aminoacidic portion need to be deprotected in order to functionalize the 
fullerene. With a hydrogenation with Pd/C in atmosphere of hydrogen in MeOH we were 
able to obtain the product 67 in a quantitative way. 
 
Scheme 75: deprotection of 66 
Now the substrate is ready for the “Prato reaction”. Since the substrate is very precious, we 
decided to modify the protocol using an excess of Pristine Fullerene and a higher 
concentration, among 3 mg for mL, paraformaldehyde and toluene heated to reflux. This 
time the mechanism is slightly different from the previous one, because the presence of a 
free carboxylic acid lead to a decarboxylation, and the fullerene pyrrolidine has no 
stereocenter. This factor simplified the synthesis and ensured the optical purity of the 
product. Despite of this changes the functionalization was accomplished with success, giving 
the product 68 with 50% yield. 
114 
 
 
Scheme 76: “Prato reaction” between 67 and Fullerene 
The final step of the reaction was the deprotection of the nitrogen of the catalyst, performed 
with trifluoroacetic acid in dichloromethane to obtain the final catalyst 69, who was washed 
with saturated NaHCO3 solution to free the ammonium salts giving the final catalyst in 99% 
yield, ready to be used.  
 
Scheme 77: final deprotection for the synthesis of 69 
The synthesized catalyst has been fully characterized and their property has been explored. 
It seems to be stable if strictly stored under nitrogen to prevent any oxidation of the 
fullerene. The Michael reaction we used for the previous catalyst X unfortunately did not 
gave good results because catalyst 16 is not soluble in a mix of solvents that contains 
methanol or ethanol, while is completely soluble in dichloromethane. The problem is that 
the Michael reaction that use benzoic acid as a co-catalyst needs a polar protic solvent. Then, 
we looked in literature on a way to perform the reaction in DCM as solvent. As reported in 
a work by Pericas103 the Michael addition of malonates to aldehydes give also good results 
in DCM if using a base like LiOAc as a co-catalyst instead of benzoic acid. In this way, the 
activation of the malonate passes through the formation of an enolate instead of an enol. 
Then we explored the reaction and the results are reported in Table 20: 
                                                          
103 E. Alza, S. Sayalero, P. Kasaplar, D. Almas, M. A. Pericas, Chem. Eur. J. 2011, 17, 11585 – 11595 
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Entrya R1 R2 solvent 69(%) LiOAc(%) t(h) Conv(%)b ee(%)c 
1 
Ph 
45a 
Me 
46a 
DCM 10 30 8 85 92 
2 
Ph 
45a 
Me 
46a 
DCM/MeOH 
9:1 
10 30 5 97 80 
3 
Ph 
45a 
Me 
46a 
DCM/MeOH 
95:5 
10 30 5 96 84 
4 
Ph 
45a 
Me 
46a 
DCM 5 15 16 91 91 
5 
pNO2-Ph 
45b 
Me 
46a 
DCM 5 15 24 83 85 
6 
pF-Ph 
45c 
Me 
46a 
DCM 5 15 24 89 85 
7 
pCH3-Ph 
45d 
Me 
46a 
DCM 5 15 24 88 84 
8 
Et 
45e 
Me 
46a 
DCM 5 15 24 0 n.d. 
9 
Ph 
45a 
Et 
46b 
DCM 5 15 
24 
48 
74 
82 
/ 
93 
10 
Ph 
45a 
Bn 
46c 
DCM 5 15 
24 
48 
79 
80 
/ 
92 
11 
Ph 
45a 
t-Bu 
46d 
DCM 5 15 24 0 n.d. 
Table 20: a) reaction conditions: Aldehyde 45(1eq.), malonate 46(3eq.), catalyst 69, LiOAc and solvent 0.5M. b) 
determined via 1H-NMR of the reaction mixture. c) determined via chiral HPLC after derivatization with Ph3CHCOOEt 
51. h = hours n.d. = not determined. 
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The results of this trials are really interesting. As a starting point, the reaction between 
cinnamaldehyde and dimethyl malonate in only DCM as solvent with 10% catalyst (entry 1) 
gave a good conversion of 85% after 8 hours, and the enantiomeric excess was 92%, the 
same as the subunit in the homogeneous phase. This is an indication that the spacer length 
is enough to allow the reaction without interference due to fullerene. Then in entry 2-3 we 
explored the role of an amount of MeOH on the reaction. While the reaction rate is 
increased, there is a drop in ee. This can be related to the better solubility of lithium acetate 
in the reaction media, that allows a faster formation of the enolate, but probably also the 
increase of the background reaction. Then, the use of only DCM as solvent was chosen as 
the best condition. The catalyst loading was also reduced to 5% with good results, and the 
scope of the reaction was expanded on different aromatic α,β-unsaturated aldehydes, with 
quite good results in 24h. The limitations are related to aliphatic aldehydes (entry 8) which 
didn’t show formation of the product. This is probably due to the formation of the 
corresponding dienamine, instead of the iminium. Also, different malonates were explored 
with good results. The only malonate which didn’t show any reaction is the di tertbutyl 
malonate, for hindrance reason.  
These results are quite satisfying, and the products were obtained in high conversion, short 
reaction time, low catalyst loading (5% is a quite low value for organocatalysts) and good 
enantiomeric excess. The reactions were very reproducible using different batches of 
catalyst. But the most important thing is that only very particular enamine-activated 
processes were reported with a Maruoka-like organocatalyst, like α-oxydation of aldehyde. 
This is the first example of an organocatalyst bearing a trityl group in an iminium-activated 
reaction. 
Another important factor that need to be tested is the recycle of the catalyst. In order to 
check the recyclability of the catalyst we performed a cycle of reaction with 10% of catalyst, 
after 16 hours the reaction is diluted in a non-solvent like MTBE, that dissolves the reagents 
but not the catalyst, and the mixture is centrifuged. This protocol allowed to recover the 
supernatant and start a new reaction with recycled catalyst. The results are reported in 
Table 21: 
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Cyclea t(h) Conv (%)b ee(%)c 
1 16 99 91 
2 16 95 90 
3 16 87 90 
4 16 41 90 
5 16 10 n.d. 
Table 21: a) reaction conditions: Aldehyde 45a(1eq.), malonate 46a(3eq.), catalyst 69(10%), LiOAc 
(30%) and DCM 0.5M. Reaction mixture diluted in MTBE and centrifuged (5000 rpm, 5 minutes), 
solvent removed. b) determined via 1H-NMR of the reaction mixture. c) determined via chiral HPLC 
after derivatization with Ph3CHCOOEt 51. h = hours. n.d. = not determined 
Also in this case the results gave interesting indications. The first 3 cycle gave very good 
results in conversion, with only a slight but expected decrease (probably due to loss of little 
amount of material), while in the fourth and fifth cycles there is a strong drop in conversion. 
This can occur probably for the formation of molecular aggregates, that makes not available 
some of the catalytic units for the reaction. Since this feature seems strictly related to nature 
of fullerene, this can be seen as a limitation for this material. On the other side, the 
enantiomeric excess is not changed during all the cycles, indicating that the catalytic unity is 
always stable and is not affected by decomposition (like in Jorgensen-Hayashi supported 
catalysts).  
 
4.7 Conclusion 
 
In conclusion, a deep study on functionalization of carbon-based nanomaterial has been 
accomplished. In particular, in collaboration with Prof. Prato and co-workers, we have 
successfully synthesized a fullerene-supported Trytyl pyrrolidine, able to perform 
enantioselective Michael addition of malonate to α,β-unsaturated aldehydes with results 
similar to literature. This is the first example of the use of a trityl Pyrrolidine organocatalyst 
in iminium ion activation mode. The catalyst has been recycled up to three times, and further 
studies will be done in order to build more stable catalysts, and to expand the number of 
reaction possible.  
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4.8 Synthetic Procedures and Product characterization 
General Information. 1H and 13C NMR spectra were recorded on Varian Gemini 200 or Inova 
400 NMR instruments with a 5 mm probe. Chemical shifts (δ) are reported in ppm, relative 
to the residual peaks of deuterated solvent signals. HPLC-MS analyses were performed on 
an Agilent Technologies HP1100 instrument coupled with an Agilent Technologies MSD1100 
single-quadrupole mass spectrometer. A Phenomenex Gemini C18, 3 μm (100 x 3mm) 
column was employed for the chromatographic separation: mobile phase H2O/CH3CN, 
gradient from 30% to 80% of CH3CN in 8 min, 80% of CH3CN until 22 min, then up to 90% of 
CH3CN in 2 min, flow rate 0.4 mL min−1. Mass spectrometric detection was performed in full-
scan mode from m/z 50 to 2500, scan time 0.1 s in positive ion mode, ESI spray voltage 4500 
V, nitrogen gas 35 psi, drying gas flow rate 11.5 mL min-1, fragmentor voltage 30 V. CSP-HPLC 
analyses were performed on an Agilent Technologies Series 1200 instrument using Daicel® 
chiral columns and n-hexane/2-propanol (n-Hex/IPA) mixtures. Optical rotation 
measurements were performed on a polarimeter Schmidt+Haensch UniPol L1000. Flash 
chromatography purifications were carried out using Merck silica gel 60 (230-400 mesh 
particle size). Thin layer chromatography was performed on Merck 60 F254 plates. 
Commercial reagents were used as received without additional purification.  TGA analysis 
has been performed on the instrument TGA Q500 (TA Instruments) under nitrogen with 
equilibration at 100°C followed by a 10°C/min gradient until 800°C. (T = working 
temperature, ∆m = mass variation). Raman analysis have been performed with an Invia 
Renishaw (50x) microspectromer and a laser source at 532, 633 e 785 nm. (RBM = radial 
breathing mode, D = D band, G = G band, 2D = D sovratone band). 
Synthesis and Product Charactherization 
 
32: A suspension of trans-L-hydroxyproline (2,1 g, 16 mmol) in cyclohexanone  
(10 mL, 96 mmol) is heated 160°C using a Dean-Stark apparatus to remove water for 3h, 
until a yellow clear solution is formed. After, the mixture is cooled to room temperature and 
H2O (8 mL, 444 mmol) is added. The reaction is stirred for 1 h. Finally, the acqueous layer is 
collected and the organic phase is extracted with additional H2O. The combined acqueous 
layers are concentrated under vacuum and dried to obtain the crude product as a dark 
brown oil, that is used without further purification. 
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33: To a solution of 32 (1,4 g, 16 mmol) in DCM (40 mL) and Et3N (6,7 mL, 48 mmol) at 0°C is 
added Boc2O (4,2 g, 19,2 mmol). The mixture is stirred at room temperature overnight. After, 
the reaction is quenched with saturated NH4Cl and extracted with DCM. The combined 
organic layers are dried over Na2SO4, filtered and concentrated under reduced pressure. The 
crude product is purified via flash chromatography (DCM/MeOH 9:1), giving the 
corresponding product 6 as a brown oil (2,1 g, 11,2 mmol, 70% over two steps). Compound 
characterized in literature.104  
 
34: To a solution of 33 (565 mg, 3 mmol) in DCM (6 mL) at 0°C is slowly added Et3N (420 μL, 
3 mmol) and MsCl (234 μL, 3 mmol). ). The mixture is stirred at room temperature overnight. 
After, the reaction is quenched with H2O and extracted with DCM. The combined organic 
layers are washed with brine, dried over Na2SO4, filtered and concentrated under reduced 
pressure. The crude product is purified via flash chromatography (Cy/AcOEt 8:2), giving the 
corresponding product 34 as a brown oil (750 mg, 2,8 mmol,94%). 1H-NMR (400MHz, CDCl3) 
δ = 1,46 (s, 9H), 2,14 (m, 1H), 2,26 (br, 1H), 3,04 (s, 3H), 3,47 (dd, J = 17,3; 10,2 Hz; 1H), 3,59 
(dd, J = 13,1; 4,4 Hz; 1H), 3,66 (br, 2H), 5,26 (m, 1H). Compound characterized in literature.105 
 
35: To a solution of 34 (295 mg, 1,1 mmol) in DMF (3 mL) at rt NaN3 (145 mg, 2,2 mmol) is 
slowly added under stirring. The mixture is heated to 70°C and the reaction is stirred 
overnight. After, the mixture is cooled to room temperture, diluted with AcOEt (3 mL) and 
washed with acqueous 5% LiCl to remove the DMF. The organic layer is dried over Na2SO4, 
                                                          
104 F. Sternfeld, A. R. Guiblin, R. A. Jelley, V. G. Matassa, A. J. Reeve, P. A. Hunt, M. S. Beer, A. Heald, J. A. Stanton, B. 
Sohal, et al., J. Med. Chem. 1999, 42, 677–690. 
105 H. Zhang, Y. Chuan, Z. Li, Y. Peng, Adv. Synth. Catal. 2009, 351, 2288–2294. 
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filtered and concentrated under reduced pressure. The crude product 35 is obtained as a 
brown oil (210 mg, 991 μmol, 90%) 1H-NMR (400MHz, CDCl3) δ = 1,46 (s, 9H), 2,01 (m, 2H), 
3,44 (m, 4H), 4,11 (m, 1H). Compound characterized in literature.  
 
31: 10% Pd/C (121 mg, 114 μmol) is added to a solution of 35 (482 mg, 2,3 mmol) in MeOH 
(6 mL) and the reaction is stirred under H2 atmosphere for 1h. After, the reation mixture is 
filtered through celite and washed with MeOH. The solvent is removed under reduced 
pressure and the crude is purified via flash chromatography (DCM/MeOH 95:5), obtaining 
31 as a dark brown oil (295 mg, 1,6 mmol, 70%). 1H-NMR (400MHz, CDCl3) δ = 1,46 (s, 9H), 
1,68 (bs, 1H), 2,05 (dt, J = 12,7; 6,2 Hz; 1H), 3,05 (m, 1H), 3,48 (m, 5H). Compound 
characterized in literature. 
 
36: acqueous solution of NaNO2 (2,1 g, 30 mmol) is slowly added over 30 min to a stirring 
solution of 3-aminobenzoic acid (4,8 g, 35 mmol) in 48% HBF4 (7,8 mL, 60 mmol) at -5°C. 
After, the precipitate is filtered and washed with cold Et2O/MeOH 4:1 (2 x 10 mL), and dried 
under vacuum, affording 36 as a pale yellow solid without further purification (6,4 g, 27 
mmol, 77%). 13C-NMR (100 MHz, DMSO-d6) δ = 117,6; 132,2; 133,8; 133,9; 136,3; 141,0; 
164,4. 
Compound already present in literature.106  
 
48: A solution of ethyl bromoacetate (357 μL, 3,22 mmol) in CH3CN (3,7 mL) is added 
dropwise to a stirring solution of amine 31 (500 mg, 2,68 mmol) and Et3N (748 μL, 5,37 
                                                          
106 G. F. Kolar, Zeitschrift fur Naturforsch. - Sect. B J. Chem. Sci. 1972, 27, 1183–1185. 
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mmol) in CH3CN (7,4 mL) at 0°C. The mixture is stirred at room temperature for 2 h. After, 
the solvent is removed under reduced pressure, water is added and is extracted with AcOEt. 
The organic phase is washed with brine, saturated NaHCO3 and brine again, dried with 
Na2SO4, filtered and concentrated under reduced pressure. The crude product is purified 
with flash chromatography (DCM/MeOH 97:3) yielding product 48 as a yellow oil (349 mg, 
1,28 mmol, 485). 1H-NMR (400MHz, CDCl3) δ = 1,28 (t, J = 7,1 Hz, 3H), 1,45 (s, 9H), 1,77 (m, 
1H), 2,03 (dt, J = 13,4; 6,1 Hz; 1H), 3,15 (m, 1H), 3,35 (dt, J = 11,1; 5,7 Hz; 2H), 3,43 (s, 2H), 
3,49 (m, 2H), 4,20 (q, J = 7,1 Hz; 2H). Compound already characterized in literature.107 
 
49: To a solution of C60 (100 mg, 139 μmol) in toluene (100 mL) is added 48 (41,6 mg, 153 
μmol) and paraformaldehyde (8,3 mg, 278 μmol). The mixture is heated to reflux for 4h. 
after TLC analysis (toluene/AcOEt 6:1, no double adduct formation), another aliquote of 48 
and paraformaldehyde is added. The reaction is stirred at reflux another hour. After TLC 
analysis (toluene/AcOEt 6:1, double adduct formation) the heating is interrupted. The 
reaction mixture is directly purified by flash cromatography (gradient from only toluene to 
toluene/AcOEt 6:1). The product obtained is dissolved in CHCl3, precipitated by adding 
MeOH, centrifugated (3000 rpm, 10 minutes), and the solidi s recollected. The product is 
dried under vacuum, obtaining a brown solid (71,2 mg, 71 μmol, 50%).  1H-NMR (400MHz, 
CDCl3) δ = 1,33 (t, J = 7,1 Hz; 3H), 1,53 (s, 9H), 2,39 (br, 2H), 3,53 (m, 1H), 3,72 (br, 2H), 3,94 
(br, 2H), 4,41 (m, 2H), 4,63 (dd, J = 25; 8,9 Hz; 1H), 5,25 (d, J = 7 Hz; 1H), 5,34 (s; 0,5H), 5,44 
(s; 0,5H). 13C-NMR (100 MHz, CDCl3) δ = 14,4; 14,5; 28,6; 61,5; 63,2; 69,2; 69,4; 72,5; 72,7; 
74,8; 77,2; 79,6; 136,4-159,9 (16 signals); 154,6; 155,6. 
                                                          
107 A. Banerjee, V. A. Kumar, Bioorg. Med. Chem. 2013, 21, 4092–4101. 
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50: To a suspension of 49 (60 mg, 59,7 μmol) in DCM (10 mL) at 0°C is added trifluoroacetic 
acid (10 mL) and the mixture is stirred for 2h. After, after TLC analysis (DCM/acetone 9:1), 
the solvent is evaporated and the product is dissolved in DCM and washed with saturated 
NaHCO3 and water. After, MeOH is added until complete precipitation of the product occurs, 
the suspension is centrifugated (3000 rpm, 10 minutes) and the solid is collected and dried 
under vacuum (39,9 mg, 44,1 μmol, 74%). 1H-NMR interpretation is difficult because of poor 
solubility in CDCl3 or CD3OD. Presence of the free amine observed thanks to Michael 
reaction. 
 
54: Ethyl chloroformiate (4,13 mL ,42 mmol, 1.05 eq.) is added dropwise to a stirring 
suspension of (R)-3-hydroxypyrrolidin-1-ium chloride 53 (4,94 g, 40 mmol, 1 eq.) and K2CO3 
(5,67 g, 41 mmol, 1.025 eq.) in dry MeOH (80 mL) at 0°C. The reaction is stirred at room 
temperature overnight. After, water is added and MeOH is removed under vacuum, and 
then is extracted with DCM, dried over Na2SO4, dried and concentrated under vacuum. The 
crude product is purified by flash cromatography (AcOEt) to give the corresponding product 
54 (4.98 g, 31.3 mmol, 78%) as a pale yellow oil. 1H NMR (400 MHz, CDCl3) δ = 4.46 (qt, J = 
4.5, 2.3 Hz, 1H), 4.13 (q, J = 7.1 Hz, 2H), 3.60 – 3.34 (m, 4H), 2.07 – 1.87 (m, 3H), 1.25 (t, J = 
7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 155.20, 69.72 (d, J = 80.0 Hz), 60.77 (d, J = 3.0 Hz), 
53.82 (d, J = 40.6 Hz), 43.62 (d, J = 24.6 Hz), 33.28 (d, J = 57.7 Hz), 14.43 (d, J = 1.7 Hz). 
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55: A solution of compound 54 (4.78 g, 30 mmol, 1 eq.) in THF (10 mL) is added dropwise to 
a stirring suspension of NaH (1.26 g, 60% w/w, 31,5 mmol, 1.05 eq.) in THF (20 mL) at 0°C 
and is kept stirring at 0°C for 30 minutes.  After, a solution of benzyl Bromide (3.75 mL, 31.5 
mmol, 1.05 eq.) in THF (10 mL) is added dropwise at 0°C and finally TBAI (554 mg, 1.5 mmol, 
0.05 eq.) is added. The reaction is stirred at room temperature overnight. After, the reaction 
is quenched with saturated NH4Cl and water. The acqueous phase is extracted with Et2O, 
dried over Na2SO4, filtered and concentrated under vacuum. The crude product is purified 
by flash cromatography (Cy/AcOEt 75:25) to give the corresponding product 55 (6.81 g, 27.3 
mmol, 91 %) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ = 7.40 – 7.24 (m, 5H), 4.52 (d, J = 
6.6 Hz, 2H), 4.13 (q, J = 7.1 Hz, 3H), 3.49 (s, 4H), 2.14 – 1.88 (m, 2H), 1.26 (t, J = 7.1 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ = 155.18 , 138.00 , 128.38 , 127.64 , 127.51 , 77.66 , 70.81 , 
60.88 , 51.18 , 43.94 , 30.97 (d, J = 90.3 Hz), 14.80; HPLC-MS (ESI) tr = 8.8 min; [M+H]+ 250.0 
m/z,  [M+Na]+ 272.0 m/z. 
 
56: KOH (15,15 g, 270 mmol, 10 eq.) is added to a stirring solution of compound 55 (6,73 g, 
27 mmol, 1 eq.) in EtOH/H2O 4:1 (50 mL) and the reaction is refluxed for 72h. Finally, the 
reaction is cooled to room temperature, ethanol is removed under vacuum and the 
acqueous phase is extracted with DCM. The organic phase is dried over Na2SO4, filtered and 
concentrated under vacuum. The crude product is purified with flash cromatography 
(DCM/MeOH/NH4OH 90:10:2) to give the corresponding compound 56 (4,73 g, 26,7 mmol, 
99%) as a brown oil. 1H NMR (400 MHz, CDCl3) δ 7.39 – 7.20 (m, 5H), 4.47 (d, J = 1.3 Hz, 2H), 
4.13 (ddd, J = 5.0, 3.4, 1.8 Hz, 1H), 3.97 (bs, 1H), 3.21 – 3.07 (m, 1H), 2.95 (tdd, J = 12.4, 5.9, 
1.3 Hz, 1H), 1.98 – 1.85 (m, 2H). 13C NMR (100 MHz, CDCl3) δ = 138.05, 128.08 , 127.30, 
127.28 , 79.48 , 70.52 , 52.55 , 49.37 , 45.21 , 32.33. 
 
57: To a stirring solution of 56 (1,33 g, 7,5 mmol, 1 eq.), Na2EDTA 0,01M (11,25 mL, 0,112 
mmol, 0,01 eq.) and NaHCO3 (3,15 g, 37,5 mmol, 5 eq.) in CH3CN/THF 4:1 (15 mL) at 0°C, 
Oxone (4,84 g, 7,88 mmol, 1,05 eq.) is added in 4 portions over 1 hour. The mixture is kept 
stirring at 0°C for 1 hour. Finally, after TLC (DCM/MeOH 95:5), the reaction mixture is diluted 
AcOEt and extracted, then the acqueous phase is further extracted with DCM. The combined 
organic phases are dried over Na2SO4, filtered and concentrated under vacuum. The crude 
product is purified with flash cromatography (DCM/MeOH 98:2) to give the corresponding 
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nitrone 57 (0,86 g, 4,5 mmol, Y = 60%) as a brown oil. 1H NMR (400 MHz, CDCl3) δ = 7.42 – 
7.28 (m, 5H), 7.11 (d, J = 3.7 Hz, 1H), 4.79 (d, J = 7.7 Hz, 1H), 4.63 – 4.52 (m, 1H), 4.26 – 4.13 
(m, 2H), 3.92 (q, J = 11.0, 7.9 Hz, 1H), 2.65 – 2.50 (m, 1H), 2.25 (ddt, J = 13.6, 8.7, 3.9 Hz, 1H). 
13C NMR (100 MHz, CDCl3) δ = 137.31, 134.26 , 128.78 , 128.33 , 128.00 , 78.38 , 71.74 , 61.44 
, 27.74 . 
 
58: To a solution of triphenylmethane (4,89 g, 20 mmol, 2 eq.) in THF (40 mL) at 0°C is slowly 
added a BuLi solution 1,6M in Hexane (13,13 mL, 21 mmol, 2,1 eq.) under Ar. The solution 
became deeply red and the mixture is kept stirring at 0°C for 1 hour. After, a solution of 
nitrone 57 (1,91 g, 10 mmol, 1 eq.) in THF (10 mL) is added dropwise at 0°C. The reaction is 
stirred at room temperature for 2 h. Finally, the reaction is quenched with saturated NH4Cl 
and THF is removed under reduced pressure. The acqueous suspension is extracted with 
DCM and the combined organic phases are dried over Na2SO4, filtered and concentrated 
under vacuum. The crude product is purified with flash cromatography (CyHex/AcOEt 95:5). 
The pure hydroxilamine (3,2 g, 7,44 mmol, 74%) is directly dissolved in AcOH (80 mL), and 
Pd/C al 10% (1,05 g, 0.99 mmol, 0,1 eq.) is added. The mixture is kept stirring under H2 (1 
atm) atmosphere overnight. After, the suspension is removed by filtration on a celite pad, 
washing with MeOH, and the solvent is removed under reduced pressure. After, water is 
added and a solution of NaOH 5% is added until pH 9, then is extracted with DCM. the 
combined organic phases are dried over Na2SO4, filtered and concentrated under vacuum. 
The crude product is purified with flash cromatography CyHex/AcOEt 1:1 to give the 
corresponding product 58 (2,49 g, 7,56 mmol, 76%) as a pale yellow solid. 1H NMR (400 MHz, 
CDCl3) δ = 7.40 (d, J = 7.8 Hz, 5H), 7.33 – 7.13 (m, 10H), 4.86 (d, J = 1.4 Hz, 1H), 4.19 (d, J = 
5.3 Hz, 1H), 3.06 (ddd, J = 11.6, 9.6, 6.0 Hz, 1H), 2.75 (ddd, J = 9.5, 7.9, 1.4 Hz, 1H), 2.48 (bs, 
2H), 1.39 (dd, J = 13.3, 5.9 Hz, 1H), 0.57 (dddd, J = 13.4, 11.7, 8.0, 5.4 Hz, 1H). 13C NMR (100 
MHz, CDCl3) δ = 130.11 , 127.97 , 126.40, 75.36 , 72.53 , 60.79 , 44.86 , 35.53 ; HPLC-MS (ESI) 
tr = 26 min; [M+H]+ 330.0 m/z; m.p.= 165-170°C. 
 
59: To a solution of compound 7 (2.1 g, 5 mmol, 1 eq.) in DCM (20 mL) and Et3N (766 μL, 5,5 
mmol, 1,1 eq.) at 0°C Boc2O (1,15 g, 5,25 mmol, 1,05 eq.) is added. The reaction mixture is 
stirred overnight. After, the reaction is quenched with saturated NH4Cl, the organic phase is 
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collected and the acqueous phase is extracted with DCM. the combined organic phases are 
dried over Na2SO4, filtered and concentrated under vacuum. The crude product is purified 
with flash cromatography CyHex/AcOEt 1:1 to give the product 8 (2,5 g , 4,81 mmol, 96%) as 
a pale yellow solid. 1H NMR (400 MHz, CDCl3) δ = 7.45 – 7.41 (m, 6H), 7.28 – 7.09 (m, 9H), 
5.75 (s, 1H), 4.35 (d, J = 5.2 Hz, 1H), 3.52 (q, J = 9.7 Hz, 1H), 2.95 (td, J = 10.7, 2.5 Hz, 1H), 
1.33 (s, 9H), 1.29 – 1.18 (m, 1H), -0.01 (dtd, J = 14.8, 9.9, 5.2 Hz, 1H). 13C NMR (100 MHz, 
CDCl3) δ = 157.62 , 144.80, 130.81, 127.46, 126.11, 80.03 , 76.28 , 72.45 , 60.82 , 49.46 , 
32.30 , 28.33. HPLC-MS (ESI) tr = 13.3 min; [M-t-Bu]+ 372.0 m/z; m.p.= 85-90°C. 
 
60: A solution of compound 59 (215 mg, 0,5 mmol, 1 eq.) in THF (2 mL)  is added dropwise 
to a stirring suspension of NaH (22 mg, 60% w/w, 0,55 mmol, 1.1 eq.) in THF (2 mL) at 0°C 
and is kept stirring at 0°C for 1 hour.  After, a solution of Propargyl Bromide (65 µL, 0,6 mmol, 
1.2 eq.) in THF (2 mL) is added dropwise at 0°C. The reaction is stirred at room temperature 
overnight. After, the reaction is quenched with saturated NH4Cl and water. The THF is 
removed under vacuum and the acqueous phase is extracted with AcOEt, dried over Na2SO4, 
filtered and concentrated under vacuum. The crude product is purified by flash 
cromatography (Cy/AcOEt 80:20) to give the corresponding product 60 (210 mg, 0,45 mmol, 
Y = 90 %) as a yellow solid. 1H NMR (400 MHz, CDCl3) δ 7.48 – 7.10 (m, 15H), 5.79 (s, 1H), 
4.27 – 4.16 (m, 2H), 3.95 (dd, J = 16.2, 2.3 Hz, 1H), 3.42 (q, J = 9.7 Hz, 1H), 2.93 (td, J = 10.6, 
2.5 Hz, 1H), 2.34 (t, J = 2.4 Hz, 1H), 1.49 – 1.37 (m, 1H), 1.32 (s, 9H), -0.24 (dtd, J = 14.7, 9.8, 
5.1 Hz, 1H).  13C NMR (100 MHz, CDCl3) δ = 157.22 , 144.79, 130.96, 127.42, 126.08, 82.48 , 
80.03 , 77.36 , 74.50 , 71.28 , 61.16 , 54.95 , 49.50 , 28.33, 26.37; HPLC-MS (ESI) tr = 15.5 
min; [M-t-Bu]+ 412.0 m/z, m.p.=75-80°C. 
 
63: 2-Bromo-Benzyl acetate (1,58 mL, 10 mmol, 1 eq.) is slowly added to a stirring solution 
of 3-amino-1-propanol (1,90 mL, 25 mmol, 2.5 eq.) in CH3CN (20 mL), and the mixture is 
stirred for 2h. After, the solvent is removed under vacuum. The crude product is purified 
with flash cromatography (AcOEt/MeOH 9:1) to give the corresponding product 63 (1,46 g , 
6,54 mmol, 71%) as a colorless liquid. 1H NMR (400 MHz, CDCl3) δ = 7.40 – 7.27 (m, 5H), 4.69 
(s, 2H), 4.00 (s, 2H), 3.56 (dt, J = 8.5, 6.0 Hz, 4H), 3.09 (s, 0H), 1.92 (bs, 1H), 1.85 – 1.71 (m, 
2H). 13C NMR (100 MHz, CDCl3) δ = 164.33, 141.15 , 128.39 , 127.37 , 126.92 , 64.79 , 58.65 , 
49.79 , 43.12 , 29.02; HPLC-MS (ESI) tr = 3.4 min; [M+H]+ 224.0 m/z 
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64: To a solution of 63 (1,12 g, 5 mmol, 1 eq.) in DCM (20 mL) and Et3N (836 μL, 6 mmol, 1.2 
eq.) is slowly added CbzCl (785 μL, 5,5 mmol, 1.1 eq.) at 0°C. The reaction mixture is stirred 
at room temperature overnight. After, the reaction is quenched with saturated NH4Cl, the 
organic phase is collected and the acqueous phase is extracted with DCM. the combined 
organic phases are dried over Na2SO4, filtered and concentrated under vacuum. The crude 
product is purified with flash cromatography (AcOEt) to give the corresponding product 64 
(1,7 g, 4,76 mmol, 95%) as a colorless liquid. 1H NMR (400 MHz, CDCl3) δ = 7.41 – 7.21 (m, 
10H), 5.14 (dd, J = 29.6, 2.9 Hz, 4H), 4.04 (d, J = 35.3 Hz, 2H), 3.62 (t, J = 5.6 Hz, 2H), 3.49 (dt, 
J = 21.6, 6.5 Hz, 2H), 3.09 (bs, 1H), 1.70 (dq, J = 11.7, 6.3, 5.8 Hz, 2H). 13C NMR (100 MHz, 
CDCl3) δ = 169.67 (d, J = 26.5 Hz), 156.77 (d, J = 39.4 Hz), 136.25 (d, J = 13.4 Hz), 135.34 (d, J 
= 16.9 Hz), 128.66 , 128.53 , 128.40 (d, J = 5.9 Hz), 128.18 (d, J = 6.1 Hz), 127.96 , 127.82 , 
67.75 (d, J = 5.8 Hz), 67.04 , 59.08 (d, J = 94.2 Hz), 49.61 (d, J = 19.6 Hz), 45.45 (d, J = 18.5 
Hz), 30.90 (d, J = 67.0 Hz); HPLC-MS (ESI) tr = 9 min; [M+H]+ 358.0 m/z, [M+Na]+ 380.0 m/z. 
 
65: To a solution of 64 (1,61 g, 4,5 mmol, 1 eq.) in DCM (15 mL) and Et3N (815 μL, 5.85 mmol, 
1.3 eq.) is slowly added MsCl (435 μL, 5,63 mmol, 1.25 eq.) at 0°C. The reaction mixture is 
stirred at room temperature overnight. After, the reaction is quenched with saturated 
NH4Cl, the organic phase is collected and the acqueous phase is extracted with DCM. the 
combined organic phases are dried over Na2SO4, filtered and concentrated under vacuum. 
The crude product is purified with flash cromatography (Cy/AcOEt 1:1) to give the 
corresponding product 65 (1,95 g , 4,48 mmol, >99%) as a pale yellow liquid. 1H-NMR (400 
MHz, CDCl3) δ = 7.42 – 7.23 (m, 10H), 5.18 (d, J = 3.9 Hz, 2H), 5.09 (d, J = 10.9 Hz, 2H), 4.25 
(dt, J = 21.5, 6.1 Hz, 2H), 4.05 (d, J = 24.8 Hz, 2H), 3.55 – 3.41 (m, 2H), 2.91 (d, J = 46.9 Hz, 
3H), 2.00 (dp, J = 19.2, 6.4 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 169.66 , 156.22 (d, J = 37.5 
Hz), 136.29 (d, J = 2.3 Hz), 135.34 (d, J = 8.3 Hz), 128.69 (d, J = 2.7 Hz), 128.55 (t, J = 2.8 Hz), 
128.39 , 128.30 , 128.13 (d, J = 2.3 Hz), 127.83 , 67.88 , 67.70 (d, J = 15.5 Hz), 67.35 – 67.04 
(m), 49.99 , 45.55 (d, J = 66.8 Hz), 37.24 , 28.24 (d, J = 45.4 Hz), HPLC-MS (ESI) tr = 9.9 min; 
[M+H]+ 436.0 m/z, [M+H2O]+ 453.0 m/z. 
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62: To a solution of 65 (1,74 g , 4 mmol, 1 eq.) in DMF (15 mL) at 0°C is slowly added NaN3 
(468 mg , 7.2 mmol, 1.8 eq.). The reaction is stirred at room temperature overnight. After, 
the reaction is diluted with AcOEt and washed with a solution of LiCl at 5%. Then the organic 
phase is dried over Na2SO4, filtered and concentrated under vacuum. The crude product is 
purified with flash cromatography (Cy/AcOEt 1:1) to give the corresponding product 62 (1,09 
g, 2,85 mmol, 71%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ = 7.45 – 7.21 (m, 10H), 5.18 
(d, J = 1.4 Hz, 2H), 5.10 (d, J = 7.4 Hz, 2H), 4.04 (d, J = 24.6 Hz, 2H), 3.44 (dt, J = 8.7, 6.9 Hz, 
2H), 3.33 (dt, J = 26.5, 6.7 Hz, 2H), 1.81 (dp, J = 20.2, 6.8 Hz, 2H). 13C NMR (100 MHz, CDCl3) 
δ = 169.43 (d, J = 4.6 Hz), 156.00 (d, J = 49.7 Hz), 136.24 , 135.24 (d, J = 8.3 Hz), 128.51 , 
128.44 , 128.35 , 128.31 , 128.19 , 127.98 (d, J = 11.8 Hz), 127.74 (d, J = 14.7 Hz), 67.45 (d, J 
= 20.8 Hz), 66.86 (d, J = 3.5 Hz), 49.58 (d, J = 11.4 Hz), 48.65 (d, J = 21.0 Hz), 46.20 (d, J = 81.3 
Hz), 27.59 (d, J = 30.5 Hz). 
 
66: A solution of CuSO4·5H2O(10.7 mg, 0.043 mmol, 0.1 eq.) in H2O (0.5 mL)  and a solution 
of sodium ascorbate (17 mg, 0.086 mmol, 0.2 eq.) in H2O (0.5 mL)  are slowly added to a 
stirring solution of the corresponding azide 62 (164 mg, 0.43 mmol, 1 eq.) and alchine 60 
(201 mg, 0.43 mmol. 1 eq.) in tert-butanol (1 mL) and the resulting suspension is stirred 
overnight at room temperature. After, the reaction is diluted with AcOEt and the acqueous 
phase is extracted. The organic phases are dried over Na2SO4, filtered and concentrated 
under vacuum. The crude product is purified by flash cromatography (Cy/AcOEt 80:20) to 
give the corresponding product 66 (340 mg, 0,4 mmol, 93 %) as a white solid. 1H NMR (400 
MHz, CDCl3) δ 7.71 (s, 1H), 7.43 – 7.27 (m, 16H), 7.22 – 7.10 (m, 9H), 5.82 (s, 1H), 5.19 (s, 
2H), 5.12 (d, J = 2.8 Hz, 2H), 4.61 (dd, J = 26.0, 12.3 Hz, 1H), 4.47 – 4.32 (m, 3H), 4.14 – 4.00 
(m, 3H), 3.53 – 3.34 (m, 1H), 2.98 – 2.85 (m, 2H), 1.61 – 1.48 (m, 1H), 1.32 (s, 9H), -0.13 (dtd, 
J = 14.7, 9.7, 5.2 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 169.66 , 157.08 , 156.22 (d, J = 9.1 Hz), 
145.04 (d, J = 32.2 Hz), 144.65 (d, J = 1.6 Hz), 136.08 (d, J = 5.3 Hz), 135.16 (d, J = 8.5 Hz), 
130.66, 128.64 (d, J = 3.7 Hz), 128.51 (d, J = 3.1 Hz), 128.31 (d, J = 2.6 Hz), 128.12, 127.78 , 
127.26, 125.90 , 123.27 , 122.53 , 83.13 (d, J = 16.0 Hz), 79.67 , 71.08 , 67.77 (d, J = 23.6 Hz), 
67.12 , 61.37 (d, J = 7.5 Hz), 60.96 , 49.87 (d, J = 26.2 Hz), 49.42 , 47.54 , 46.16 (d, J = 46.1 
Hz), 29.29 (d, J = 22.7 Hz), 28.20, 26.63; HPLC-MS (ESI) tr = 17.3 min; [M+H]+ 850.0 m/z,  
[M+Na]+ 872.0 m/z. 
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67: Compound 66 (239 mg, 0,28 mmol) is dissolved in MeOH (3 mL), and 10% Pd/C (30 mg, 
28 μmol, 0.1 eq.) is added. The mixture is kept stirring under H2 (1 atm) atmosphere 
overnight. After, the suspension is removed by filtration on a celite pad, washing with 
MeOH, and the solvent is removed under reduced pressure. After, the product is dissolved 
in DCM and cold Pentane in added dropwise at 0°C, leading to the precipitation of a white 
solid. The solvent is removed by filtration and the product is dried under vacuum to give the 
product 67 (175 mg, 0,28 mmol, 99%) as a white solid. 1H NMR (400 MHz, CDCl3) δ = 7.72 (s, 
1H), 7.35 (d, J = 7.7 Hz, 6H), 7.12 (dt, J = 13.8, 7.1 Hz, 9H), 5.76 (s, 1H), 4.58 – 4.42 (m, 3H), 
4.30 (d, J = 12.2 Hz, 1H), 4.02 (d, J = 5.0 Hz, 1H), 3.74 (s, 2H), 3.46 – 3.31 (m, 1H), 3.12 (s, 2H), 
2.91 – 2.79 (m, 1H), 2.47 (s, 2H), 1.49 (t, J = 12.0 Hz, 1H), 1.25 (s, 9H), -0.08 – -0.25 (m, 1H). 
13C NMR (100 MHz, CDCl3) δ = 171.06 , 157.00 , 144.99 , 144.60 , 130.60 , 127.28 , 125.98 , 
123.58 , 83.40 , 79.63 , 70.99 , 61.41 , 60.98 , 53.44 , 50.36 , 49.37 , 47.46 , 44.58 , 28.20 , 
26.86; HPLC-MS (ESI) tr = 8.9 min; [M+H]+ 626.0 m/z. 
 
68: Pristine C60 (168 mg, 0.23 mmol, 1.25 eq.) is dissolved in Toluene (60 mL) and is sonicated 
for 20 min under Ar. After, compound 67 (117 mg, 0.19 mmol, 1 eq.) and Paraformaldehyde 
(14 mg, 0.47 mmol, 2,5 eq.) are added and the reaction mixture is refluxed for 1 h. After, the 
reaction is cooled to room temperature and directly purified by flash chromatography (first 
Toluene to remove unreacted pristine C60, after Toluene/Ethyl Acetate 7:3) giving the 
corresponding functionalized Fullerene 68 (122 mg, 0.93 mmol, 50%) as a Brown Powder. 1H 
NMR (400 MHz, CDCl3) δ = 7.79 (s, 1H), 7.48 – 7.35 (m, 5H), 7.22 – 7.10 (m, 10H), 5.85 (s, 
1H), 4.86 – 4.76 (m, 1H), 4.68 (d, J = 12.2 Hz, 1H), 4.54 – 4.35 (m, 4H), 4.10 (s, 1H), 3.57 – 
3.33 (m, 1H), 3.21 – 3.04 (m, 1H), 3.02 – 2.76 (m, 1H), 2.61 – 2.47 (m, 1H), 2.44 – 2.28 (m, 
4H), 1.31 (s, 10H), -0.02 – -0.28 (m, 1H).13C NMR (100 MHz, CDCl3) δ = 157.12, 154.69, 147.31, 
146.25, 146.07, 145.95, 145.63, 145.43, 145.29, 144.66, 144.53, 143.09, 142.63, 142.20, 
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142.05, 141.89, 140.19, 136.12, 130.65, 127.29, 125.95, 123.02, 83.25, 71.11, 70.56, 67.75, 
61.59, 60.95, 51.04, 49.41, 48.26, 31.89, 29.67, 29.32, 29.20, 28.23, 26.78, 22.66, 14.07. 
 
69: Compound 68 (140 mg, 0,11 mmol, 1 eq.) is dissolved in DMC (20 mL), and sonicated for 
20 min. After, TFA (1 mL, 13,3 mmol, 250 eq.) is added dropwise at 0°C. The mixture is stirred 
at room temperature overnight. After, the mixture is concentrated under vacuum, the crude 
solid is dissolved in DCM and the organic phase is washed with saturated NaHCO3 and Brine, 
dried over Na2SO4, filtered and concentrated under vacuum. The crude product is purified 
with flash cromatography DCM/MeOH 99:1 to give the corresponding product 69 (128 mg, 
0.10 mmol, 99%) as brown powder. 1H NMR (400 MHz, CDCl3) δ = 7.77 (s, 1H), 7.35 (s, 6H), 
7.26 – 7.11 (m, 9H), 4.85 – 4.78 (m, 3H), 4.67 (d, J = 12.0 Hz, 1H), 4.48 – 4.40 (m, 5H), 3.86 
(d, J = 5.0 Hz, 1H), 3.13 (t, J = 6.6 Hz, 2H), 2.99 – 2.87 (m, 1H), 2.75 (t, J = 8.2 Hz, 1H), 2.56 (p, 
J = 6.8 Hz, 2H), 1.66 (dd, J = 13.3, 5.3 Hz, 1H), 0.43 (dp, J = 12.7, 6.4 Hz, 1H). 13C NMR (100 
MHz, CDCl3) δ = 154.67, 147.32, 146.25, 146.08, 145.92, 145.62, 145.42, 145.35, 145.30, 
144.53, 143.09, 142.65, 142.20, 142.05, 141.88, 140.19, 136.11, 129.96, 127.55, 125.96, 
123.05, 83.23, 77.29, 77.18, 76.97, 76.66, 70.92, 70.55, 67.67, 62.64, 61.00, 50.71, 48.05, 
44.87, 30.47, 29.03. 
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General procedure for oxidation of pCNT 32 and 33: 
 
A suspension of pSWCNT 32 or pMWCNT 33 4M Nitric Acid, after 20 min sonication, is heated 
to reflux for 8 h. After, the reaction is cooled to room temperature, diluted with water and 
filtered on a 0,45 μm filter under vacuum. The filtrate is suspended in water, sonicated for 
20 min and filtered again. The operation is repeated until water does not reach pH of almost 
6. After, the CNTs are washed with MeOH and Et2O and dried under vacuum. 
Synthesis of SWCNT Ox 34: 
pSWCNT 32 (100 mg), HNO3 4M (100 mL). SWCNT Ox 34 are obtained (100 mg). 
TGA : T = 200 – 700 °C; ∆m = - 16,9 %;  functionalization = 5,4 % → 3,8 μmol/mg. 
Raman : RBM = 272,5 cm-1; D = 1366,6 cm-1; G = 1593,8 cm-1; 2D = 2673,1 cm-1  
a 532 nm. 
Synthesis of MWCNT Ox 35: 
pMWCNT 33 (100 mg), HNO3 4M (100 mL). MWCNT Ox 35 are obtained (99,6 mg). 
TGA : T = 200 – 700 °C; ∆m = - 1,77 %;  functionalization = 0,5 % → 0,4 μmol/mg. 
Raman : D = 1357,9 cm-1; G = 1582,8 cm-1; 2D = 2691,5 cm-1 a 532 nm. 
Re-oxidation MWCNT Ox 35: MWCNT Ox 35 (99,6 mg), HNO3 8M (100 mL). MWCNT Ox 35 
more functionalized are obtained (78,1 mg). TGA: T = 200 – 700 °C; ∆m = - 3,6 %; 
funzionalizzazione = 1 % → 0,8 μmol/mg. 
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General procedure for arylation of pCNT 32 and 33 
 
To a sospension of pSWCNT 32 or pMWCNT 33 in ODCB or NMP, after 20 minutes sonication, 
the diazonium salt is added and the mixture is heated to 60°C overnight. After, the mixture 
is cooled to room temperature, filtered using a 0,45 μm “JHWP” filter under vacuum, 
washing with the reaction solvent, H2O and THF. The solid is suspended again in THF, 
sonicated for 20 minutes, and filtered again. The operation is repeated until the solvent after 
filtration is colorless. Finally. CNTs are washed with MeOH ed Et2O and dried under vacuum. 
Synthesis of SWCNT Ar 37 e MWCNT Ar 38, according to the general procedure:  
Entry 1: pSWCNT 32 (100 mg, 8,33 mmol), 36 (1,96 g, 8,33 mmol), ODCB (100 mL). SWCNT 
Ar 37 (141 mg) are obtained. TGA : T = 200 – 700 °C; ∆m = - 13,7 %;  functionalization = 1,6 
%  
→ 1,1 μmol/mg. 
Re-arylation SWCNT Ar 37: SWCNT Ar 37 (90 mg, 7,5 mmol), 36 (1,77 g, 7,5 mmol), ODCB 
(90 mL). More functionalized SWCNT Ar 37 are obtained (88,4 mg). TGA : T = 200 – 700 °C; 
∆m = - 21,9 %;  Functionalization = 1,8 % → 1,2 μmol/mg.  
pSWCNT 32 (10 mg, 0,83 mmol), 36 (196 mg, 0,83 mmol), ODCB (10 mL). SWCNT Ar 37 are 
obtained (14 mg). TGA : T = 200 – 700 °C; ∆m = - 21,5 %;  functionalization = 2,7 % → 1,8 
μmol/mg. Raman : RBM = 197,8 cm-1; D = 1332,3 cm-1; G = 1595,2 cm-1; 2D = 2668,9 cm-1 a 
532 nm. 
Entry 2: pSWCNT 32 (10 mg, 0,83 mmol), 36 (196 mg, 0,83 mmol), NMP (10 mL). SWCNT Ar 
37 are obtained (12,4 mg). TGA : T = 200 – 700 °C; ∆m = - 21,8 %;  functionalization = 2,8 % 
→ 1,8 μmol/mg. Raman : RBM = 270,9 cm-1; D = 1330,9 cm-1; G = 1592,5 cm-1; 2D = 2659,4 
cm-1 a 532 nm. 
132 
 
Entry 3: pMWCNT 33 (100 mg, 8,33 mmol), 36 (1,96 g, 8,33 mmol), ODCB (100 mL). MWCNT 
Ar 38 are obtained (106,4 mg). TGA : T = 200 – 700 °C; ∆m = - 5,0 %;  functionalization = 0,5 
% → 0,4 μmol/mg. 
Re-arylation MWCNT Ar 38: MWCNT Ar 38 (50 mg, 4,2 mmol), 36 (982 mg, 4,2 mmol), ODCB 
(50 mL). MWCNT Ar 38 are obtained (50 mg). TGA : T = 200 – 700 °C; ∆m = - 4,8 %;  
functionalization = 0,5 % → 0,4 μmol/mg. 
General procedure for amide coupling between CNT 34, 37, 38 and amine 31 
 
To a suspension of functionalized CNT in DMF, after 20 minutes sonication under argon, are 
added coupling reagents and DIPEA, and the reaction is stirred at room temperature for 24 
hours. After, amine 31 in DMF is added, and the mixture is heated at 80°C for 48h (with 
HATU) or at room temperature for 48 hours (with EDC/NHS). Then, after cooling, the solidi 
s filtered on a 0,45 μm “JHWP” filter under vacuum, washing with solvent reaction, H2O e 
THF. The solid is suspended again in THF, sonicated for 20 minutes, and filtered again. The 
operation is repeated until the solvent after filtration is colorless. Finally, CNTs are washed 
with MeOH ed Et2O and dried under vacuum. 
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Synthesis of SWCNT Ox - CAT 39, SWCNT Ar - CAT 40 e MWCNT Ar - CAT 41, according to 
general procedure:  
 
Entry 1: SWCNT Ox 34 (10 mg), DMF (100 mL), HATU (317 mg, 833 μmol), DIPEA (182 μL, 
1,10 mmol), amine 31 (103 mg, 555 μmol). SWCNT Ox – CAT 39 are obtained (11,6 mg). TGA 
: T = 200 – 700 °C; ∆m = - 24,4 %;  functionalization = 1,8 % → 1,1 μmol/mg. Raman : RBM = 
272,5 cm-1; D = 1333,8 cm-1; G = 1593,8 cm-1; 2D = 2660,6 cm-1 a 532 nm. 
Entry 2: SWCNT Ox 34 (10 mg), DMF (100 mL), EDC•HCl (160 mg, 833 μmol), DIPEA (136 μL, 
833 μmol), NHS (96 mg, 833 μmol), amine 31 (103 mg, 555 μmol). SWCNT Ox – CAT 39 (12,6 
mg) are obtained. TGA : T = 200 – 700 °C; ∆m = - 16,2 %;  functionalization = 1,1 % → 0,8 
μmol/mg. Raman: RBM = 270,9 cm-1; D = 1349,4 cm-1; G = 1593,8 cm-1; 2D = 2665,4 cm-1 a 
532 nm. 
Entry 3: SWCNT Ar 37 (50 mg), DMF (200 mL), HATU (1,6 mg, 4,2 mmol), DIPEA (908 μL, 5,6 
mmol), amine 31 (517 mg, 2,8 mmol). SWCNT Ar – CAT 40 are obtained (48,2 mg). TGA : T = 
200 – 700 °C; ∆m = - 22,4 %;  functionalization = 1,2 % → 0,8 μmol/mg. 
Entry 4: MWCNT Ar 38 (50 mg), DMF (200 mL), HATU (1,6 mg, 4,2mmol), DIPEA (908 μL, 5,6 
mmol), amine 31 (517 mg, 2,8 mmol). MWCNT Ar – CAT 41 are obtained (49,8 mg). TGA : T 
= 200 – 700°C; ∆m = - 5,3 %;  functionalization = 0,2 % → 0,2 μmol/mg. 
General procedure for deprotection of CNT 39, 40 e 41 
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To a suspension of functionalized CNTs in THF, after 20 minutes sonication, is added 
trifluoroacetic acid at 0°C and the mixture is stirred at room temperature overnight. Then, 
after cooling, the solidi s filtered on a 0,45 μm “JHWP” filter under vacuum, washing with 
solvent reaction, H2O e THF. The solid is suspended again in THF, sonicated for 20 minutes, 
and filtered again. The operation is repeated until the solvent after filtration is colorless. 
Finally, CNTs are washed with MeOH ed Et2O and dried under vacuum. 
Synthesis of SWCNT Ox – CAT 42, SWCNT Ar – CAT 43 e MWCNT Ar – CAT 44 according to 
general procedure:  
 
Entry 1: SWCNT Ox – CAT 39 (12,6 mg), TFA (2 mL), THF (10 mL). SWCNT Ox – CAT 42 are 
obtained (9 mg). TGA : T = 200 – 700°C; ∆m = - 20,4 %;  functionalization = 2,7 % → 1,8 
μmol/mg. 
Entry 2 SWCNT Ar – CAT 40 (48,0 mg), TFA (8 mL), THF (50 mL). SWCNT Ar – CA 43 are 
obtained (44,9 mg). TGA : T = 200 – 700°C; ∆m = - 20,5 %; functionalization = 1,6 % → 1,1 
μmol/mg. 
Entry 3: MWCNT Ar – CAT 41 (48,0 mg), TFA (8 mL), THF (50 mL). MWCNT Ar – CAT 44 are 
obtained (34,8 mg). TGA : T = 200 – 700°C; ∆m = - 5,6 %; functionalization = 0,4 % → 0,3 
μmol/mg. 
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General procedure for Michael reaction with catalysts 42,43 e 44: 
 
Dimethylmalonate 46a (1 eq.) is added to a stirring suspension of supported catalyst (30%), 
cinnamaldehyde 45a (1.5 eq.), PhCOOH (30%) and water in the selected reaction solvent. 
The reaction is left stirring for the desired time. Conversion is measured by 1H-NMR 
spectroscopy of the reaction mixture.  
Michael addition with catalyst 50: 
 
To a suspension of 50 (30 mg, 34,2 μmol), cynnamaldehyde 45a (22 μL, 171 μmol), PhCOOH 
(4,2 mg, 34,2 μmol), in DCM/EtOH 1:1 (0,75 mL + 0,75 mL) at 0°C is added dimethylmalonate 
46a (13 μL, 113 μmol). The reaction is stirred for 3 days. The conversion is measured by 1H-
NMR spectroscopy on the reaction mixture. After, the solvent is removed under reduced 
pressure and the product is derivatized using witting reagent (43,2 mg, 124 μmol) in DCM 
(250 μL), and stirred overnight. Finally, water is added and extracted with DCM. The organic 
layer is concentrated and the crude derivatized product is purified by flash chromatography 
(CyHex/AcOEt 8:2). CSP-HPLC: IC, Hex/iPrOH 7:3, 0,5 mL min-1, 40°C, rt= 13,1 min; 19,2 min. 
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Procedures of catalysis, recycle and product characterization with catalyst 69 
 
Standard Procedure for reaction of Malonates and Aldehydes catalyzed by catalyst 69: in 
a typical reaction catalyst 69 (5%) is charged in a centrifuge vial, dissolved in DCM (200 µL, 
0,5 M) and sonicated for 5 minutes. After, LiOAc (15%) and Aldehyde 45 (0,1 mmol, 1 eq.) 
are added to the solution. Finally, Malonate 46 (0,3 mmol, 3 eq.) is added and the solution 
is stirred for the desired time (20-48h). Finally, the reaction is diluted with MTBE (1 mL, 3 
times) and centrifugated (5 min, 5000 rpm, 3 times). The organic layer is collected, 
concentrated under vacuum and the crude is analyzed with H-NMR. For e.e. determination 
the crude is diluted in MeOH and ylide 51 is added. The solution is stidded for 1h. After, the 
mixture is concentrated and purified by flash chromatography (Cy/AcOEt 80:20) to give the 
corresponding derivatized product 52 for analysis. 
  
Standard Procedure for recycle of catalyst 69: in a typical reaction catalyst 16 (10%) is 
charged in a centrifuge vial, dissolved in DCM (200 µL, 0,5M) and sonicated for 5 minutes. 
After, LiOAc (30%) and cynnamaldehyde 45a (0,1 mmol, 1 eq.) are added to the solution. 
Finally, dimethylmalonate 46a (0,3 mmol, 3 eq.) is added and the solution is stirred for 16h. 
Finally, the reaction is diluted with MTBE (1 mL, 3 times) and centrifugated (5 min, 5000 rpm, 
3 times). The organic layer is collected, the catalyst is washed with H2O, MTBE ad 
concentrated under vacuum. After the solvent is recharged for a new reaction with recycled 
catalyst.  
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CSP-HPLC separation condition for adducts 47: 
 
47aa: IC, Hexane : i-PrOH 80:20, 0.5 mL/min, 40°C, t1: 16,77 min, t2: 25.01 min 
 
47ba: AD, Hexane : i-PrOH 80:20, 0.5 mL/min, 40°C, t1: 25,25 min, t2: 31.48 min 
 
47ca: IC, Hexane : i-PrOH 80:20, 0.5 mL/min, 40°C, t1: 14,02 min, t2: 15.55 min 
 
47da: IC, Hexane : i-PrOH 70:30, 0.5 mL/min, 40°C, t1: 12,83 min, t2: 15.06 min 
 
47ab: IC, Hexane : i-PrOH 70:30, 0.5 mL/min, 40°C, t1: 11,49 min, t2: 16.99 min 
 
 47ac: IC, Hexane : i-PrOH 70:30, 0.5 mL/min, 40°C, t1: 12,75 min, t2: 16.92 min 
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